<?xml version="1.0" encoding="utf-8"?>
<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd"><eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511"><eadid>FA1103A.xml</eadid><filedesc><titlestmt><titleproper type="filing">Rockefeller University collection of The Medical Letter publication, 1996-2004</titleproper><titleproper>A Guide to the Rockefeller University collection of The Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper></titlestmt><publicationstmt><publisher>Rockefeller Archive Center</publisher><address><addressline>15 Dayton Avenue</addressline><addressline>Sleepy Hollow 10591</addressline><addressline>archive@rockarch.org</addressline><addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline></address></publicationstmt></filedesc><profiledesc><creation>This finding aid was produced using ArchivesSpace on <date>2020-06-25 00:05:39 -0400</date>.</creation><descrules>Describing Archives: A Content Standard</descrules></profiledesc></eadheader><archdesc level="collection">
  <did>
    <langmaterial>
      <language langcode="eng">English</language>
    </langmaterial>
    <repository>
      <corpname>Rockefeller Archive Center</corpname>
    </repository>
    <unittitle>Rockefeller University collection of The Medical Letter publication</unittitle>
    <origination label="Creator">
      <corpname role="aut" source="naf">Rockefeller University</corpname>
    </origination>
    <origination label="Creator">
      <corpname role="aut" source="naf">Medical Letter, Inc</corpname>
    </origination>
    <unitid>FA1103A</unitid>
    <physdesc altrender="whole">
      <extent altrender="materialtype spaceoccupied">131.21 Cubic Feet</extent>
    </physdesc>
    <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
  </did>
  <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
    <head>Processing Information</head>
<p>Minimal processing</p>  </processinfo>
  <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
    <head>Preferred Citation</head>
<p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>  </prefercite>
  <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
    <head>Conditions Governing Access</head>
<p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>  </accessrestrict>
  <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
    <head>File Plan</head>
<p>Former Classification: I 891-U</p>  </fileplan>
  <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
    <head>Other Finding Aids</head>
<p>For additional Medical Letter materials open for research see:</p><p>FA241 Rockefeller University collection of the Medical Lettter publication</p>  </otherfindaid>
  <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
    <head>Scope and Contents</head>
<p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>  </scopecontent>
  <bioghist id="6c159867ba2a2151b8b7399752c3890b">
    <head>Biographical / Historical</head>
<p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>  </bioghist>
  <dsc><c id="722d135ab2e6b9a0415068e6118db069" level="file"><did><unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="1080971ef0169cd39024ce7ed6b25bff" label="Mixed Materials [A0000000075844]" type="box">1</container><container id="611016821e00a7722f1a0c593f156798" parent="1080971ef0169cd39024ce7ed6b25bff" type="folder">1-4</container></did><accessrestrict id="6413d819e0f61297a55139d343bc6b2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e0dd5900ff39bfca71872aabc11f428" level="file"><did><unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="ffb7ea509dbb95712436bdc1345b784c" label="Mixed Materials [A0000000075844]" type="box">1</container><container id="ee3d8ed9996ee326842411d33ea2f734" parent="ffb7ea509dbb95712436bdc1345b784c" type="folder">5-7</container></did><accessrestrict id="656f8049cade326890b44a882a172390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file"><did><unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="10ff07d46d7f0db65aa3c3e3e6a5c545" label="Mixed Materials [A0000000075844]" type="box">1</container><container id="a394ef1ff3316e67a9144d94bf5d7049" parent="10ff07d46d7f0db65aa3c3e3e6a5c545" type="folder">8-12</container></did><accessrestrict id="ca3616172a78ef218806617937be4ae3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="299c68349552c9c16b93a8a4762f739e" level="file"><did><unittitle>TML, 38-35 - New drugs for HIV</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="31554596c27ab2cfebfd95a085bc3e3e" label="Mixed Materials [A0000000075844]" type="box">1</container><container id="aa75387f3a7a5f296e3f81a396e76891" parent="31554596c27ab2cfebfd95a085bc3e3e" type="folder">13-17</container></did><accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="db1390d27116c924754f13d0f0457f7d" label="Mixed Materials [A0000000075844]" type="box">1</container><container id="faf964e78ea8fb0ab109a1002831837e" parent="db1390d27116c924754f13d0f0457f7d" type="folder">18</container></did><accessrestrict id="6490910db6cb9773d516babe0e3ba2c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="25c672276d8de231f00bfa483bb42cb2" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="17a1b17d8484e0b4442a0392ae0a4d54" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="f71d1e21d0d5ce474d3b584ce32b63ac" parent="17a1b17d8484e0b4442a0392ae0a4d54" type="folder">1-3</container></did><accessrestrict id="2d841e9b213eca4386b5020a0f960ab2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="520cba0819f4d1a661ffbae9d84a72d2" level="file"><did><unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="c1627b909770c3e7dc7bdf20f27766bd" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="6ba3bea785d93f36f731187d278da976" parent="c1627b909770c3e7dc7bdf20f27766bd" type="folder">4-6</container></did><accessrestrict id="391e7265783eb309c372f58724caf420"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b466c2ae20545eb902a029aabfadd4a2" level="file"><did><unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle><unitdate type="inclusive">1996 March 29</unitdate><container altrender="Record Storage Box (Paige)" id="b7249bbb0e095af71681af024fff079c" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="134f2ad77d62382c6a38a9d286ac714d" parent="b7249bbb0e095af71681af024fff079c" type="folder">7-9</container></did><accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ef71891079fc8afb056a13746e052f75" level="file"><did><unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle><unitdate type="inclusive">1996 August 30</unitdate><container altrender="Record Storage Box (Paige)" id="ccec2c19b7455b1c0802def7341bf34a" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="5b82f61272ef46c100b9d15f5768e063" parent="ccec2c19b7455b1c0802def7341bf34a" type="folder">10-16</container></did><accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="630284f8fa9310d4604f35f82942ec99" level="file"><did><unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="6df4cc42bc0ecb87c4d69d9413c3f9b3" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="f1c2d2d0f29413c05933c2c23a6584ef" parent="6df4cc42bc0ecb87c4d69d9413c3f9b3" type="folder">17-18</container></did><accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="188d21cdc0a939e7c90e5d717239c56b" label="Mixed Materials [A0000000075845]" type="box">2</container><container id="cb4a88afcb4fc22565973c3ce73aa3b9" parent="188d21cdc0a939e7c90e5d717239c56b" type="folder">19-20</container></did><accessrestrict id="c9d5e1a415d2921805aa74b729504b02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="bbe1ff3dc2ee1611595e7ea27d1f90b5" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="f1842499efa3937be87780df4ea2d467" parent="bbe1ff3dc2ee1611595e7ea27d1f90b5" type="folder">1</container></did><accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e8440ccfa5de303b70df4a8556b7da1" level="file"><did><unittitle>TML, 38-103 - Bone Density Testing</unittitle><unitdate type="inclusive">1996 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="3f697834e2ed83d81240130b54839254" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="cedc187c3d9a2879b626743b11e02e3e" parent="3f697834e2ed83d81240130b54839254" type="folder">2-3</container></did><accessrestrict id="9371d9820f979006c113e8341494696d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2bc3e056d1f8fa2492e7303d95310131" level="file"><did><unittitle>TML, 37-109 - Dirithromycin</unittitle><unitdate type="inclusive">1995 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="97dc31de95452b0ee3d33fab52938f11" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="dce55d67e31f5fcd44406ecac6c0aa89" parent="97dc31de95452b0ee3d33fab52938f11" type="folder">4-7</container></did><accessrestrict id="70e63df474c05d465a52ed6834a63c2e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="404e68490aeea4bc03276bd2e1972297" level="file"><did><unittitle>TML, 38-108 - Calcium Supplements</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="a8573e96675d5020cc1fd629d4874a72" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="4bf31f3ed8a3786583ce21df664783b3" parent="a8573e96675d5020cc1fd629d4874a72" type="folder">8-12</container></did><accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="787f855d64193a39aa5fa640c29b09f9" level="file"><did><unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="7ebf6291e18eb3551ed851464a2712fe" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="6dae4fed88351cfd6ea183b36dac6064" parent="7ebf6291e18eb3551ed851464a2712fe" type="folder">13-16</container></did><accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="6ee9fed32bd765fba31910157fc457da" level="file"><did><unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="b86215dd2c0eca1c5c578d90274f86a9" label="Mixed Materials [A0000000075846]" type="box">3</container><container id="ffbcc229b13c2d9e686da5ba95e9cbf1" parent="b86215dd2c0eca1c5c578d90274f86a9" type="folder">17-19</container></did><accessrestrict id="fe428baa314a27bf86569a7a685bf75c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file"><did><unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="cf71f281ad5e0050d05d23a04c5e93a7" label="Mixed Materials [A0000000075847]" type="box">4</container><container id="4e33ac24308eb7999b071742bd50217c" parent="cf71f281ad5e0050d05d23a04c5e93a7" type="folder">1-4</container></did><accessrestrict id="cd47248ae2cfc55d2fb4424654263054"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file"><did><unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="613d2405cf868d502e946c2f262791ad" label="Mixed Materials [A0000000075847]" type="box">4</container><container id="bf617b1c527e4a48fee3d869a96f271d" parent="613d2405cf868d502e946c2f262791ad" type="folder">5</container></did><accessrestrict id="2fb3ed462271aeec0fb14801053de435"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9050bc8c28970ad791e377582e9c079c" level="file"><did><unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle><unitdate type="inclusive">1996 August 2</unitdate><container altrender="Record Storage Box (Paige)" id="08855b27bfd80184af3e518347828aad" label="Mixed Materials [A0000000075847]" type="box">4</container><container id="f8d645247d1953854b51dd2778dba264" parent="08855b27bfd80184af3e518347828aad" type="folder">6-13</container></did><accessrestrict id="88da501863cd117b47bcae321e4b3b00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="5c5e7299af1de05e46453f0fea0e1720" level="file"><did><unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="868618063d67cb7b1b66e3a470753f11" label="Mixed Materials [A0000000075847]" type="box">4</container><container id="0224e2da3aa61f075254588eae6b6dc0" parent="868618063d67cb7b1b66e3a470753f11" type="folder">14-18</container></did><accessrestrict id="0f7c6d142759503d2196573bb0b89f9a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0f91362447d7a3cdff68d7ebac520b38" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="66d23b934c872301c13374ddea21e1f5" label="Mixed Materials [A0000000075847]" type="box">4</container><container id="4d41515e882ebe91794a6dad09f7512b" parent="66d23b934c872301c13374ddea21e1f5" type="folder">19-20</container></did><accessrestrict id="4e5c9545497b1cea799d01d6d8e16965"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c714362a04b8f852b521155e586e0af2" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="504e568c059e5215b6e08806b9e6a1ec" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="cb6f040806dbbeaf03e3ef8d30afb9eb" parent="504e568c059e5215b6e08806b9e6a1ec" type="folder">1</container></did><accessrestrict id="a545b57ddc41b86449988949e310c707"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="484f5bda82347b92c1fd763adae1bf8a" level="file"><did><unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="e034f1b89aa2a3b8efb3bc9c2825a39f" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="376afc722e560acc38a5e1e6c19d1c2a" parent="e034f1b89aa2a3b8efb3bc9c2825a39f" type="folder">2-5</container></did><accessrestrict id="0ae4223f8a683f538d4cd77c366f1250"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8d0423127d33593f9f53a6262dc9f97c" level="file"><did><unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="17985e0a8c975b4c535f89d5df5f6747" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="a8abaf0d88f93b36075c0e758be5e126" parent="17985e0a8c975b4c535f89d5df5f6747" type="folder">6-8</container></did><accessrestrict id="ed7cc80f5cac6080418667469e63fcc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="a348057f4e83121c70f8e63e18862273" level="file"><did><unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="8107e23f7ed7ec1acf70697e1d0445a5" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="d07c08b123efdae9b322cd1c5cd4c031" parent="8107e23f7ed7ec1acf70697e1d0445a5" type="folder">9-10</container></did><accessrestrict id="9060f4c1941e62cde507283711c42123"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4fb37dc500fa2658eede9f802e9df8f8" level="file"><did><unittitle>TML, 38-95 - Fexofenadine</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="763c36fd6e8189e5e9b43ce8e4793b3f" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="e3409045b5864a23f0d86dee7b0171fe" parent="763c36fd6e8189e5e9b43ce8e4793b3f" type="folder">11-12</container></did><accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="64be8e3eb6b9a7f019087998bc44abd8" level="file"><did><unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle><unitdate type="inclusive">1995 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="f958d4dd24a1206f0ac2485581150a97" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="2358100268d7732818842323c2c1e208" parent="f958d4dd24a1206f0ac2485581150a97" type="folder">13-16</container></did><accessrestrict id="695bcbd1bf632b907b932d7960966f9f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="3b56a8ab207b90baa9893a8239e6ce7f" label="Mixed Materials [A0000000075848]" type="box">5</container><container id="1e8105cc5791310bc0c9a539a0d9c190" parent="3b56a8ab207b90baa9893a8239e6ce7f" type="folder">17-21</container></did><accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="35c106caf84841f600db741ede502382" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="2d0fe009dff85c76abeb2d59dde7a6d6" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="f04bb77bf47972aa8a331a2466630d60" parent="2d0fe009dff85c76abeb2d59dde7a6d6" type="folder">1</container></did><accessrestrict id="f54d8351e9c7683733c760ddc9c6386f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9c02c90545e46d220940cf2a507e0a28" level="file"><did><unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="2d3836dfaeb41f34ac77c0058336152c" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="36d363b226151043591f51460bad4af2" parent="2d3836dfaeb41f34ac77c0058336152c" type="folder">2-3</container></did><accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file"><did><unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="9f2f4b6c196163d10656ffb82bea6e64" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="b321a7a4f00d119330179d379d7a1fc8" parent="9f2f4b6c196163d10656ffb82bea6e64" type="folder">4-6</container></did><accessrestrict id="7105d2dd194378e7c1b806e1786142c0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="237f462175824d3b36e04281c83344ac" level="file"><did><unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="f738bf7a90b84749cb0cbf2133a225b1" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="546650eaabeeaf131707f655706f70be" parent="f738bf7a90b84749cb0cbf2133a225b1" type="folder">7-8</container></did><accessrestrict id="d0c68415f609b87b8e322217b54f482b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file"><did><unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="7cba2fd45a87bddef827a8e649c3099f" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="629d1d26b80d72af98583956c972d38f" parent="7cba2fd45a87bddef827a8e649c3099f" type="folder">9-13</container></did><accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="df185de80953b9ba72734fc53563026f" level="file"><did><unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle><unitdate type="inclusive">1995 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="014fdb66a131da85f7edb03a4804c117" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="c08740b4600ba35669adc32ae85987a8" parent="014fdb66a131da85f7edb03a4804c117" type="folder">14-16</container></did><accessrestrict id="ee2185b1e98265927be53db9e0fa2dda"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9ea393808d7941a34a9237ff7d3e21d0" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="ef9c506b8b079b9da32c1efe5a7cffb7" label="Mixed Materials [A0000000075849]" type="box">6</container><container id="314072d51451a106c5f37b66aeb2c3f5" parent="ef9c506b8b079b9da32c1efe5a7cffb7" type="folder">17-20</container></did><accessrestrict id="052ebcc34a91845237e97c0df53775e3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b5728f730c61991eb3d049832355c05c" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="c69f661dc7b010f6cead7eb2951be049" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="e62ba8844a39c8e4e0cb20dcf7b5a5cd" parent="c69f661dc7b010f6cead7eb2951be049" type="folder">1-2</container></did><accessrestrict id="8725ceb0317248c73c37ce2386f5e01b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="34fded3e81407289cef7298c43db888c" level="file"><did><unittitle>TML - Drugs of Choice - Pain</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="6caab23b1d308bd9e36070d396813c43" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="ca740e7507c0854d9798e1c0f6f3d39a" parent="6caab23b1d308bd9e36070d396813c43" type="folder">3-7</container></did><accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="73f114dc6e630afb990634a443031d95" level="file"><did><unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle><unitdate type="inclusive">1995 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="9a6a0778e72b38faf1f7ced874c9361d" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="d5477b0c201a6fb8c7a8dd14234707f7" parent="9a6a0778e72b38faf1f7ced874c9361d" type="folder">8-10</container></did><accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3ff759a8063b390ff0175205e40649d" level="file"><did><unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="5adeb7ac0e41d3ae7150a43b75d779fd" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="fc77439d0412e12c96e47e748dc13427" parent="5adeb7ac0e41d3ae7150a43b75d779fd" type="folder">11-13</container></did><accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file"><did><unittitle>TML, 38-17 - Advice for Travelers</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="be9430e488398bdb75fa7f41cc20f034" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="aefc97ba9f5dcaa2bc59de5722983efe" parent="be9430e488398bdb75fa7f41cc20f034" type="folder">14-16</container></did><accessrestrict id="c3bea7a676bd5b9981068ccf42242297"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="314ebfe0a12d0bad31002df2bbabf782" level="file"><did><unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle><unitdate type="inclusive">1995 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="1be5a0672976e7a9c3ac55b72c03211a" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="5a1989a273a846b2bb6415bdfde366d6" parent="1be5a0672976e7a9c3ac55b72c03211a" type="folder">17</container></did><accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="fa30b8e25d30bd60ee7b9207731748dd" level="file"><did><unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="5dc01799c5ef141f29688c34528ce645" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="bca08d59d2d31ca75f71c9c16358e5f2" parent="5dc01799c5ef141f29688c34528ce645" type="folder">18</container></did><accessrestrict id="5726a4d76a933c3152d68d2618f96f58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="76dcb6a56a7b5f83636afb906304e3de" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="b177d897e7daeab677f8445e65f0d872" label="Mixed Materials [A0000000075850]" type="box">7</container><container id="de26198a7d94765576e333e11501b97c" parent="b177d897e7daeab677f8445e65f0d872" type="folder">19</container></did><accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="cb5601be1597ec4dbbe0054142768af1" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="ff88ea5bbc13cb99ed8b134fc1ef84f2" parent="cb5601be1597ec4dbbe0054142768af1" type="folder">1-4</container></did><accessrestrict id="5afb2bc4dd74607653137719b41bcbd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file"><did><unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="3628b9d554604ce60769316d29b01386" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="c3b1735be564b5e1953361512279c122" parent="3628b9d554604ce60769316d29b01386" type="folder">5-6</container></did><accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c90350a57c09afa4b1edf8990faf82c4" level="file"><did><unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="451155030715d9aac8d26a804bf77402" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="18b891d04cb767e336e3a6272578527f" parent="451155030715d9aac8d26a804bf77402" type="folder">7-10</container></did><accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="838bd206e5b57f1350c9a04ae42f2583" level="file"><did><unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="5d2f258b74ed731c67f880cc15f4e12f" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="4057916b135f58307e500627e93573da" parent="5d2f258b74ed731c67f880cc15f4e12f" type="folder">11-14</container></did><accessrestrict id="2e48e9ac6a735700c373ee378f599caa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="45a205e5a189cb71c6708535b75c4937" level="file"><did><unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="3953c31a8338bd41008b7dc377d5be77" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="36d079043e378715bb811d4e1e9746f7" parent="3953c31a8338bd41008b7dc377d5be77" type="folder">15-16</container></did><accessrestrict id="0c7d5401af543b0c0983defbe212a6e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2cbe2967f283fa20d7d713e0125238d8" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="f8893eb6979e5a6b7fe33fe936cde62b" label="Mixed Materials [A0000000075851]" type="box">8</container><container id="ba4f5098140893d6d8e1d7ae8d2539cd" parent="f8893eb6979e5a6b7fe33fe936cde62b" type="folder">17-18</container></did><accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f7093bc2141bbd10998f3dc5ff41875b" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="68ca8899916dd4680327e22a6ffd5f16" label="Mixed Materials [A0000000075852]" type="box">9</container><container id="d0127481097c8c0c830e0d9f5ac9b1cb" parent="68ca8899916dd4680327e22a6ffd5f16" type="folder">1-3</container></did><accessrestrict id="5de98fca91cbe16591ff580840223c8c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file"><did><unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="39fc1cdf2a6f2978a18079431c5f8681" label="Mixed Materials [A0000000075852]" type="box">9</container><container id="9c2081d9c24b4bb61f349263e25246d6" parent="39fc1cdf2a6f2978a18079431c5f8681" type="folder">4-7</container></did><accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0ab086d0742f0a6f31a054d358cbefcf" level="file"><did><unittitle>TML, 35-62 - Nedocromil for asthma</unittitle><unitdate type="inclusive">1993 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="ad2813e6db623f4196413aea2575849e" label="Mixed Materials [A0000000075852]" type="box">9</container><container id="b234504aa79d57eeb393e374ae3eb950" parent="ad2813e6db623f4196413aea2575849e" type="folder">8-12</container></did><accessrestrict id="d876b6e0e035d2d97ee9711f878a831c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9f3042b173404cf6a3ccd9df900d20c0" level="file"><did><unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="e2f9d05c27f3a068fe546a714fec696d" label="Mixed Materials [A0000000075852]" type="box">9</container><container id="49d03d72060e76276026c3e366a5c6ef" parent="e2f9d05c27f3a068fe546a714fec696d" type="folder">13-18</container></did><accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file"><did><unittitle>TML, 38-53 - Prostatron</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="24c678fa1e6fa740ea5c8fee2b3613db" label="Mixed Materials [A0000000075852]" type="box">9</container><container id="f1a6154a2516afd8a5ef5fb763e7c2bb" parent="24c678fa1e6fa740ea5c8fee2b3613db" type="folder">19-20</container></did><accessrestrict id="fa8555c81ed0ff184e52c7e939db327c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file"><did><unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="5035336e2deb3ba7af10cfb0765cc007" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="9167e9dddd7d14d59e83edd83b31fcf2" parent="5035336e2deb3ba7af10cfb0765cc007" type="folder">1-3</container></did><accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c1416d4fc58c7899cbc27ca73d15c172" level="file"><did><unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="17cc9dca1bbf9cb8b7ed924f5fd7ed0b" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="f4844652885b0751966fa988049cfa2a" parent="17cc9dca1bbf9cb8b7ed924f5fd7ed0b" type="folder">4-5</container></did><accessrestrict id="76d78aedee8d1ddf219a07affe27bb10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="26af25957e59124a08f91eba499fc700" level="file"><did><unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="30f07b7b80444b07a549270e71ce9fb9" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="be08e8de0c775d8339c6bcbbd74572af" parent="30f07b7b80444b07a549270e71ce9fb9" type="folder">6-7</container></did><accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4273a72d699f99aeabfcab12d5bde513" level="file"><did><unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="3899ef9a120cac7f3d2db4fcfc97e386" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="22feae273c78e1af784ebe144b244c06" parent="3899ef9a120cac7f3d2db4fcfc97e386" type="folder">8-11</container></did><accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="afa8fcead3849c57e46148fac07fdf16" level="file"><did><unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="adfe99128f1e2126f64d80163178c5a3" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="21e309d49172a952d9a0232f4b5d25c6" parent="adfe99128f1e2126f64d80163178c5a3" type="folder">12-15</container></did><accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e83fc33c009862fb85873ce44225451e" level="file"><did><unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="5121ee2711d397e62aa103865ca912d7" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="e2ca8dc16882c6bd2653e0cb34f7f272" parent="5121ee2711d397e62aa103865ca912d7" type="folder">16-18</container></did><accessrestrict id="f4f4ca0b76dee28258679841660c3e53"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="1d1e2499f47a2c5a2498c508251c060e" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="413baa905e1e5d0644c8a891fcc98d19" label="Mixed Materials [A0000000075853]" type="box">10</container><container id="6bd29e6faab969f7ae9afa93991e112f" parent="413baa905e1e5d0644c8a891fcc98d19" type="folder">19</container></did><accessrestrict id="5e026f0f926c42121383574e48a743ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3cd99c272218799e02c72a5e28f33c9" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="c9b42de82f56c236ee93054cfee477ed" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="1ec513f1cacd1fb976bfbc02d35da41e" parent="c9b42de82f56c236ee93054cfee477ed" type="folder">1-2</container></did><accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2146f075bfb01adf0c99fddbe6268b26" level="file"><did><unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="36202b3115891c0f45847fee4a50e4f5" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="e4e0f40e26960cbf716e6fe3b876c648" parent="36202b3115891c0f45847fee4a50e4f5" type="folder">3-5</container></did><accessrestrict id="a1dd4aa7256167e609397b035b7478d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7a2f268994b16b4876604d64167ade0b" level="file"><did><unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="b4e8147a2c585569387bc0bbc7bb719a" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="f8c03fabb2a637f12d5ccd2a8e7208c5" parent="b4e8147a2c585569387bc0bbc7bb719a" type="folder">6-8</container></did><accessrestrict id="c284795ebfbae6dd142f49e2c3d64449"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file"><did><unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="ef8046ebcc710598f3f4a374486bffed" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="a27e1daf38f13ff30d3bac85e0ee19b1" parent="ef8046ebcc710598f3f4a374486bffed" type="folder">9-11</container></did><accessrestrict id="d93e4e485f03621de43519409ecd0ebb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d2847f832cf8b7dfa8bae10d4079561b" level="file"><did><unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="e1b97c45e37af134754ad0401c429b0b" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="dbea807f2c59df8e55ec0121dd6d3598" parent="e1b97c45e37af134754ad0401c429b0b" type="folder">12-14</container></did><accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="07f911d357717fedb196ba2a95b08c6f" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="60b8599d862e7252c5547d0ba8464fc1" label="Mixed Materials [A0000000075946]" type="box">11</container><container id="f47c7ec16d5c146bd5481349a5c3cb4c" parent="60b8599d862e7252c5547d0ba8464fc1" type="folder">15-19</container></did><accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="a66c553218197f9d80cfce798ea2227f" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="67f5794d4412ce323911596304788bc4" parent="a66c553218197f9d80cfce798ea2227f" type="folder">1-2</container></did><accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file"><did><unittitle>TML, 38-65 - Drugs past their expiration date</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="de4f3cfc1415abb856d3247d7b9a4904" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="1e6fdadb39fce5b736bdfa0c676867a2" parent="de4f3cfc1415abb856d3247d7b9a4904" type="folder">3-4</container></did><accessrestrict id="861175c1c60e1d08ff94909fca12e380"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file"><did><unittitle>TML, 38-38 - Ibutilide</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="37d99699cfaf3a6c8006da738fffc3f8" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="7e142c557f38e46ebe3bf26fc82ef7ae" parent="37d99699cfaf3a6c8006da738fffc3f8" type="folder">5-6</container></did><accessrestrict id="d854aa1bc446941f011a8970567a2b37"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="93c5ceb8486269a6440d4a1164bd8a19" level="file"><did><unittitle>TML, 38-91 - DHEA</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="8653adc795e8f94435cb57016ae0ce2c" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="17b2052412216d56bd4e9d07184cde12" parent="8653adc795e8f94435cb57016ae0ce2c" type="folder">7-9</container></did><accessrestrict id="0b753cb331038a0a1193ae254361f43e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="489aaa51c24f7c3822366d6381860b83" level="file"><did><unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="46528c2ed21ab0368b11a94008d41d30" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="4488abe981133e9023811b388d50e5e7" parent="46528c2ed21ab0368b11a94008d41d30" type="folder">10-14</container></did><accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="3a54f51aec4a83bee985f1670be2aff6" level="file"><did><unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="13caeaa474c63c2c64de012884a66114" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="01e0d7b15d0ab4cf637cd1def888c9b5" parent="13caeaa474c63c2c64de012884a66114" type="folder">15</container></did><accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="43193a32312eb0204d12fd64fa6b6993" level="file"><did><unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="f35f1952d986dfb57e57feb8ce9ebc7c" label="Mixed Materials [A0000000075854]" type="box">12</container><container id="5bc32448e241f4bffdf48d135a480a51" parent="f35f1952d986dfb57e57feb8ce9ebc7c" type="folder">16-18</container></did><accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="49b7007dcadc3c636c88f299dc526e0d" level="file"><did><unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="2ae401646a1b66d368e1b89ec6407dcb" label="Mixed Materials [A0000000075855]" type="box">13</container><container id="be7365cd98df349108c434459505d1c3" parent="2ae401646a1b66d368e1b89ec6407dcb" type="folder">1-3</container></did><accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="61b0c640e3f013a34c64133724020fa2" level="file"><did><unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle><unitdate type="inclusive">1997 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="6b62f87f802021e93c2382a649e40df9" label="Mixed Materials [A0000000075855]" type="box">13</container><container id="0ec88adaa95011ca2d8c3522397f6787" parent="6b62f87f802021e93c2382a649e40df9" type="folder">4-12</container></did><accessrestrict id="84c4988675afd57f7b095139aa7bfdfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="133977107f40fa3272c401b7abcc89de" level="file"><did><unittitle>TML, 39-18 - Zileuton for asthma</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="99dffc0c2cf0dbc763ed3e9d90e1e6f5" label="Mixed Materials [A0000000075855]" type="box">13</container><container id="acdef37e029c782464b97f8806ef1e87" parent="99dffc0c2cf0dbc763ed3e9d90e1e6f5" type="folder">13-14</container></did><accessrestrict id="4717fa288dd120e806e05499350ddf6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be46a606b805462c6cc03b6ec8b2c39e" level="file"><did><unittitle>TML, 39-9 - Zinc for the common cold</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="a5a57d59561c878e79807c30fcc10731" label="Mixed Materials [A0000000075855]" type="box">13</container><container id="660487ed24cbc84b4a8235a8063a192f" parent="a5a57d59561c878e79807c30fcc10731" type="folder">15-17</container></did><accessrestrict id="ad1088be46d6652eb0405e32258a0bf9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="4fba9a191d2a4f7380210c7cddb0eaca" label="Mixed Materials [A0000000075855]" type="box">13</container><container id="eff981619ce94450bfc66d183f3248c2" parent="4fba9a191d2a4f7380210c7cddb0eaca" type="folder">18-20</container></did><accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c3fee2e8cf6e2d58695098807e086dab" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="93fe1b022a00c1b12e4debabe7d9eb69" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="c1c26f948dda1bcb42d678c5402dad3a" parent="93fe1b022a00c1b12e4debabe7d9eb69" type="folder">1</container></did><accessrestrict id="898d939f278bc6e6c335eb092f07c5a8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="393de6e6b75d4f4817695af30349dd68" level="file"><did><unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="f4c86c97d8e6bf54b8b3dfce1a7b3fb4" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="1ef3428d92ac4e2ae7ee4fecf5602ea7" parent="f4c86c97d8e6bf54b8b3dfce1a7b3fb4" type="folder">2-4</container></did><accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="4be741eb1bacb7f18527f5b2df647302" level="file"><did><unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="e445f7765ab95e8ccba985339b3979f9" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="b5672fbb250be8b2972769c8f28fd022" parent="e445f7765ab95e8ccba985339b3979f9" type="folder">5-10</container></did><accessrestrict id="7550d2d00d3b056285daa384c568544b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b81fc7aadd5fecc407e846095655da0e" level="file"><did><unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="8afa61966b3a3f50e137499fdc11cf9f" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="a54406682ed6ea5474e57652c2d1342f" parent="8afa61966b3a3f50e137499fdc11cf9f" type="folder">11-15</container></did><accessrestrict id="0f1f31dc544a7820b6b3740572840e2c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d6a872b6263ad2beca76d2809d741c78" level="file"><did><unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="229413c52ad46738bf62f3e52dfa2500" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="60cb267bd77b7b08ee16af5c15c237dd" parent="229413c52ad46738bf62f3e52dfa2500" type="folder">16</container></did><accessrestrict id="37b13c54d0d04ba5299304f96256cfc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="62572ae54e7b47c32783a5b7f9f92261" level="file"><did><unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="fffc69f692a64e6b8eaa2c785145be1a" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="a3a499083d129898d2979b72769bf8a5" parent="fffc69f692a64e6b8eaa2c785145be1a" type="folder">17-19</container></did><accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bbfc9de7adb6df0701f6173947f38bd2" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="398fd24eae24bd6ca4d7367b595dcb34" label="Mixed Materials [A0000000075856]" type="box">14</container><container id="6f0537c3858a6879fd1944ade8c8d02f" parent="398fd24eae24bd6ca4d7367b595dcb34" type="folder">20</container></did><accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6b378b12b2f16c81d85d36343d81a41b" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="93385b1115ec2f7fda736111ebf8b93c" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="e040cbeb6bcd1b9dd1eee683a8e76fcc" parent="93385b1115ec2f7fda736111ebf8b93c" type="folder">1-2</container></did><accessrestrict id="62290c3388efd25a1b03329c60a4c2c5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bf256a51de793456a4c7d083f141288c" level="file"><did><unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="2bb45849993d10357019d8606f829724" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="b9db7b80bc5f37346eee9a152807e187" parent="2bb45849993d10357019d8606f829724" type="folder">3-5</container></did><accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e50c791d98c44790d8141d27cd4cfcab" level="file"><did><unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="5c43053705b523e7b1401ad5d304bfcf" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="f7369f9eeaa4477e53340e27d5f7b71c" parent="5c43053705b523e7b1401ad5d304bfcf" type="folder">6-8</container></did><accessrestrict id="264d6479c0b4544b7007e8c452a7cee5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12444cf584e83734f66bfc290040544a" level="file"><did><unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="e5b00d2dfc590ffed63a2b5cd4214112" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="b1b2363c34be30b22ff428859baa3ada" parent="e5b00d2dfc590ffed63a2b5cd4214112" type="folder">9-11</container></did><accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="64f0edfa5bd3b5159911a74e751d912b" level="file"><did><unittitle>TML, 39-43 - Valsartan for hypertension</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="d891833a3d833288bc02785a41b613c8" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="4165fdea51eb2a32f5936be1fe12e101" parent="d891833a3d833288bc02785a41b613c8" type="folder">12-14</container></did><accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eb014687998353d0fb60326357526127" level="file"><did><unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle><unitdate type="inclusive">1997 January 3</unitdate><container altrender="Record Storage Box (Paige)" id="493ea02d46f8cd2503723bd053874f30" label="Mixed Materials [A0000000075857]" type="box">15</container><container id="5af1f7551868f6fc47f8d210e57d305d" parent="493ea02d46f8cd2503723bd053874f30" type="folder">15-20</container></did><accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3436a17eac9c6f31692eb5d354b51a44" level="file"><did><unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="b2d2e54c9b501d193a52ff28cd760c62" label="Mixed Materials [A0000000075858]" type="box">16</container><container id="da15994ce340dddeb7ea632dfe0ec72a" parent="b2d2e54c9b501d193a52ff28cd760c62" type="folder">1-4</container></did><accessrestrict id="9f23fe9c137d23133c2b5049c5b64530"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file"><did><unittitle>TML, 39-105 - New drugs for psoriasis</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="8efffce1f02744e341bb35ef03e4ab9b" label="Mixed Materials [A0000000075858]" type="box">16</container><container id="6678f16b6f68e253176f9af64fb8d1ca" parent="8efffce1f02744e341bb35ef03e4ab9b" type="folder">5-8</container></did><accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file"><did><unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle><unitdate type="inclusive">1997 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="2a9e1b1cf21875554dc335e150db1d55" label="Mixed Materials [A0000000075858]" type="box">16</container><container id="c0838da1b447a99fc245487535a56cdb" parent="2a9e1b1cf21875554dc335e150db1d55" type="folder">9-15</container></did><accessrestrict id="dbaf4673299ed575f189876448054a58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="123a71748e8ade20af228276bab2d8b6" level="file"><did><unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="e33862e90cef0390b860ec52a4e60c66" label="Mixed Materials [A0000000075858]" type="box">16</container><container id="43ba4141a9c5b891744f1bb5a155d744" parent="e33862e90cef0390b860ec52a4e60c66" type="folder">16-18</container></did><accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="498df0f2d9dce92679b2aa347629be3f" level="file"><did><unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="ba9e84bf7398e2d0fe75ba4ebd4d4696" label="Mixed Materials [A0000000075859]" type="box">17</container><container id="6434826513e3a24f3b82f667e268e7cd" parent="ba9e84bf7398e2d0fe75ba4ebd4d4696" type="folder">1-2</container></did><accessrestrict id="b2dca34162d6868414a816046edfdff2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file"><did><unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="a7381d2af656c5fd2d2adb53bf292a09" label="Mixed Materials [A0000000075859]" type="box">17</container><container id="33a4805faed37ab58daf7f823bcb72b9" parent="a7381d2af656c5fd2d2adb53bf292a09" type="folder">3-5</container></did><accessrestrict id="6532d645696e8a65297e0563e103f695"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file"><did><unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="7e821c2a7ba01c19e67e63647d9461a8" label="Mixed Materials [A0000000075859]" type="box">17</container><container id="57d6a9706586dfab6ed8df9b50bf5aa2" parent="7e821c2a7ba01c19e67e63647d9461a8" type="folder">6-10</container></did><accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fdd2b028e08760f46ba2467c4b638924" level="file"><did><unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle><unitdate type="inclusive">1997 March 14</unitdate><container altrender="Record Storage Box (Paige)" id="52046b6fdb93f38602254af5397c6aa8" label="Mixed Materials [A0000000075859]" type="box">17</container><container id="17e2265961ff508c4167331d917fbecf" parent="52046b6fdb93f38602254af5397c6aa8" type="folder">11-16</container></did><accessrestrict id="28f03f207bd6c378f505103883232f68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="42935bf2b5b11b084838a1252d3b3db8" level="file"><did><unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="d79046c3648e9f880b50ed58c04aa253" label="Mixed Materials [A0000000075859]" type="box">17</container><container id="534a08b8cc1fdd7716a1176e2bac0eeb" parent="d79046c3648e9f880b50ed58c04aa253" type="folder">17</container></did><accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file"><did><unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="d31be7925714a4296665c583e84a85fe" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="140f2ce6b5bb16577a99c1bdc95c796b" parent="d31be7925714a4296665c583e84a85fe" type="folder">1-2</container></did><accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="856acb144bbba7a94b1cb63f73185f43" level="file"><did><unittitle>TML, 39-56 - Pentosan</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="ca49694cf65e0790a367de340ed3f3c7" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="554506501b6bc9f104efe0c500e29cf6" parent="ca49694cf65e0790a367de340ed3f3c7" type="folder">3-4</container></did><accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="afd34d20934d1be77bfc49f4d1241183" level="file"><did><unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="4f98ca40c604b5a05c016671cf6b5283" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="75743db53e2d59f4963d53a7c4254dca" parent="4f98ca40c604b5a05c016671cf6b5283" type="folder">5-8</container></did><accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="de42e2f43ebae331da9c0b8180abb87c" level="file"><did><unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="5aa236857ed1c6901dfb3f712a9d4150" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="171323d5df62d78bb6f54cb221fc0944" parent="5aa236857ed1c6901dfb3f712a9d4150" type="folder">9-11</container></did><accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="96ceef3812b648bc28698beed66c5d75" level="file"><did><unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="51e81204ce6efddbb03924dfa02f725b" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="f1eb6536501f9f79b02d9a8b973a2663" parent="51e81204ce6efddbb03924dfa02f725b" type="folder">12-14</container></did><accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eaedccce6a322747a43e566f8dfc2b7d" level="file"><did><unittitle>TML - Drugs of Choice</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="5e7054e6b6f382a9d26fbdd134d3e099" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="03f315f60f42c1c8c6b4aec1f35b83e3" parent="5e7054e6b6f382a9d26fbdd134d3e099" type="folder">15-17</container></did><accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95b6682482a9d062317fcf262cc7f718" level="file"><did><unittitle>TML, 39-85 - Influenza vaccine</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="43b4eb57108f59ff0e1e134675c51dc6" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="b9bf17a283e9086e567b1f765bcc8b55" parent="43b4eb57108f59ff0e1e134675c51dc6" type="folder">18</container></did><accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="9c5534af6d0a227ae1ad47876c813383" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="9827b01972373fe2ee7ca96b010737b0" label="Mixed Materials [A0000000075860]" type="box">18</container><container id="63d11f21286f68be541ec6aceaf9a9f5" parent="9827b01972373fe2ee7ca96b010737b0" type="folder">19</container></did><accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="c79cba575c72677f0fe19716c686ce59" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="517948042f0bf45c6689ab625d22c75d" parent="c79cba575c72677f0fe19716c686ce59" type="folder">1</container></did><accessrestrict id="36454ffdeab70b1b39646403fa3b2960"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0cdb2a091afd3228142c89eb37d2380a" level="file"><did><unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="1f95d8429a28888e2f874d997f8e39b8" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="f368b3644f5e7bb01b19834682e827ca" parent="1f95d8429a28888e2f874d997f8e39b8" type="folder">2-3</container></did><accessrestrict id="d975c63ad23263fd275260f9460dcf1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f4d2ffb826a588ff6c493adbd06a92be" level="file"><did><unittitle>TML, 39-64 - Drugs for epilepsy</unittitle><unitdate type="inclusive">1997 February 6</unitdate><container altrender="Record Storage Box (Paige)" id="2fb947c2dfa57a5a5fb7cf8674e75379" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="3cec3ce40d30aa272b2d0a47d56ecff6" parent="2fb947c2dfa57a5a5fb7cf8674e75379" type="folder">4-6</container></did><accessrestrict id="c20b70cbd97aa855e62537fb259a09f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="028b89ba84e332c879eab9899c191875" level="file"><did><unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="07b09c3a7574e29e27fea592204b811f" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="5532ed927349c2c1c147ea82441ee1b0" parent="07b09c3a7574e29e27fea592204b811f" type="folder">7-9</container></did><accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file"><did><unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="ada9b5b7bfdc18f520731d4227e4a217" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="60bb320959e2f77ae4e0661b57ff85be" parent="ada9b5b7bfdc18f520731d4227e4a217" type="folder">10-13</container></did><accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6bf77dfe11efd36cf8146b826560cb4c" level="file"><did><unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="a78b40960f8d4e090071f967997c729d" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="283e9055ec6abecd4f2423aa57e9fdcc" parent="a78b40960f8d4e090071f967997c729d" type="folder">14-16</container></did><accessrestrict id="58267fbb42c582dd03ac8830411c1803"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f36ff800dacbd73013d42dab42cf5f5b" level="file"><did><unittitle>TML, 38-6 - Drugs for head lice</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="8aee763709390a34e26057a0082246ec" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="f66064e63590fb1a92ba0a586803b9e1" parent="8aee763709390a34e26057a0082246ec" type="folder">17-18</container></did><accessrestrict id="92296119b0cbe67e59973a003090f421"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e13f3fa0ec576057f7033815a81111e1" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="37cd8043966cac6c82292c5673d41260" label="Mixed Materials [A0000000075861]" type="box">19</container><container id="a04399f0cb22127b79e85236d6a086c5" parent="37cd8043966cac6c82292c5673d41260" type="folder">19-20</container></did><accessrestrict id="e7cb03a6203eb58d2833529692c66d60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="74d631d9305a34ee3efd25d110461762" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="944a3084033df4e9c09593872369a8a1" parent="74d631d9305a34ee3efd25d110461762" type="folder">1-2</container></did><accessrestrict id="d913972842d3a79acf9b906df7f951e7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95d8be151e4ef26242db019df375f791" level="file"><did><unittitle>TML, 39-94 - Drugs for hypertension</unittitle><unitdate type="inclusive">1997 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="5f840c6d144a139a74ecf8741fa01346" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="3122a3b0cdd6c3815b6ee693f365ec35" parent="5f840c6d144a139a74ecf8741fa01346" type="folder">3-5</container></did><accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f8696aa81da52173ff18b97bd7eb4067" level="file"><did><unittitle>TML, 39-19 - Adapalene for acne</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="6d38fb1ef0f7236c6df7f0d300e6f191" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="498bd6c2ef4d092a53deb993d767f7a4" parent="6d38fb1ef0f7236c6df7f0d300e6f191" type="folder">6-7</container></did><accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file"><did><unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="3aba7617d4e4d8c83d81579efd9c13de" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="966a6c84beedc856f59a6d4750d62a37" parent="3aba7617d4e4d8c83d81579efd9c13de" type="folder">8-9</container></did><accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file"><did><unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="4de7cb91de526d2f391f428e6181481f" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="587ce5cd09e71278c149ebd5b6581663" parent="4de7cb91de526d2f391f428e6181481f" type="folder">10-13</container></did><accessrestrict id="2c8bdc164c637c083bf92b35d52554fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="36e76c3b20aacff333ba5d98cfca27de" level="file"><did><unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="58f0302071baf67bb53b571fa22f80c1" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="c178def2e916b8dd8282a001726d9b47" parent="58f0302071baf67bb53b571fa22f80c1" type="folder">14-15</container></did><accessrestrict id="55bd4c86ccf4811f99aac2673693e945"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e4ca902373c4579a78db0d3b8d513633" level="file"><did><unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="3d14bc535e0a71e2489fba2a744854d5" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="016fe7031173e8e42510db3077dfa39a" parent="3d14bc535e0a71e2489fba2a744854d5" type="folder">16-17</container></did><accessrestrict id="18bd5ce580d159e1acce03ad34266cc9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file"><did><unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="3430e9d4fac3b39a604a12b4bda6013a" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="a3ba75e55d9021221387fb8ff77b9196" parent="3430e9d4fac3b39a604a12b4bda6013a" type="folder">18-19</container></did><accessrestrict id="c12a956b010223394c6ca9d2025942d6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="56fc5093674d1372e80ed218ae8bd368" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="4a748e82d28e06c505c1f228948b63ff" label="Mixed Materials [A0000000075862]" type="box">20</container><container id="d7d6c05575ff2a35f7e989020c9dc738" parent="4a748e82d28e06c505c1f228948b63ff" type="folder">20</container></did><accessrestrict id="12b089183fda270bbeecc135b190b589"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1f85013ec13e639596b728f22f1aafc4" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="36099e01cc19969aaea54ddc69b290f8" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="5d8ca8e8bf727b1d8304f089a35678b8" parent="36099e01cc19969aaea54ddc69b290f8" type="folder">1-2</container></did><accessrestrict id="8a33d90a046f00da2d8b9b030020c09e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4a11be555144c67db801913b3a95361" level="file"><did><unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="91b49a64861d555e8271c806da14c4b4" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="ec1930ed2d338fc3a60522a7eee0bc90" parent="91b49a64861d555e8271c806da14c4b4" type="folder">3-6</container></did><accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file"><did><unittitle>TML - Dovonex</unittitle><unitdate type="inclusive">1993</unitdate><container altrender="Record Storage Box (Paige)" id="62fec96f42138a18155b277f7d726ba7" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="4c1b2fec8d045b18f4b213eb5436bdc1" parent="62fec96f42138a18155b277f7d726ba7" type="folder">7</container></did><accessrestrict id="7ed0890a439df753466be5a70bc31770"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file"><did><unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="b7401ed105eb4c5d782794ec7d165a79" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="50c1370433b6a80ca9e8af3e0f53c58a" parent="b7401ed105eb4c5d782794ec7d165a79" type="folder">8-9</container></did><accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0f25168045c3874b852fc2566864c22b" level="file"><did><unittitle>TML, 37-1 - Drugs for asthma</unittitle><unitdate type="inclusive">1996 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="68549987883cee365b621f66ed763602" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="27207a07c7f51f846c8c5305301a7dbc" parent="68549987883cee365b621f66ed763602" type="folder">10-14</container></did><accessrestrict id="5124cbd46d2a439f4f59c00468b6016b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="dbe0049fdc51d967d42b54af228c58ae" level="file"><did><unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="3aa9a7469dcba99d81881ae5b7595f4f" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="fb7b9bd6b2b6b318b40e3902577c6af9" parent="3aa9a7469dcba99d81881ae5b7595f4f" type="folder">15-16</container></did><accessrestrict id="108454fd852ec91b5893f1a78b4694b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3fff697896297fb5b3e546b99c7bb615" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="04a2aaf7f17f4208d52260b24f755667" label="Mixed Materials [A0000000075863]" type="box">21</container><container id="3efcd5d6641948524ebef04ab5a01c6a" parent="04a2aaf7f17f4208d52260b24f755667" type="folder">17-21</container></did><accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ac009d8a6eba90db98f499f6852dd496" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="89c75d53e4ab316385c64d2adffe948f" label="Mixed Materials [A0000000075864]" type="box">22</container><container id="68c7bff8102e66da67ef94128c406ade" parent="89c75d53e4ab316385c64d2adffe948f" type="folder">1-3</container></did><accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="364c7d8d424593144cdef790c4e94d75" level="file"><did><unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle><unitdate type="inclusive">1997 December 12</unitdate><container altrender="Record Storage Box (Paige)" id="6de401f3c94d7ea4670c9431ae985969" label="Mixed Materials [A0000000075864]" type="box">22</container><container id="9d4e68890435abdd89b40a78173c6b1e" parent="6de401f3c94d7ea4670c9431ae985969" type="folder">4-9</container></did><accessrestrict id="a96e0ada70322de7df279993ca3ff3a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file"><did><unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1997 October 24</unitdate><container altrender="Record Storage Box (Paige)" id="bac162a1a047bf8d988933d89e565bad" label="Mixed Materials [A0000000075864]" type="box">22</container><container id="76fb781b80d186461107cb7b783fa7ac" parent="bac162a1a047bf8d988933d89e565bad" type="folder">10-15</container></did><accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6568c1026445dec6f8e364671c21bd39" level="file"><did><unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="b72b0c3426dd6073304433c50ff227c5" label="Mixed Materials [A0000000075864]" type="box">22</container><container id="5202ab95feb8bb355b92bd6a3f2199e9" parent="b72b0c3426dd6073304433c50ff227c5" type="folder">16-18</container></did><accessrestrict id="8df589a9af326009da84ebecd5cf8932"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b0b4f71d2ecf84b337ced4a504f89306" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="b6dae8fd3a75422818aa342a7e63996b" label="Mixed Materials [A0000000075864]" type="box">22</container><container id="7e9a3ee0a13ff021f3ba866e9f9370aa" parent="b6dae8fd3a75422818aa342a7e63996b" type="folder">19</container></did><accessrestrict id="8df622f363be5b50961c92589e209dc4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="731b9cebf9fd2d940744b334653e6cd6" label="Mixed Materials [A0000000075865]" type="box">23</container><container id="92b1288f378c721742e4f07223d0408e" parent="731b9cebf9fd2d940744b334653e6cd6" type="folder">1-4</container></did><accessrestrict id="181d3a4b218653d1790e4861871f62dd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file"><did><unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="0ad4e248ae49a930a75dd1ff86de21ed" label="Mixed Materials [A0000000075865]" type="box">23</container><container id="a803cbfcbcb0524ba962e9455cb953a2" parent="0ad4e248ae49a930a75dd1ff86de21ed" type="folder">5-9</container></did><accessrestrict id="f5705dc19e306f206ec780b8d160e15c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3f1ba5c10401cadfc440c87da71224cb" level="file"><did><unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="f5aa98eb703446a3c739ebe887322db1" label="Mixed Materials [A0000000075865]" type="box">23</container><container id="3f9840c1aed015eaabc862d9cf07f9c8" parent="f5aa98eb703446a3c739ebe887322db1" type="folder">10-11</container></did><accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6311bd1ab3c17838b525980881eb7804" level="file"><did><unittitle>TML, 38-17 - Drugs for migraine</unittitle><unitdate type="inclusive">1995 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="9a3c81fedebe59a789ff766aedd19692" label="Mixed Materials [A0000000075865]" type="box">23</container><container id="7e375d9733fe0e4df40997b2a1839285" parent="9a3c81fedebe59a789ff766aedd19692" type="folder">12-16</container></did><accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d46efc5621917384073357b190321659" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="a1adf6ac49b57f4a6c9e6e6b70ee1f38" label="Mixed Materials [A0000000075865]" type="box">23</container><container id="07930ada30da0448a4b4c6689560fe82" parent="a1adf6ac49b57f4a6c9e6e6b70ee1f38" type="folder">17-21</container></did><accessrestrict id="663777121320adda427992b307d1db2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="2fa636d94ff69ee2ff2320c5edf04d90" label="Mixed Materials [A0000000075866]" type="box">24</container><container id="5253b1c902b5c4c44606d179b8edb946" parent="2fa636d94ff69ee2ff2320c5edf04d90" type="folder">1</container></did><accessrestrict id="702b01fd73a7deda0a72869d6f566a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="318ae2efe1275c93a47e9ae522f706ea" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="39f530a5bc85d261b0176264bccac4c7" label="Mixed Materials [A0000000075866]" type="box">24</container><container id="9e01eb52e86597d4242291a7645c3a2c" parent="39f530a5bc85d261b0176264bccac4c7" type="folder">2-3</container></did><accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file"><did><unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="c9a184f4fbe735a9e747c8e58d42c600" label="Mixed Materials [A0000000075866]" type="box">24</container><container id="a35a6cb42b7a4ae9667fb5265d40a93d" parent="c9a184f4fbe735a9e747c8e58d42c600" type="folder">4-6</container></did><accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file"><did><unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="fa7c2c52b06576960b056476de838893" label="Mixed Materials [A0000000075866]" type="box">24</container><container id="133fefa251189349305414736056a512" parent="fa7c2c52b06576960b056476de838893" type="folder">7-9</container></did><accessrestrict id="6a61863bdf42f359838de02eb3140260"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c2e1fc197d7490d826da206b516a38a5" level="file"><did><unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="eead0c9bf87add441a2b6dfc1502a8b1" label="Mixed Materials [A0000000075866]" type="box">24</container><container id="2a71ff87b7022270ef48a6900b18373b" parent="eead0c9bf87add441a2b6dfc1502a8b1" type="folder">10-16</container></did><accessrestrict id="5d151812a70ad7aab1e31b15864a8198"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fc12244326436c163ce3062f2ee5441e" level="file"><did><unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="28e0c3fe439ef2f7e686892ca299d0d2" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="3cb78220502d644be0783eff96ceffc1" parent="28e0c3fe439ef2f7e686892ca299d0d2" type="folder">1-3</container></did><accessrestrict id="010c90cf26351f4881154a4f6ad41ad3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file"><did><unittitle>TML, 40-113 - Citalopram for depression</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="7734dbb2d205584ae72b7c3216b48c3b" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="daf73fe9243d44bfe028c7274fd4b25d" parent="7734dbb2d205584ae72b7c3216b48c3b" type="folder">4-8</container></did><accessrestrict id="e132e378e63282bf8014cd21bd84bf26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="85788caeb20c27238d916bb497645405" level="file"><did><unittitle>TML, 40-52 - Anthrax vaccine</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="3632085f5f88a73eb88cbc44e5f5da0b" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="c316a118a02874fd9abb226c90817bd3" parent="3632085f5f88a73eb88cbc44e5f5da0b" type="folder">9-10</container></did><accessrestrict id="0a33ad6cdce119b325c656b5c6f11151"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7481cf56a926bcaa665f596bebcba058" level="file"><did><unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="e24e4c07ade5c25cb235a60bc4d5cbc7" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="3e44f73d4352f461a245903c77276bc4" parent="e24e4c07ade5c25cb235a60bc4d5cbc7" type="folder">11-13</container></did><accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="276f7a6dda26470f835e467b2e300373" level="file"><did><unittitle>TML, Sildenafil - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="9facb57262218cadb621b04f71fe2f95" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="e0960159259e35e124cf673ba7752c8e" parent="9facb57262218cadb621b04f71fe2f95" type="folder">14-16</container></did><accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file"><did><unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="05758199130571562f7aa5cd3c7c0e84" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="7575a8f2be1da15fda4514762d5a0483" parent="05758199130571562f7aa5cd3c7c0e84" type="folder">17-19</container></did><accessrestrict id="548bd13d1ee4dd091a7071fb17973086"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e605d151c50d15b7436fa8b95fabcc04" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="ba02e0130cc48d2502e79deb84463603" label="Mixed Materials [A0000000075867]" type="box">25</container><container id="258c88b0c5a5e2f9adb6db9dff628252" parent="ba02e0130cc48d2502e79deb84463603" type="folder">20-21</container></did><accessrestrict id="72272d08b8d2095400f484d84b5c8623"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="4f977f10b733a7f39804503a3afed49d" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="9da39d9dc4d5fc1b1f2a787a450f21a1" parent="4f977f10b733a7f39804503a3afed49d" type="folder">1</container></did><accessrestrict id="e61fbc122231a69d11de05471824b4f7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="58fc0933c16d75f16f20c226741f40fc" level="file"><did><unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle><unitdate type="inclusive">1998 February 13</unitdate><container altrender="Record Storage Box (Paige)" id="e622cc5671f969e58ce212fd4e3ac753" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="ef19caada126cd9cb2c4bdc578f91b26" parent="e622cc5671f969e58ce212fd4e3ac753" type="folder">2-5</container></did><accessrestrict id="cd18c294101a7fb036bca53986751b48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f466040faafb3cd515b6f7e5924186a3" level="file"><did><unittitle>TML, 40-47 - Advice for Travelers</unittitle><unitdate type="inclusive">1998 April 24</unitdate><container altrender="Record Storage Box (Paige)" id="af6ab5e31beaf1bba8b9f573957166d7" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="70f54be5c776a6fd5f099c0d7c14b403" parent="af6ab5e31beaf1bba8b9f573957166d7" type="folder">6-9</container></did><accessrestrict id="d3ea0598c816f490bd7b26c48572450a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d9d7051c247d055cb3a4caa57119bc34" level="file"><did><unittitle>TML, 40-68 - Fenofibrate</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="8dcf5a8f0371c5ae66faee5be5b47895" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="12d9f237f1e57c6380363eb6756b8b13" parent="8dcf5a8f0371c5ae66faee5be5b47895" type="folder">10-13</container></did><accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0902f98f4048374d057a60de2d1b7855" level="file"><did><unittitle>TML, 40-30 - Trovafloxacin</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="90ffea7d6c4dd8e60841e798d75caff9" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="4989cbf514c977ae90be0f2fc5e48f61" parent="90ffea7d6c4dd8e60841e798d75caff9" type="folder">14-16</container></did><accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="40a127b41aba4ab1210aebb60355f7eb" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="a28185078da937f777f00a79b5a8ae7f" label="Mixed Materials [A0000000075868]" type="box">26</container><container id="4665de70e833c7ac605cef7b3cbb19b7" parent="a28185078da937f777f00a79b5a8ae7f" type="folder">17-18</container></did><accessrestrict id="aa2e94224c5f71c8078141e7e709d476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2821241f88ab33b4108c2fb8ef546a03" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="24a54af0d984a532051191dcfd961afc" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="6a0f3e6dc2f3659299ed6007f1ba9959" parent="24a54af0d984a532051191dcfd961afc" type="folder">1-2</container></did><accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a5e3fba9d86330d4c75e3f31b4844108" level="file"><did><unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="6ae42e94fdb80d25102da5cd16be9021" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="a5191bda77af0a5a4b8cd831f6e24d3f" parent="6ae42e94fdb80d25102da5cd16be9021" type="folder">3-4</container></did><accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="41484f1614916c304d00c6a0e2776c25" level="file"><did><unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="c80b0bd0991e08a17e3c53666b8e6777" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="9b328f8e6c416421d4c344db1668a0f7" parent="c80b0bd0991e08a17e3c53666b8e6777" type="folder">5-7</container></did><accessrestrict id="9e54423aecee12c7635588555d8c357f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="18a33071dfc9246e7c9a4f9970fc624f" level="file"><did><unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="206b6794c0831e11172959dd78ef0c07" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="fe8947cfd9de37d10f7c7fcf2223038d" parent="206b6794c0831e11172959dd78ef0c07" type="folder">8-9</container></did><accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file"><did><unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="65d80e43bea36a4bd7e143b468bc2c6a" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="fbed9baf9dcb14a5e55e0248b6e3eff1" parent="65d80e43bea36a4bd7e143b468bc2c6a" type="folder">10-12</container></did><accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c689105113c5b23ebb896f340bf02ea0" level="file"><did><unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="a7d33d0e4ebe2061b3400ab31157645b" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="522290e1273032af4d89116119d7bf97" parent="a7d33d0e4ebe2061b3400ab31157645b" type="folder">13</container></did><accessrestrict id="dc4b7b184944400de9cfe92635a05ead"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="705d7bf07e8ff402ef32c0df389a3828" level="file"><did><unittitle>TML, 40-89 - Antiplatelet</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="df9734aa2766f31edb94879b636fb254" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="304dfa2f777db56bca46e5290525a6fe" parent="df9734aa2766f31edb94879b636fb254" type="folder">14-16</container></did><accessrestrict id="ae0c798c535816e3564f3b350306c0eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="cc4045365330c91030e2afc2941ff362" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="e30d885f8af0cfb155898581fb52b6d3" label="Mixed Materials [A0000000075869]" type="box">27</container><container id="6d718078496d954389097f0f6ae9fb3d" parent="e30d885f8af0cfb155898581fb52b6d3" type="folder">17-19</container></did><accessrestrict id="d3830363a0deac040fb1a2187fcc43a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="74cd9f3df4304220a489f3cd523e97f4" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="48c47a28d442a69d17dc3c2b4b7cc30f" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="ab10e182e87a63922f10df8bb117906b" parent="48c47a28d442a69d17dc3c2b4b7cc30f" type="folder">1</container></did><accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8f7886d013678b0f444c0e7ce3af676b" level="file"><did><unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="1dfafe79506f212f9a1e39aebc8bfef7" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="b6c6bb0b21b7f5cd4fdb657f7d0c7a1b" parent="1dfafe79506f212f9a1e39aebc8bfef7" type="folder">2</container></did><accessrestrict id="8e2b80b72a52938a5c321da498c8b722"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="236c02b396ea229adb1f079d93029f01" level="file"><did><unittitle>TML, 40-32 - Sibutramine for obesity</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="de0af0c4a914e5a31f7baacd4c8c17e2" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="84516c4fed2cfcebd0e7262ac8eb2fa2" parent="de0af0c4a914e5a31f7baacd4c8c17e2" type="folder">3-5</container></did><accessrestrict id="83216716b614ac8cc38fcaa01b43355e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="34d5d1374a9121f748a24968ebe6c128" level="file"><did><unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="21b3a964e0c87d89419a27e8ccbae486" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="4af21a3889be594a536bdae91423f46f" parent="21b3a964e0c87d89419a27e8ccbae486" type="folder">6-8</container></did><accessrestrict id="9f78fcde35549e85ae6f6ddddad23091"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file"><did><unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="4f377cb960f99ff203dad76508121179" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="136138889b877f73597228e2f9926ea0" parent="4f377cb960f99ff203dad76508121179" type="folder">9</container></did><accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fae1826f224dc5554dd9d77d43d63320" level="file"><did><unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle><unitdate type="inclusive">1998 January 2</unitdate><container altrender="Record Storage Box (Paige)" id="3d11ec0dde6468ca0a284f4b24345006" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="c894434b4a5e061877c6a0fa618e742e" parent="3d11ec0dde6468ca0a284f4b24345006" type="folder">10-11</container></did><accessrestrict id="3cf800c016782dc93e3a36b622f7b36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file"><did><unittitle>TML, 40-75 - Vitamin supplements</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="b1df78cf3901ba83efaccb15aeaa2d8d" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="9196da152e08779658a970f268c3ed65" parent="b1df78cf3901ba83efaccb15aeaa2d8d" type="folder">12-16</container></did><accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="06914f95afdacb00ca224c63b35cc3e5" level="file"><did><unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="95e4390be613902bd40008293fa92e72" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="6457aa3dcb361e0122be8448b747c15b" parent="95e4390be613902bd40008293fa92e72" type="folder">17-18</container></did><accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="01c78cfbc9a67c0875e803238ff24cf9" label="Mixed Materials [A0000000075870]" type="box">28</container><container id="2341a4343543e7f8414dd9093a39e102" parent="01c78cfbc9a67c0875e803238ff24cf9" type="folder">19</container></did><accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="d8e18ad280a53c52ec66ed403ff3c3fe" label="Mixed Materials [A0000000075871]" type="box">29</container><container id="0c9a9545570df54847cf99c4b10e3f3b" parent="d8e18ad280a53c52ec66ed403ff3c3fe" type="folder">1-5</container></did><accessrestrict id="530223b01deda9e053da32d105382b18"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="559cb584a41d6690a7e856498ab89795" level="file"><did><unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="96fc4cb66f677462226c636f74f570df" label="Mixed Materials [A0000000075871]" type="box">29</container><container id="c5c9f4bfacd081f7517c725805466ca4" parent="96fc4cb66f677462226c636f74f570df" type="folder">6-7</container></did><accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ece2250f2916521ae284b1830da4848e" level="file"><did><unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="1a93885448d9f49a3f7757aff2ec72f8" label="Mixed Materials [A0000000075871]" type="box">29</container><container id="2c465124c70830e4bf9cb4bab56d338f" parent="1a93885448d9f49a3f7757aff2ec72f8" type="folder">8-11</container></did><accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7dd5458e0da29270a7d0b887632c23ac" level="file"><did><unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="eeb3e7364b9cd6ae4e5ea3a037708085" label="Mixed Materials [A0000000075871]" type="box">29</container><container id="85ba33c15b279e59d409b3d5f8785f30" parent="eeb3e7364b9cd6ae4e5ea3a037708085" type="folder">12-14</container></did><accessrestrict id="0b261ea329af56d20325ac31bcf03cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file"><did><unittitle>TML, 40-53 - Dolasetron</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="cdd6da7dadc2713cf093da009c2946d5" label="Mixed Materials [A0000000075871]" type="box">29</container><container id="381760889bc8ac4bbcd35d0cf9c7fd1b" parent="cdd6da7dadc2713cf093da009c2946d5" type="folder">15-18</container></did><accessrestrict id="2f191b313a6f595b28c9d77fec25b021"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file"><did><unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="643356f73dd3776f26d20fecd68e5d23" label="Mixed Materials [A0000000075872]" type="box">30</container><container id="c753e0a56c5a9928c004ccb9831c2e20" parent="643356f73dd3776f26d20fecd68e5d23" type="folder">1-4</container></did><accessrestrict id="5fe32f0354336c745f49eaad8ec99c60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6332598d843148b2b6fcca7483c23ff2" level="file"><did><unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle><unitdate type="inclusive">1998 March 27</unitdate><container altrender="Record Storage Box (Paige)" id="ea63bd31c16ad87570eb543887694a7a" label="Mixed Materials [A0000000075872]" type="box">30</container><container id="72fdf02f38cbcc959ee57583c8d4c041" parent="ea63bd31c16ad87570eb543887694a7a" type="folder">5-8</container></did><accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6062e376e8011b03bf27092730e8219d" level="file"><did><unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="aaa787fc4c4f6e72eafbb6b97d86f7aa" label="Mixed Materials [A0000000075872]" type="box">30</container><container id="29ce1e096f92488ca302b7e2958840c3" parent="aaa787fc4c4f6e72eafbb6b97d86f7aa" type="folder">9-12</container></did><accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="de828b3fc932777396bebd27f5fab7dd" level="file"><did><unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle><unitdate type="inclusive">1998 December 18</unitdate><container altrender="Record Storage Box (Paige)" id="9d8e7e529abb7d6ed45076eee9476dd4" label="Mixed Materials [A0000000075872]" type="box">30</container><container id="f04be888d87845a37de7ffc7253bffa3" parent="9d8e7e529abb7d6ed45076eee9476dd4" type="folder">13-16</container></did><accessrestrict id="ec87238d62e4af8195602bcb6756e8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="cb008c1b5dc5a7e5c54c90f3d6a1308f" label="Mixed Materials [A0000000075872]" type="box">30</container><container id="fd40c43d3405275adaf1a7e10f8d29e7" parent="cb008c1b5dc5a7e5c54c90f3d6a1308f" type="folder">17-19</container></did><accessrestrict id="e69b8784cca126a51aa694fe76fa93ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="13029629c9a2c8c4645ba910bddc0ec5" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="5f1a671d649d7430c1ebea1f4896a35e" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="95d11c2065391f2e5eadc61eed477ae9" parent="5f1a671d649d7430c1ebea1f4896a35e" type="folder">1-3</container></did><accessrestrict id="efd535a28d84b26cb3f39bdbca07f951"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c768307fb6b27100b14034cebd5227a9" level="file"><did><unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="cb106f319310f27541de35a1a8a8d798" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="39b989662893af139c62b1630fcc1813" parent="cb106f319310f27541de35a1a8a8d798" type="folder">4-8</container></did><accessrestrict id="4fead382cbe8272480e24c54bdac4aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="edbc39d29ce93f5d2d89c1070b90a888" level="file"><did><unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="842d806c735831e24461262981ea240f" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="4944f348da76f158fad8f8883ff97509" parent="842d806c735831e24461262981ea240f" type="folder">9-10</container></did><accessrestrict id="4761d1070aff6ae3d4f74655713baaa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6d7c66707bdf53045a7ff953d6e108d3" level="file"><did><unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="1c9463f26710d8f50b4cd3d589e9f2e6" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="e2f17584fb42198b4694ca36d9cef3a0" parent="1c9463f26710d8f50b4cd3d589e9f2e6" type="folder">11-13</container></did><accessrestrict id="94fdedf900cf20f12d378b25deedc2ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a07a54028f90ac0076d2802b57942911" level="file"><did><unittitle>TML, 40-64 - A new rabies vaccine</unittitle><unitdate type="inclusive">1998 June 14</unitdate><container altrender="Record Storage Box (Paige)" id="7d1f13288a6c2a6000e06da329c04f35" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="f036e11a47f52ad6049f6e594f57fa68" parent="7d1f13288a6c2a6000e06da329c04f35" type="folder">14-15</container></did><accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file"><did><unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="672e6f0c0dda8c67e8461d27a4373625" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="4b9cc3be451d5a8870f3de4bca180f2e" parent="672e6f0c0dda8c67e8461d27a4373625" type="folder">16-18</container></did><accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fa4c88d1fa307e4c1c36721c687359e5" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="89329a8a9125e537f31f141452c0abe4" label="Mixed Materials [A0000000075873]" type="box">31</container><container id="9248afeaf6e61b6fe22613a4874668bb" parent="89329a8a9125e537f31f141452c0abe4" type="folder">19</container></did><accessrestrict id="4326873ad2b2259141a757cbab189cb2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b31307f7682d799e34699487a403a926" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="3f765cf7d417ccd87adc0b26a2e4a4d0" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="da0aad87ff173f47753d70a71fcf7f5a" parent="3f765cf7d417ccd87adc0b26a2e4a4d0" type="folder">1-2</container></did><accessrestrict id="2802926a9875868eb77bbf4162293dea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file"><did><unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="617601294183c0d57c647789703cdcb9" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="2b7362fdabbdcf1d0443fce3f7fbe351" parent="617601294183c0d57c647789703cdcb9" type="folder">3-8</container></did><accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fc1c9413add7682bf34765d07e37871c" level="file"><did><unittitle>TML - Cholesterol-Lowering - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="d6f41196f0bca680f071d06133215cd9" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="6fe8917c9e370bea4548308f6720cbd1" parent="d6f41196f0bca680f071d06133215cd9" type="folder">9-10</container></did><accessrestrict id="263b366a38ae16d96e1447c8e1c8953b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="9212aaed4209e15330e340d1c8675d23" level="file"><did><unittitle>TML - Parasitic Infections - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="73bdf45900327c03f546e20e553168d7" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="1c2b459d4e81e5d8d5b8baa63547b57b" parent="73bdf45900327c03f546e20e553168d7" type="folder">11-14</container></did><accessrestrict id="5db4f9b0242f10ed336d20896e08899c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="367ee47d6747fc683d4571ad991fcb28" level="file"><did><unittitle>TML - Malaria - Drugs for parastic infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="3b5e75298ba053f10d956aa98e55f948" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="862279727a8522b673b73079879f35f4" parent="3b5e75298ba053f10d956aa98e55f948" type="folder">15-16</container></did><accessrestrict id="e3f66807c02c01517706efbf9eeaff5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="6dd9a8d9e0b088f8f4bda1e8ddac00bc" label="Mixed Materials [A0000000075874]" type="box">32</container><container id="c17a629403573de475e039781b78cd70" parent="6dd9a8d9e0b088f8f4bda1e8ddac00bc" type="folder">17</container></did><accessrestrict id="f6a6fff3786ff1d521cdf342567849ee"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d41d005cf4c13e14913cd67a32a5047" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="d0243c128cb9f52eda405bd5943b167d" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="e7cd75d1866269ab15a86d6fd66d70a8" parent="d0243c128cb9f52eda405bd5943b167d" type="folder">1-2</container></did><accessrestrict id="8075ff059f0d4d931fa3535cefb097fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a70dd9355ee98a30aebc26b8daacffc8" level="file"><did><unittitle>TML - Psychiatric Symptoms - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="e97fabf9ff3bbc3d6f764e97ce04340e" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="2dd29333b2b24895a211762d175d125a" parent="e97fabf9ff3bbc3d6f764e97ce04340e" type="folder">3</container></did><accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file"><did><unittitle>TML, 40-109 - Candesartan</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="4db29473a8054a3f56ff45f902f6eeb7" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="5b84d57223a1ecd2e901642fcddaf70b" parent="4db29473a8054a3f56ff45f902f6eeb7" type="folder">4-6</container></did><accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e61911867cf616602aa72255f38dc9ba" level="file"><did><unittitle>TML, 40-77 - Interleukin-11</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="df61febff16b97f2180f5e3d2a407bcf" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="bc7c8e3a0d5f8655bbe2112748ffb16e" parent="df61febff16b97f2180f5e3d2a407bcf" type="folder">7-9</container></did><accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4f7233bf7c77fcfc22d806ea70169968" level="file"><did><unittitle>TML, 40-85 - Cefdinir</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="7afbc11eb4a8de849590483cc63c717f" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="bc4f2c4d4c091f8319467bc0fd53010c" parent="7afbc11eb4a8de849590483cc63c717f" type="folder">10-12</container></did><accessrestrict id="028c35e32d1addf3672d48cb03ad70d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="910ff3d576f61dcba1783abe6210dff1" level="file"><did><unittitle>TML, 40-79 - Drugs for pain</unittitle><unitdate type="inclusive">1998 August 14</unitdate><container altrender="Record Storage Box (Paige)" id="108c03f4f93ff3f709fe695bfe6cdf4b" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="14f38d78e4744972a28a560fbc691614" parent="108c03f4f93ff3f709fe695bfe6cdf4b" type="folder">13-17</container></did><accessrestrict id="72993e3876c2683037ab6df23f908193"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="960c1722fd9da508635b32ac38c60f80" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="a00fb2dac57518932314df6fd649773e" label="Mixed Materials [A0000000075875]" type="box">33</container><container id="56f0b54ed41d43dca5aef66465d1569a" parent="a00fb2dac57518932314df6fd649773e" type="folder">18-19</container></did><accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8e8879c55ee8242081f7f64851b4db08" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="43a473c2279a16cfc74e3f5ae1c28860" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="4c187ac134141c1bb6f563c56ae556a8" parent="43a473c2279a16cfc74e3f5ae1c28860" type="folder">1-2</container></did><accessrestrict id="54d5c0c828c3316a8382b3f15461804c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="5d664f33dcd2cabbe962a4227379c390" level="file"><did><unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="654a6127eef3bb6002a1d49b73e3eee4" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="bfc028c625cdefc019c4e642af696c11" parent="654a6127eef3bb6002a1d49b73e3eee4" type="folder">3-4</container></did><accessrestrict id="df311ee9e0d78fb33b148774389da7c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d76a36572332e4c480702f762cc9918" level="file"><did><unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="6f57da842ae13b5b57c5545ee3cf8501" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="4f2ead3dda966fe5bc8076cfccfbd190" parent="6f57da842ae13b5b57c5545ee3cf8501" type="folder">5-8</container></did><accessrestrict id="c3ab3185c9cf9153482322e821491aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="affe7599f3c787d823e95823bfc0cbfc" level="file"><did><unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November</unitdate><container altrender="Record Storage Box (Paige)" id="4cac70f85fb1590a612fbf38cd708b84" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="d8e93efa2d321daab57b48769194d159" parent="4cac70f85fb1590a612fbf38cd708b84" type="folder">9-10</container></did><accessrestrict id="544789c77c743995f3e1041b8e18aab6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2e2e66929019d8531954a7ad095700fb" level="file"><did><unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="4de994c8873cfb6eaf9495009329760f" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="01eaef000ee19c44244ce0b2fee4e0c9" parent="4de994c8873cfb6eaf9495009329760f" type="folder">11-13</container></did><accessrestrict id="c00a8622a08054369fa43b3f435559cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4043d39a1cb0cf7a9edea397c7574337" level="file"><did><unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="dee160b48f8f048117c7698515103f39" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="2ab9f799e93290f7f183256225fb6ac2" parent="dee160b48f8f048117c7698515103f39" type="folder">14-16</container></did><accessrestrict id="5ed653620eb193653bb7be17c3823301"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e5341af61e6a0539c242e29242b615c6" level="file"><did><unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="19de5ba7802ac967987fde4d7ed651df" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="78e9910cff2857d95b95d710a7b02e3f" parent="19de5ba7802ac967987fde4d7ed651df" type="folder">17-18</container></did><accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3f39fb343e118836671bfce7c8c9e0be" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="fd5b3ed820c04841265f8260f69d211b" label="Mixed Materials [A0000000075876]" type="box">34</container><container id="26baf79e0059633756e147cc94b99e78" parent="fd5b3ed820c04841265f8260f69d211b" type="folder">19</container></did><accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e43a7710b28863a0de4803cfd4c0b542" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="6ff9b92d1a3f3d549058237667c13ce0" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="de6201ab6f979c0a92981670cff674b4" parent="6ff9b92d1a3f3d549058237667c13ce0" type="folder">1-2</container></did><accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file"><did><unittitle>TML, 40-103 - Thalidomide</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="46c4c4fa23cdc0ff11e996b24ce1d62b" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="5236c0a46e19d04f0a83a6a93b7b26f9" parent="46c4c4fa23cdc0ff11e996b24ce1d62b" type="folder">3-6</container></did><accessrestrict id="afd021cfb4388a63de5e218998fd47c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="31cfa0b79a02b7866aa0dc7e48743280" level="file"><did><unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle><unitdate type="inclusive">1998 October 9</unitdate><container altrender="Record Storage Box (Paige)" id="62160df30979da9880979d8eae103fde" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="94531011182b2402647f9ccf834d9f12" parent="62160df30979da9880979d8eae103fde" type="folder">7-12</container></did><accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35138cee47bea646beb32b2995d4598" level="file"><did><unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="ac4e3a732de639b081c32c42cbede08e" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="fc886c9b39d2c5dc19a75c2807c00254" parent="ac4e3a732de639b081c32c42cbede08e" type="folder">13</container></did><accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7c2b7e050833f74d66d0b600d186eae5" level="file"><did><unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="e02e4d229ad3fe26653218c7f7207031" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="45f16750c480594bde09de4319c6fe78" parent="e02e4d229ad3fe26653218c7f7207031" type="folder">14-16</container></did><accessrestrict id="bcbeeba99d41f442379b4633e1dc7778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a4342729d9ef2567742167972402009f" level="file"><did><unittitle>TML, 39-107 - St. John's Wort</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="53be9461b30220205089d35198fbaf05" label="Mixed Materials [A0000000075877]" type="box">35</container><container id="8de7a6ffb2dd76aea7f428c47096002b" parent="53be9461b30220205089d35198fbaf05" type="folder">17-18</container></did><accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ddfb397d4b944785854d8ea719c202bd" level="file"><did><unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="e1b201250d271dbbefe568df8111810f" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="1ac98d96214699aaa97bbae8e69c935b" parent="e1b201250d271dbbefe568df8111810f" type="folder">1-2</container></did><accessrestrict id="854b0f58396665c4e2d4a0465f949fd7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="35b97709b422b46ecdc94c987c5952ec" level="file"><did><unittitle>TML, 41-39 - Advice for travelers</unittitle><unitdate type="inclusive">1999 April 23</unitdate><container altrender="Record Storage Box (Paige)" id="d4c4316c1564ed3cf07676863c12d9a8" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="837f73e782adbc8de4ffa3056eacd190" parent="d4c4316c1564ed3cf07676863c12d9a8" type="folder">3-4</container></did><accessrestrict id="04ad6f830bf72709637049c7b301499d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="f916a9e5c338ff7fc1707311815267f1" level="file"><did><unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="16b1dc976b8fed37fd2fcfd38185ba49" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="940a5d33722112f756a61e87b9040162" parent="16b1dc976b8fed37fd2fcfd38185ba49" type="folder">5-7</container></did><accessrestrict id="113f676d893d247079b5e4ff614aec1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2fc16ae414cf9dd501de68ee706014d5" level="file"><did><unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="20a319f36bacaedcf0b5e680f8ef6076" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="bb60b6457467e751629724f8811da800" parent="20a319f36bacaedcf0b5e680f8ef6076" type="folder">8-10</container></did><accessrestrict id="17d7935132e18e8bac890aeefcb5960f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3922b9c381c0b19cb3d63cbe803305a6" level="file"><did><unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="0896a29ab59aa150731207b9dea5e9b8" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="b34b693d7a7aea5a0dceedac80197173" parent="0896a29ab59aa150731207b9dea5e9b8" type="folder">11-12</container></did><accessrestrict id="481e161096febedcc11b1ed837e0109b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file"><did><unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="6b6ee3ab91df8b84aace681041f79d6c" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="52d022dc8c9b92779a72550e00e145d7" parent="6b6ee3ab91df8b84aace681041f79d6c" type="folder">13-14</container></did><accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="65d972dc57e884b250ec76744f2d84f9" level="file"><did><unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="b9638b67174b8434b7a737f6fbb309b5" label="Mixed Materials [A0000000075878]" type="box">36</container><container id="6f9f48acbf27d3075bc60cdb7497a840" parent="b9638b67174b8434b7a737f6fbb309b5" type="folder">15-17</container></did><accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file"><did><unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="ac9ef3e1c28848102b0552b8b741bded" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="feb8de69706e32374ea8ae0ea8858418" parent="ac9ef3e1c28848102b0552b8b741bded" type="folder">1-4</container></did><accessrestrict id="b25acf713bbbe8621cf294856e16ba28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ec877eb8397cacf7d82d77f65b127412" level="file"><did><unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="92658a55472ea91330fe47f653c9fb52" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="4684ce385898e593a740ad3b66cf12a0" parent="92658a55472ea91330fe47f653c9fb52" type="folder">5-6</container></did><accessrestrict id="5090105f2f60079c4d3f971adf860516"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file"><did><unittitle>TML, 41-123 - Temozolomide</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="de701814effdd673397b76896f25bcea" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="417f0254eca6eda19ed71210e52a4298" parent="de701814effdd673397b76896f25bcea" type="folder">7-8</container></did><accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file"><did><unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="199e80f5a373bb8eb76ff02911e589ec" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="335a29ad63997047dda3420a95b01534" parent="199e80f5a373bb8eb76ff02911e589ec" type="folder">9-11</container></did><accessrestrict id="af177345fcae67c9d255185c0a10e870"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="024012e8b7f7de531d716961ead029ce" level="file"><did><unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="392e32732b7fbb8fa5b4412cc170f0d1" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="04fc0d3540b6ef83f3a89ca664143668" parent="392e32732b7fbb8fa5b4412cc170f0d1" type="folder">12-13</container></did><accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a9621527ed50246d7a862b61f10afb79" level="file"><did><unittitle>TML, 41-110 - Rabeprazole</unittitle><unitdate type="inclusive">1999 November 9</unitdate><container altrender="Record Storage Box (Paige)" id="c71eb580e05d738fff52cb4ac6610914" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="fd068728d190620516f79fe1988ad0f9" parent="c71eb580e05d738fff52cb4ac6610914" type="folder">14-15</container></did><accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="fcec222c26512f8ebe8b672bf459fbe9" level="file"><did><unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="02687dc6fba70ed20bf061abf98fa333" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="53059e402005c40160ac5a04555dd524" parent="02687dc6fba70ed20bf061abf98fa333" type="folder">16-17</container></did><accessrestrict id="5eabb94693fe31a0f053df4c9645327d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c2530250616ca691ba7d71e8d92ca5e1" level="file"><did><unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="b890d40fb84044c5e7f1be23084daac2" label="Mixed Materials [A0000000075879]" type="box">37</container><container id="8a1918c2dbc2dac600bfcda1c992ada5" parent="b890d40fb84044c5e7f1be23084daac2" type="folder">18-19</container></did><accessrestrict id="96db099c24d150d666b7ebe07b50d611"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e80acff708763c79ba27fdf7b90311e5" level="file"><did><unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="c7426bbd18654e32ed79c5112a5ee5e4" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="14af461364e9d24740ec21bca059e52a" parent="c7426bbd18654e32ed79c5112a5ee5e4" type="folder">1-3</container></did><accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="703b499487840917db1eeb7a3bbf97c3" level="file"><did><unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="6259740158d6f6a85c7dc754a0e0b8ed" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="6c7bba43a298a3ba7b2df0f6157298bf" parent="6259740158d6f6a85c7dc754a0e0b8ed" type="folder">4-7</container></did><accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file"><did><unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Record Storage Box (Paige)" id="5f1f776d6358b21705247f25892af0ff" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="15db13a771ed6c5dc412af9971a09a50" parent="5f1f776d6358b21705247f25892af0ff" type="folder">8-10</container></did><accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="755deaec93a3a8f46413cdb9d38a9847" level="file"><did><unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="c0e868dca939cd28783e693a21718806" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="0d1e40980bc48c3e7fdb196fb4756b1b" parent="c0e868dca939cd28783e693a21718806" type="folder">11-13</container></did><accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file"><did><unittitle>TML, 41-20 - Homeopathic products</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="1bbc29e603d31649d1ae83d393626361" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="6339ab85286db75a5e49573a4e7db735" parent="1bbc29e603d31649d1ae83d393626361" type="folder">14-16</container></did><accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f8ace5b9ab967ce17459254fb17ca75" level="file"><did><unittitle>TML, 41-55 - Orlistat for obesity</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="f753ca20a3510863d616cb1ff27780f9" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="d425004506411498d269bf10a30549c4" parent="f753ca20a3510863d616cb1ff27780f9" type="folder">17</container></did><accessrestrict id="3afad4f5d733d9716d22ba16c44983fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="b2928e0b146edbf6a03684604b2f6230" level="file"><did><unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="33752e32de248d444e0c9f694b6fb65d" label="Mixed Materials [A0000000075880]" type="box">38</container><container id="94bc3e15eda7cccde49c4ed921139ac8" parent="33752e32de248d444e0c9f694b6fb65d" type="folder">18</container></did><accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e394fdb910a180949b33fcfe30e8b17c" level="file"><did><unittitle>TML, 41-23 - Drugs for hypertension</unittitle><unitdate type="inclusive">1999 March 12</unitdate><container altrender="Record Storage Box (Paige)" id="01392e3b04ffc79f80079ee48c5886a1" label="Mixed Materials [A0000000075881]" type="box">39</container><container id="c74d75d8c78eeca9b9792c20e3e4fea0" parent="01392e3b04ffc79f80079ee48c5886a1" type="folder">1-6</container></did><accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file"><did><unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle><unitdate type="inclusive">1999 December 3</unitdate><container altrender="Record Storage Box (Paige)" id="e1f70de3b05fe9baef3b371007daab91" label="Mixed Materials [A0000000075881]" type="box">39</container><container id="81c1198d1767a90f7a1a1530f6114b06" parent="e1f70de3b05fe9baef3b371007daab91" type="folder">7-10</container></did><accessrestrict id="ddc058cf574899e5d0347e37efa9598e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e42d2f63edb58feb20931053061b1339" level="file"><did><unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="8ec82d7095a5165d9fd020115932c675" label="Mixed Materials [A0000000075881]" type="box">39</container><container id="8c5f2b2d3c443fbae7c49f85ac928666" parent="8ec82d7095a5165d9fd020115932c675" type="folder">11</container></did><accessrestrict id="2bf75590065032d73df0e0fa13732a7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="28427104a307e9895b1500110c4ba78c" level="file"><did><unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="e6cbb842cc1d90489b29a1a7373da5f5" label="Mixed Materials [A0000000075881]" type="box">39</container><container id="dee4c561fa7e710d5274c4ff539fd82c" parent="e6cbb842cc1d90489b29a1a7373da5f5" type="folder">12-16</container></did><accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4c7b991a97b85bed8305af27776e491" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="067cf32f472af11dbe044f841212fd71" label="Mixed Materials [A0000000075881]" type="box">39</container><container id="387377b6d72adf1a1c4fb1578ca0d505" parent="067cf32f472af11dbe044f841212fd71" type="folder">17-18</container></did><accessrestrict id="9b77ea87c2f2795c19e71f426864b471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="efd202ef6564adfebc4106108c9561f2" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="e91496f6281da5966d8e4c98629d08b9" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="efce0b06c1829d92530cb27f2dd16d1e" parent="e91496f6281da5966d8e4c98629d08b9" type="folder">1-2</container></did><accessrestrict id="6304e26af10a0e94e7ef043fee53ad70"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5422bbde47d91ace2df22b5b7527a0e6" level="file"><did><unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="14031c9943957706afad65fb085fea40" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="2af7657ee7b8e03748ff421156694c9f" parent="14031c9943957706afad65fb085fea40" type="folder">3-6</container></did><accessrestrict id="e16a540da639162df21cb6fa8cf623e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="087aeda452bdc8c1f70b599b752d152a" level="file"><did><unittitle>TML, 41-67 - A new conjugated estrogen</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="78095e3813dcc2615537a4c8661e58d4" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="e6c6947e58507b58172db8ff3aaca016" parent="78095e3813dcc2615537a4c8661e58d4" type="folder">7-8</container></did><accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e1ba3784eccce1db97752b63119a9737" level="file"><did><unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="8364fd10bb4a5b94e90a498679e99cea" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="bf2d8335f107ed54ad4a8aa652267dba" parent="8364fd10bb4a5b94e90a498679e99cea" type="folder">9</container></did><accessrestrict id="a078c6c919634b8920e26478d73bef6a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ee9f72d21997962aa5e1d76e60f28954" level="file"><did><unittitle>TML, 41-68 - Laser hair removal</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="93fb4e6ebcbad0e9ce87e56bfa741798" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="a86b5d4b10ebf0f612c4d21b38b3136c" parent="93fb4e6ebcbad0e9ce87e56bfa741798" type="folder">10-11</container></did><accessrestrict id="0797b526bde059f59517ea165bdcb518"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f4d6a53975d9232738144f364667da0" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="27e753722c1fe69052f1313533e0dc5a" label="Mixed Materials [A0000000075882]" type="box">40</container><container id="0088fad55752795a1f95aa06c207c56f" parent="27e753722c1fe69052f1313533e0dc5a" type="folder">12-16</container></did><accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5db523527161519d86f176dd07137b4b" level="file"><did><unittitle>TML, 41-5 - Drugs for Asthma</unittitle><unitdate type="inclusive">1999 January 15</unitdate><container altrender="Record Storage Box (Paige)" id="6cd7b14c7f221bece05e8ea5c8c808a6" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="aed3a452d8b166eeab8b8f83f2e27292" parent="6cd7b14c7f221bece05e8ea5c8c808a6" type="folder">1-5</container></did><accessrestrict id="24b467056399b27bd316ca395f5c8a5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3c1f55d592280bce047dbd773f816697" level="file"><did><unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Record Storage Box (Paige)" id="19941749fec9cc18abf74ae751c558b5" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="ba4a88309c11ca6d9444d77e87523756" parent="19941749fec9cc18abf74ae751c558b5" type="folder">6-8</container></did><accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a5ef95fdd53a4ad00be13d575b720a90" level="file"><did><unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="e204c5ad299a5673fd85fcb19a95eb3f" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="4052ee563c0f8881b98e45733baa7c92" parent="e204c5ad299a5673fd85fcb19a95eb3f" type="folder">9</container></did><accessrestrict id="1246d47b99a5b28275ca7ac909e04e17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c9b5394af1307b91512bebaa47987a03" level="file"><did><unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="8b71ba02798f0e0f76f513ed363626aa" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="31ef8993caaae096577aa7d488d73e07" parent="8b71ba02798f0e0f76f513ed363626aa" type="folder">10-11</container></did><accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9431f5004a39b8a0d9a05be98633933b" level="file"><did><unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="52205209bebfe43446034ab9db5d21a6" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="634947a092a34498c3256fb1c259796b" parent="52205209bebfe43446034ab9db5d21a6" type="folder">12-13</container></did><accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa75d744d2b7b8eae4e0c83305434171" level="file"><did><unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="c2417794ed6ad96cde24cfef5688a307" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="f4f511c82e2ac4d1fbf9903d4a7e9512" parent="c2417794ed6ad96cde24cfef5688a307" type="folder">14-15</container></did><accessrestrict id="4baffc7980c89aadb8cef585c345f731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12a411c26719cadf670414ea9db35b3a" level="file"><did><unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="1830e32421e39bf2decc12fcfb51be8b" label="Mixed Materials [A0000000075883]" type="box">41</container><container id="e0d2b011713a57f9c134dbd5adb83005" parent="1830e32421e39bf2decc12fcfb51be8b" type="folder">16-18</container></did><accessrestrict id="f46608e112550ebc9f422dd17a55e3b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="50fdbec047db8cdec50f09ae8f09ce33" level="file"><did><unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="7e76541288af347a0508e249a415a9d3" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="378c419fb588df43f620d2c15d8e0a58" parent="7e76541288af347a0508e249a415a9d3" type="folder">1-3</container></did><accessrestrict id="ebda9b553416d292abf3337874edf243"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12974761e15d5b5a631f8a1708a1d0e6" level="file"><did><unittitle>TML, 41-107 - SAMe for depression</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="d0a3643c9e19ff229c915e4f930747ed" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="0cd7f422b53be44bec534ba8ea3e6961" parent="d0a3643c9e19ff229c915e4f930747ed" type="folder">4-7</container></did><accessrestrict id="9f6ccc892b5225ac4e542904aba616bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2891c6463578c91c35a01dfbc0867c34" level="file"><did><unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="454819169aaf655aef7365a3136696e0" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="48c8840961d651b6ad1be28a9edfbad3" parent="454819169aaf655aef7365a3136696e0" type="folder">8-9</container></did><accessrestrict id="b084224a8b4665a510e8da9d5962cae8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file"><did><unittitle>TML, 41:47 - Generic Drugs</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="501449b67c371ed52fe7fa17be165c34" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="4a0373e5bf48364fd85414b5d8eea934" parent="501449b67c371ed52fe7fa17be165c34" type="folder">10-15</container></did><accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d463206ca7312a03520c55b4035d6d7c" level="file"><did><unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="3e95efc29920bcf056cd7954b2fb5da2" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="7d9226b342c6101b91402d157f72b2e2" parent="3e95efc29920bcf056cd7954b2fb5da2" type="folder">16-17</container></did><accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="6a90681bbc80e6ffc34777f4c4b91f4b" label="Mixed Materials [A0000000075884]" type="box">42</container><container id="6796f92e68a217a010c71293b385f0f2" parent="6a90681bbc80e6ffc34777f4c4b91f4b" type="folder">18</container></did><accessrestrict id="a555f10f258ebdc237376c5bf299600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="813dc879c0e4261b5ae728f45f81e536" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="a3100e14a74b4f9b7f6c54fcf92d31cc" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="b369a9792f2732ed07f10389d23c396d" parent="a3100e14a74b4f9b7f6c54fcf92d31cc" type="folder">1-3</container></did><accessrestrict id="64327b946a10f94bc40f30737c8f1cd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file"><did><unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle><unitdate type="inclusive">1999 October 22</unitdate><container altrender="Record Storage Box (Paige)" id="5d7d2d34de5a75ac7920181a80544a06" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="b687a6db9b575f346caa62a7b68b7b9d" parent="5d7d2d34de5a75ac7920181a80544a06" type="folder">4-8</container></did><accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file"><did><unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="6fb32afeeeaf4f1e4c5485543f637916" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="f4d4d9eb91a55156c14f601741ecd3c4" parent="6fb32afeeeaf4f1e4c5485543f637916" type="folder">9-12</container></did><accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file"><did><unittitle>TML, 41-29 - Lyme disease vaccine</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="e785d884da1d18cec82975a2128bf608" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="11b406d444002906deb89b73ab349f72" parent="e785d884da1d18cec82975a2128bf608" type="folder">13-16</container></did><accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bb27af27ca7507bfd777f78da0d17147" level="file"><did><unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="3cead7b269b280f9e3a14604e8bf7071" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="06c09e00d9c6f1a856db999d91e11cb8" parent="3cead7b269b280f9e3a14604e8bf7071" type="folder">17-18</container></did><accessrestrict id="86662934e660af89d7aeaa4e4d013446"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="0a509435150e35f7e5666d38f523b112" label="Mixed Materials [A0000000075885]" type="box">43</container><container id="330031d250d64336e40fa38601225ef3" parent="0a509435150e35f7e5666d38f523b112" type="folder">19</container></did><accessrestrict id="53ace92e24d776a3c07d0e679ac418eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="98fd7e915d5c04bccf9bfee05be98149" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="f4110dd26913de363b2e0d71b3550ee1" label="Mixed Materials [A0000000075886]" type="box">44</container><container id="386219ac268cd55b57af5fa22f390b57" parent="f4110dd26913de363b2e0d71b3550ee1" type="folder">1-3</container></did><accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47b865bf089a172b75b4d43ce7a1e447" level="file"><did><unittitle>TML, 41-33 - Depression and anxiety</unittitle><unitdate type="inclusive">1999 April 9</unitdate><container altrender="Record Storage Box (Paige)" id="b3de0dca8cd58bbf1258324986c71a3b" label="Mixed Materials [A0000000075886]" type="box">44</container><container id="aaf81b4677532536d3c9f4ac230a94b3" parent="b3de0dca8cd58bbf1258324986c71a3b" type="folder">4-13</container></did><accessrestrict id="b0f422d658f31862e120da53fa05b6f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="71225c0666898a85e784b2cb281888c6" level="file"><did><unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="ceac5d4d076b27ccc558fe42daefab77" label="Mixed Materials [A0000000075886]" type="box">44</container><container id="86fed76231f3440de1b7fc734462e27e" parent="ceac5d4d076b27ccc558fe42daefab77" type="folder">14-16</container></did><accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="864578e6cbeecd904008b54245eae928" label="Mixed Materials [A0000000075886]" type="box">44</container><container id="68600e9ee9bc938b65645fddf0fbfe12" parent="864578e6cbeecd904008b54245eae928" type="folder">17-18</container></did><accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="ddd1dd7699f1c9dd5930a71c854e4744" label="Mixed Materials [A0000000075887]" type="box">45</container><container id="fc61b56cc5f2bf2532bb7c869c185fa3" parent="ddd1dd7699f1c9dd5930a71c854e4744" type="folder">1-3</container></did><accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="8d82b612550e56f5febd997b649248f6" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="2b5fc1dec133b586e8e6218b0dc3e5a3" label="Mixed Materials [A0000000075887]" type="box">45</container><container id="2df54a16e38da6ef1fd878b98b728069" parent="2b5fc1dec133b586e8e6218b0dc3e5a3" type="folder">4-9</container></did><accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="729c9bb0e1660ceb032fe6da8350333c" level="file"><did><unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="082b9294faa93e8a217a01af52e922ef" label="Mixed Materials [A0000000075887]" type="box">45</container><container id="68682ff894aa8d4ace7144d55f45894b" parent="082b9294faa93e8a217a01af52e922ef" type="folder">10-16</container></did><accessrestrict id="5ad67e35d3361f03756bfe78c6e60019"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="737148b055ba101acbd8ee7df7c07e4c" level="file"><did><unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="15fef5e5973761f9bb34425cdc513fdf" label="Mixed Materials [A0000000075887]" type="box">45</container><container id="1dba1e6b128857aa014beb56d9d51413" parent="15fef5e5973761f9bb34425cdc513fdf" type="folder">17-20</container></did><accessrestrict id="91985532c77a98b2be6619b3829a2c87"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="6e0f28a2b5a8cac84be32ec338816dac" level="file"><did><unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Letter Document Box" id="4ba419a89cf11e6aa16ad21d82bfc712" label="Mixed Materials [A0000000075888]" type="box">46</container><container id="ce416b5ef2806b654594c8614a8f1159" parent="4ba419a89cf11e6aa16ad21d82bfc712" type="folder">1-4</container></did><accessrestrict id="5220646ffa341e43aaef650d57ef5cbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47ee2aa0e1414311aab659a0b7791d48" level="file"><did><unittitle>TML, 41-61 - Drug interactions</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Letter Document Box" id="d6fd38556c131b0b0d2ff83e322da64b" label="Mixed Materials [A0000000075945]" type="box">103</container><container id="2467e1d822a1c635e377ce7190f6c9fd" parent="d6fd38556c131b0b0d2ff83e322da64b" type="folder">1-4</container></did><accessrestrict id="2310dca3aaada449df04e476753e097f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file"><did><unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="d258fdf087ba0a107604c313b0b11480" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="3e7b99bd42ff6758827cac5294218a1d" parent="d258fdf087ba0a107604c313b0b11480" type="folder">1-2</container></did><accessrestrict id="9580c594e1986354a883d0b4d0b71bc3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4b13f0ecb976a0758dff29129231c5ab" level="file"><did><unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="d85bdc229e3b37049e59f4c208c57c6d" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="21d1321411b5dcbcf94d550c53c94ff5" parent="d85bdc229e3b37049e59f4c208c57c6d" type="folder">3</container></did><accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="65fedbec948e0fc83c65d93e86ad6afd" level="file"><did><unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="cf96225d7a29daeedf5e8059774ec269" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="ab3dab9a2200b92400ee5f2e2d971240" parent="cf96225d7a29daeedf5e8059774ec269" type="folder">4-6</container></did><accessrestrict id="7082abcbc2a52e308ef67322853d8731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file"><did><unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="a15861b9103b9816fcd4d83886f221a5" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="4dddca32ea2ccbdf56c7037a344aa0f9" parent="a15861b9103b9816fcd4d83886f221a5" type="folder">7-9</container></did><accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file"><did><unittitle>TML, 42-27 - Curosurf</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="971fc4b33aa9a9f5ba8cc31d5c877040" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="0def9854b2e636a0d827cdedb67a7c29" parent="971fc4b33aa9a9f5ba8cc31d5c877040" type="folder">10-12</container></did><accessrestrict id="a42091b45287859d025abbb92f4814dc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c1fd925b81d971c06ec273ef08f3cb74" level="file"><did><unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="4773c695426022431e7ffce9f2b7b7b3" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="2bccebca09b2090115ea2ef49bc7764c" parent="4773c695426022431e7ffce9f2b7b7b3" type="folder">13-15</container></did><accessrestrict id="25831287c40dd007e7ad4f179aa90da2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="259c3ccf591bab51ffdaba3a9994e765" level="file"><did><unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">2000 July 10</unitdate><container altrender="Record Storage Box (Paige)" id="1f3933b748f3af7d8c9df192a187017b" label="Mixed Materials [A0000000075889]" type="box">47</container><container id="fc39a4da95305e82412761af35f0b566" parent="1f3933b748f3af7d8c9df192a187017b" type="folder">16-20</container></did><accessrestrict id="162cb0e7647f4a98954f5445c257c882"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="62b6871b865b6d75c47266161b21cb21" level="file"><did><unittitle>TML, 42-113 - Phenylpropanolamine</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="c66f0f9ce251c783b705740293d0a693" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="724acc322fef6ff55574501f28b18eae" parent="c66f0f9ce251c783b705740293d0a693" type="folder">1</container></did><accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file"><did><unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle><unitdate type="inclusive">2000 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="92f4616156f9cdc695537d04075a8249" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="34941e0e89e21dd8cd384d3078e3ef00" parent="92f4616156f9cdc695537d04075a8249" type="folder">2-4</container></did><accessrestrict id="af9a344f43755a6c943435e3e709888a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="505b60f40ff960c724ff856e304ce951" level="file"><did><unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="7ce69f3debf018c3e3cf574139edcb22" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="c4c2cf93e0620cad97281c5f6808509a" parent="7ce69f3debf018c3e3cf574139edcb22" type="folder">5</container></did><accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="86b41328d3a3f3bd0b39258221d169af" level="file"><did><unittitle>TML, 42-42 - Oral contraceptives</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="31e0c221d84dbb1c720741ca90480c79" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="88380cce5de0dde69a288111ba15f9b5" parent="31e0c221d84dbb1c720741ca90480c79" type="folder">6-11</container></did><accessrestrict id="362a441b3fc8d8a82b31585a57ea0665"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5af9d8711bf691d44ab3b1e5bb256681" level="file"><did><unittitle>TML, 42-17 - Phytoestrogens</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="ef30569f7056057a0c8b9b97ee28fdae" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="4b886154958cc8b078c8f1ef7ed2011f" parent="ef30569f7056057a0c8b9b97ee28fdae" type="folder">12-14</container></did><accessrestrict id="b6923da0f1e80e36ed724d7930240ab0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="408be2b8c6034a613b1211f2ecf9b661" level="file"><did><unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="002f2cf53d05ed83944390caec0d925c" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="f6f8e1beb380dda451c07cec867e6fb0" parent="002f2cf53d05ed83944390caec0d925c" type="folder">15-16</container></did><accessrestrict id="f012aa712ae69a791944518eafe15ae9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3335c85c5f584c0623918d305860bba9" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="218f13e1175a532c351fa741c7d04b8e" label="Mixed Materials [A0000000075890]" type="box">48</container><container id="849f65ea3ad1c96ec8a895c585c2ca91" parent="218f13e1175a532c351fa741c7d04b8e" type="folder">17-18</container></did><accessrestrict id="55427e8bb48ad2b8315333c1ff339476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c6d41dc2321b4992a2ce79264290f903" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="95820d5bea374271f2393bdebce7c52f" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="f4ade3f39550ba866035c8713a8fa345" parent="95820d5bea374271f2393bdebce7c52f" type="folder">1</container></did><accessrestrict id="a4945089c03fcb0a219bdaccf387431a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file"><did><unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="3e946e8e77a6c64bb52284b75e87f0cd" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="83b40944466f907a19bd0c46dffc4972" parent="3e946e8e77a6c64bb52284b75e87f0cd" type="folder">2-4</container></did><accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="97e9932d34799dd8520be9e13f8a01ce" level="file"><did><unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="a111aaeaa8af8c4f46cf324ed391ac7a" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="9e7e9a86075a193b4704e6133908aa8c" parent="a111aaeaa8af8c4f46cf324ed391ac7a" type="folder">5</container></did><accessrestrict id="349dee1a0f2981a7afaffa486ad92400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file"><did><unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="32acb82fada5749d4ab6a8e87a9da78a" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="aab1236a3902cd6ea9f06be396adf1ba" parent="32acb82fada5749d4ab6a8e87a9da78a" type="folder">6</container></did><accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="e0e61fb5a1e14299b5769bb3645966af" level="file"><did><unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="bd55f6b79557d6f4338c98e67dd43579" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="02a92dc32001e3e488754740a12a77c3" parent="bd55f6b79557d6f4338c98e67dd43579" type="folder">7-10</container></did><accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3d342507f2c128f34587c4f458c47ae3" level="file"><did><unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="d99fcc9598ea64dd98a75919a4598578" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="210c3ae3b08293a73536bdc59c2c09aa" parent="d99fcc9598ea64dd98a75919a4598578" type="folder">11-14</container></did><accessrestrict id="175706ce1b1be1373cdbf4234daea11e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="89f1be4de95ddec6822bda7f0e83b385" level="file"><did><unittitle>TML, 42-8 - Prevention of malaria</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="6fa06b0deb5ddead22e0bb4c5fe0cafd" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="26ce6e484853602758de15258809fa11" parent="6fa06b0deb5ddead22e0bb4c5fe0cafd" type="folder">15</container></did><accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da557a8aeefe93b11b7b65ef3275ee26" level="file"><did><unittitle>TML, 42-37 - Lyme disease</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="0146cb1d48e94f30741ba88236672edc" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="92047a5c10188a81b9c0ee922e73b074" parent="0146cb1d48e94f30741ba88236672edc" type="folder">16-18</container></did><accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9d25758af7747ace6aaf80757aac85f" level="file"><did><unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="b5e335bfa30d8b99ee4739cae05cd4a3" label="Mixed Materials [A0000000075891]" type="box">49</container><container id="e281be91d9b2dcec280007bce12bdb14" parent="b5e335bfa30d8b99ee4739cae05cd4a3" type="folder">19-20</container></did><accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8827ef8acb277df2d477589d43015ed3" level="file"><did><unittitle>TML, 42-73 - Drugs for pain</unittitle><unitdate type="inclusive">2000 August 21</unitdate><container altrender="Record Storage Box (Paige)" id="e8938ed5bc0772c73bd5394d7461f7c0" label="Mixed Materials [A0000000075892]" type="box">50</container><container id="77a559e5386639a31ce725072d70e27c" parent="e8938ed5bc0772c73bd5394d7461f7c0" type="folder">1-6</container></did><accessrestrict id="45351d67ab671d76012768894632e65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7ca68fc3cc569b193dc410a094f9a61f" level="file"><did><unittitle>TML, 42-19 - Drugs for Asthma</unittitle><unitdate type="inclusive">2000 March 6</unitdate><container altrender="Record Storage Box (Paige)" id="8b34b3698ea6ee8200d2b137ab13ab89" label="Mixed Materials [A0000000075892]" type="box">50</container><container id="df8b4a7b898f5737fb0fadc29e2ca606" parent="8b34b3698ea6ee8200d2b137ab13ab89" type="folder">7-10</container></did><accessrestrict id="843840cc3a1f4f944dcd68fb679ac778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="11f2fac87764b93bfe43bd87321c6e78" level="file"><did><unittitle>TML, 42-49 - Androgel</unittitle><unitdate type="inclusive">2000 June 1</unitdate><container altrender="Record Storage Box (Paige)" id="d2db723102ecf0f70accec9b24a43ad2" label="Mixed Materials [A0000000075892]" type="box">50</container><container id="d8a6cc6580d209f98af37f553f794e1b" parent="d2db723102ecf0f70accec9b24a43ad2" type="folder">11-13</container></did><accessrestrict id="373b10f2aaf453294914d4fe78b9487f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f519c54c8f624fc16003fa1c04fa88f0" level="file"><did><unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle><unitdate type="inclusive">2000 October 16</unitdate><container altrender="Record Storage Box (Paige)" id="574792a341a4dd37fc2f4684f28b7f82" label="Mixed Materials [A0000000075892]" type="box">50</container><container id="c3adcfdbd7ba5ce18a3b1ade1eae72ee" parent="574792a341a4dd37fc2f4684f28b7f82" type="folder">14-18</container></did><accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da9eaff7a676c3ce93fb52a83c4df992" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="4af213028367a6107c5e280907bc0a23" label="Mixed Materials [A0000000075892]" type="box">50</container><container id="dc80479c66bf29d4d3dd3b1ef7c18fd6" parent="4af213028367a6107c5e280907bc0a23" type="folder">19-20</container></did><accessrestrict id="0b717ab0083f68384631636b834fec64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f307fe5a6bafa6083a914965f47c224f" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="5ab3dfeec24e144b768c2b0e2f0d5013" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="1c708614e4bea34205361c845c6a6689" parent="5ab3dfeec24e144b768c2b0e2f0d5013" type="folder">1</container></did><accessrestrict id="dc26934d88198182e177b592f4868a43"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file"><did><unittitle>TML, 42-31 - Bexrotene</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="b9d8efe2d67f03edce8e469cb5427c52" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="0a4be01b4b8ce810f0e15d057c0d53e8" parent="b9d8efe2d67f03edce8e469cb5427c52" type="folder">2-4</container></did><accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="78aad480d71976b1ac63856f8414b2de" level="file"><did><unittitle>TML, 42-116 - Portable Defibrillators</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="8835424a4e83ff89fa6df76b0882e62e" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="c8a287a5762baf13b0b16a7b62705d74" parent="8835424a4e83ff89fa6df76b0882e62e" type="folder">5-6</container></did><accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8856ac6d297ba039f5f59b8393406463" level="file"><did><unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="0029939f57f24212228c0dd40ba135a5" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="6ba250f915e00ec0869136fda39300a4" parent="0029939f57f24212228c0dd40ba135a5" type="folder">7-10</container></did><accessrestrict id="2247b3013b5d4bd66554d265282ec46f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file"><did><unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="382e31135849147e8b4d4d6467e06bde" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="c3735a31426895d638ad6e7af1bba07f" parent="382e31135849147e8b4d4d6467e06bde" type="folder">11</container></did><accessrestrict id="35757c84324de4837de836a4d664e4bd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="390553fd7a4eea2f5cbee5002f2322bc" level="file"><did><unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="637473f42f2f91a8534bb0b277fc8846" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="9c107d9bef4af75e93511dbbcf73c273" parent="637473f42f2f91a8534bb0b277fc8846" type="folder">12-15</container></did><accessrestrict id="717bd1e1f90c70ff656382467cc26f89"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file"><did><unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="1f4893848bc7bdc69ccd0ef099296e12" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="1b0b8af2a445f5339710b78a597b047c" parent="1f4893848bc7bdc69ccd0ef099296e12" type="folder">16-17</container></did><accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="968dfa06d929ab040463fb621fb94e15" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="7f17a881e26b3fdb89c29b3ec93e579f" label="Mixed Materials [A0000000075893]" type="box">51</container><container id="5934d673aa7aa872779150e567013d2b" parent="7f17a881e26b3fdb89c29b3ec93e579f" type="folder">18-19</container></did><accessrestrict id="a7608b2e6d21017e82cac99f4c300d04"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ffb773729eccb5c024461cb32728a1f5" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="109089afe98dbea3a02cf79cf203845a" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="3dc6c481c19d43de829bc97c47e693e8" parent="109089afe98dbea3a02cf79cf203845a" type="folder">1-2</container></did><accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file"><did><unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="2176dfdf258856916b13e7e20d389285" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="0805f28b9ff30e014da5d464f82b722a" parent="2176dfdf258856916b13e7e20d389285" type="folder">3</container></did><accessrestrict id="97998d665049bfafbdf7f044ef962ac2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c88b481d9cf92fe516e086aa696f2759" level="file"><did><unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="26645eb21a7c5daea15d88ac8825cda0" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="dce8b96a1a6d3eac1c2d0b9fe95a923f" parent="26645eb21a7c5daea15d88ac8825cda0" type="folder">4-5</container></did><accessrestrict id="8158423ad1861ed096a1f762bea5ed19"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file"><did><unittitle>TML, 42-52 - Atkin's diet</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="958126ed2c4676950283272dc98601bf" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="434cddeac18579cd0d6d367096334808" parent="958126ed2c4676950283272dc98601bf" type="folder">6-8</container></did><accessrestrict id="0024c5f9b90643b42da0ff940f490484"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f039186b802088d6736b63d8692ff877" level="file"><did><unittitle>TML, 42-71 - Hypnotic drugs</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="8be06af8eeb15cf49942c38fd55af8ca" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="abfdd377af084b459db14ce04c9199ae" parent="8be06af8eeb15cf49942c38fd55af8ca" type="folder">9-12</container></did><accessrestrict id="66081d4df14137512de48118dd485bfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ddaac639270ba0e3369ea6c5bef18c02" level="file"><did><unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="95df57e31690579a811f6ce887823ab5" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="4654e01717e5debfccde77c407ed4e6c" parent="95df57e31690579a811f6ce887823ab5" type="folder">13-14</container></did><accessrestrict id="2370a9ec5de5c8b19f6823b89c720366"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3b89f483901c2a204aeb8a707d5f619e" level="file"><did><unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="38b8bfdbe546a49952586328b57b4527" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="5661adc2cebf2416a80434c1df137b43" parent="38b8bfdbe546a49952586328b57b4527" type="folder">15-17</container></did><accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file"><did><unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="c61752c20dd88535481afd15f7fc3ecf" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="1e6c87b7daa5af0594e5eb2b2076d66f" parent="c61752c20dd88535481afd15f7fc3ecf" type="folder">18-20</container></did><accessrestrict id="231c8f3761cd29bf8b9da59c1db76773"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="00070347060fb0256eff8f427b10c68c" label="Mixed Materials [A0000000075894]" type="box">52</container><container id="fb6fd7665b93cf519b13a558e739ace4" parent="00070347060fb0256eff8f427b10c68c" type="folder">21</container></did><accessrestrict id="ecde6f626cda50967973b161a20fcc74"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0670855c3da978011ef91e63b94b8614" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="253caed293583a57679a2feeb6d0298c" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="47db0856c4d59c8df096170a273506c5" parent="253caed293583a57679a2feeb6d0298c" type="folder">1-2</container></did><accessrestrict id="b1545fba52ccf81c38c8688169dab34a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file"><did><unittitle>TML - HAT - Adverse Effects</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="271fad443eba8a7ca30faf06ff2e4fd0" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="713b5f8c2f4ad185c54a680859f36776" parent="271fad443eba8a7ca30faf06ff2e4fd0" type="folder">3-4</container></did><accessrestrict id="f035a5812a9a5ba9f187b537f909316a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file"><did><unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle><unitdate type="inclusive">2000 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="79e300be2c0d8ad858b8e8ff2c2bdd1f" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="961d0026450dba75fd9c7071c9378eb8" parent="79e300be2c0d8ad858b8e8ff2c2bdd1f" type="folder">5-8</container></did><accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9370ffe6e8855002d778fc797c644238" level="file"><did><unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="e50a5c3ddf621e3f4d167fde6cb58472" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="c19c7fafb74a2e7177206300af7ef99c" parent="e50a5c3ddf621e3f4d167fde6cb58472" type="folder">9-12</container></did><accessrestrict id="a1015b3acc8c847466def1105f15644b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="354614b4cdeb7c25dce7323acfe3837f" level="file"><did><unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="c9b719ad761a481d68bc33b148046b71" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="df5e46ade5b2b1a05d08ffd286595d20" parent="c9b719ad761a481d68bc33b148046b71" type="folder">13-18</container></did><accessrestrict id="5bf74d558644f64e23255ce061463c78"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ee26dc57604d2e8beb15f5282094c199" level="file"><did><unittitle>TML, HAT - Antimicrobial Dosage</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="bb959f5adfa00a0cdc65d3bb5ccbf9f3" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="03c5133cf6be0928cc41f28f53d11020" parent="bb959f5adfa00a0cdc65d3bb5ccbf9f3" type="folder">19</container></did><accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="a088080df443869d26625b88cfb8357c" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="0e6f8f2484e90d0a199b174e8c8e358c" label="Mixed Materials [A0000000075895]" type="box">53</container><container id="c575cca93da03ea3d487e8f3ef9f655d" parent="0e6f8f2484e90d0a199b174e8c8e358c" type="folder">20</container></did><accessrestrict id="204852f90f3648c6b6e5e6274cb652ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="7bffb4d105a03940c5cbe1d4639bbbed" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="400202ebb56e09a2022e1b593ac0c8c4" parent="7bffb4d105a03940c5cbe1d4639bbbed" type="folder">1-2</container></did><accessrestrict id="19470d2540faf3143d53c5e0f0f04553"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ff8898d4bdb05f23855cdb33eaefc878" level="file"><did><unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="f655daa4999f5b8e30a6f0be8161ff3d" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="14642a84927e177e730adf7fefca1111" parent="f655daa4999f5b8e30a6f0be8161ff3d" type="folder">3-4</container></did><accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file"><did><unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="6bdcab46f18307d39278b77f82177da8" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="00467fd230b48d448e4bedbdb1fbd7c8" parent="6bdcab46f18307d39278b77f82177da8" type="folder">5-7</container></did><accessrestrict id="aee461894cb0482b20c2792522b46e12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file"><did><unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="a18eebe9adb7460a774bd0af895f0b39" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="c038187ac3aecc9e596ceaeb320124a6" parent="a18eebe9adb7460a774bd0af895f0b39" type="folder">8-9</container></did><accessrestrict id="df37cebc2f1268161ba89264e0aa24c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f8521e46162fc0e16135537e8fe60e0e" level="file"><did><unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="a3ea377777dacafbbcfbfdafe6c12a60" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="d987bad7578a703060962f3a142056af" parent="a3ea377777dacafbbcfbfdafe6c12a60" type="folder">10-11</container></did><accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="77d873ab9fa6653d75e07ecd29388474" level="file"><did><unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="1398039ff97610c363df7aace6dc0f74" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="9e81b9746afef3e5a3c8ad825356b08e" parent="1398039ff97610c363df7aace6dc0f74" type="folder">12-14</container></did><accessrestrict id="c4cc72e54e77645b47ebceda334dae90"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2c3c36361f7d26d6245b10967d53cba6" level="file"><did><unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="d6beb86383dc52482f04ebea9077ddc8" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="1ab0586c1f9e48a68d0d8e1af1f6f6b9" parent="d6beb86383dc52482f04ebea9077ddc8" type="folder">15-18</container></did><accessrestrict id="134bd94a116d4a00868b6be7c821b669"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="1206aaeeadb8ad224be10d80aa394b9f" label="Mixed Materials [A0000000075896]" type="box">54</container><container id="d0fa4fd692b6894059ae8330d4bc287c" parent="1206aaeeadb8ad224be10d80aa394b9f" type="folder">19-21</container></did><accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c29c016865d236b6f578b647c46a6676" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="5c1d2323377f5d0ae541c45a6ada0044" label="Mixed Materials [A0000000075897]" type="box">55</container><container id="2141ad1ec8e832c8b9a8ed6ecc08da1d" parent="5c1d2323377f5d0ae541c45a6ada0044" type="folder">1-2</container></did><accessrestrict id="8e3afc9c0897bcf7957059afb787d613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="11a84c4931a93611c641677fa066c761" label="Mixed Materials [A0000000075897]" type="box">55</container><container id="07103ef923f5dbe2478e983cf82b6c71" parent="11a84c4931a93611c641677fa066c761" type="folder">3-6</container></did><accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file"><did><unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="ceae2338474226a5d481ca4b2d937758" label="Mixed Materials [A0000000075897]" type="box">55</container><container id="de6e1e2ac616f6da7af1124b2316aaa4" parent="ceae2338474226a5d481ca4b2d937758" type="folder">7-8</container></did><accessrestrict id="b6c3f76765c91d59d07d1942830fb182"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file"><did><unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="8e1ee1c17c57ac3853eada461cfe3bf3" label="Mixed Materials [A0000000075897]" type="box">55</container><container id="59a560f938e08a928cb42045867c8ef3" parent="8e1ee1c17c57ac3853eada461cfe3bf3" type="folder">9-13</container></did><accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file"><did><unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle><unitdate type="inclusive">2000 September 18</unitdate><container altrender="Record Storage Box (Paige)" id="99227c2147c8a9c6c1b36303db108ddb" label="Mixed Materials [A0000000075897]" type="box">55</container><container id="0dfbce8331d566253a139f4beb11d078" parent="99227c2147c8a9c6c1b36303db108ddb" type="folder">14-18</container></did><accessrestrict id="fdc72de4846ddb965722a850fb816e7f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="85452dc178e1dadec0332fe42563215d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="a8c58dfe95102e136edd165b088901ab" label="Mixed Materials [A0000000075898]" type="box">56</container><container id="6aafb73b7e11ecf4ac6f90d3ee427316" parent="a8c58dfe95102e136edd165b088901ab" type="folder">1-4</container></did><accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file"><did><unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="a6f9beb7d412a3ee86c53823bd679d00" label="Mixed Materials [A0000000075898]" type="box">56</container><container id="aafc41b382fed4d0ea89df42b809fd1a" parent="a6f9beb7d412a3ee86c53823bd679d00" type="folder">5-8</container></did><accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41cb55e32ff2281af228fcf98e48db43" level="file"><did><unittitle>TML - Osteoporosis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="8c035483aa817c930ea7c44cfb63c91e" label="Mixed Materials [A0000000075898]" type="box">56</container><container id="68eb41e29199a446ff4194442d5e91b8" parent="8c035483aa817c930ea7c44cfb63c91e" type="folder">9-12</container></did><accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file"><did><unittitle>TML - Asthma - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="31be40e3dffa0beeb0634b3c1744c1ee" label="Mixed Materials [A0000000075898]" type="box">56</container><container id="20df84c08779f5d6ff26edcd56d0240c" parent="31be40e3dffa0beeb0634b3c1744c1ee" type="folder">13-16</container></did><accessrestrict id="38e2af006895a52bd2de3eb894293ec3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="b8267d9a913c82019abf8bdb73eda635" label="Mixed Materials [A0000000075898]" type="box">56</container><container id="63388f293c421f81207c15198e91c387" parent="b8267d9a913c82019abf8bdb73eda635" type="folder">17-20</container></did><accessrestrict id="d8d94d63528159d44953c7215892b5f2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1716a9979d5479baf368216eb3017f50" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="47a908dca133233d75f8908b6c25f1dd" label="Mixed Materials [A0000000075899]" type="box">57</container><container id="917fae9a8f39d554d2cb616bfcda5f8e" parent="47a908dca133233d75f8908b6c25f1dd" type="folder">1-4</container></did><accessrestrict id="7be18115960dc69ccd463738ce3438d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="296856f8c0a6139989dec83e2967a3f6" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="8e9520d652cc13d0478931393f60cbab" label="Mixed Materials [A0000000075899]" type="box">57</container><container id="1cb1d98e5bb95ab867807e9b3fbde098" parent="8e9520d652cc13d0478931393f60cbab" type="folder">5</container></did><accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="8c1c7d8562be1a6711a3eccd0fabdf74" label="Mixed Materials [A0000000075900]" type="box">58</container><container id="f69e1f49457e417c68bedb8776bf6bdf" parent="8c1c7d8562be1a6711a3eccd0fabdf74" type="folder">1-3</container></did><accessrestrict id="aae3719b7a851cb67c17470197b044d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8d745390980b9c7fe7639600ac855496" level="file"><did><unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="33dca6f643e278e837fc3328cdb46c29" label="Mixed Materials [A0000000075901]" type="box">59</container><container id="fa8b0061754cacfa940f1c4fe46cf77e" parent="33dca6f643e278e837fc3328cdb46c29" type="folder">1-3</container></did><accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c8e27cfe3b70673df671446dc0f171dd" level="file"><did><unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle><unitdate type="inclusive">2001 May 28</unitdate><container altrender="Record Storage Box (Paige)" id="a6dfb26757c61c99aa3458f800aa68de" label="Mixed Materials [A0000000075901]" type="box">59</container><container id="32262f8d825489771b28d605a397e3a7" parent="a6dfb26757c61c99aa3458f800aa68de" type="folder">4-10</container></did><accessrestrict id="12c485e70ce77057b564f5f005de3180"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b12b140d39cce8b86f62018ce31197dd" level="file"><did><unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="38c3d4ff42dbcb96dff6308ca53e28e3" label="Mixed Materials [A0000000075901]" type="box">59</container><container id="49c6002f8539464633c18deaa083121e" parent="38c3d4ff42dbcb96dff6308ca53e28e3" type="folder">11-13</container></did><accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file"><did><unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">2001 October 19</unitdate><container altrender="Record Storage Box (Paige)" id="1646f73f47216e3eaaf7455666a17d8f" label="Mixed Materials [A0000000075901]" type="box">59</container><container id="8396a76a97feb5ecbfdf547aabf92e9f" parent="1646f73f47216e3eaaf7455666a17d8f" type="folder">14-17</container></did><accessrestrict id="19d192e97e549e2b446276124a3eb6b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="b88201f3c8f539ebbebd23e40d11dff2" label="Mixed Materials [A0000000075901]" type="box">59</container><container id="4d81016b04195b2ce0d3e1db8d33370e" parent="b88201f3c8f539ebbebd23e40d11dff2" type="folder">18</container></did><accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3283e79cbed2dd24ba8423865f0e23c0" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="dee6259f97c5638c55fabeb97aba65ea" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="30dc774a12b667aaab7091ad75e0c864" parent="dee6259f97c5638c55fabeb97aba65ea" type="folder">1</container></did><accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file"><did><unittitle>TML, 43-9 - Beta-Blockers</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="520b1e6f6c7f69a92519494f4af91165" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="447ecea9323677485f7613a46051a516" parent="520b1e6f6c7f69a92519494f4af91165" type="folder">2-6</container></did><accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="efb930d3872ae9d77c1298a07d7d5921" level="file"><did><unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle><unitdate type="inclusive">2001 July</unitdate><container altrender="Record Storage Box (Paige)" id="4a5b1b710f17f482fcb4280100f56a62" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="f360c139a0e83f4a249ef372144f5c0d" parent="4a5b1b710f17f482fcb4280100f56a62" type="folder">7-9</container></did><accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b522bd1a5159bd2d2194d2263cc22904" level="file"><did><unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="4c71503da4d06377a90628dc747ad828" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="c435576fcf0c114ad0c5536c3aa810a0" parent="4c71503da4d06377a90628dc747ad828" type="folder">10-12</container></did><accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="46514d81205269c17a4b19d49a573235" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="323b674803dbc7e23b68687b7b6f576b" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="9f1eb438e3386930b05c7979fb985bea" parent="323b674803dbc7e23b68687b7b6f576b" type="folder">13-15</container></did><accessrestrict id="0ac715d063832982eec2283c964a4110"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6dc4850ed3f15e6085336df184251532" level="file"><did><unittitle>TML - Drugs of Choice - Osteoporosis</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a70bc6e5396ec392d7bb113a2bb3f131" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="839c247378136671e39f4bb43f37cbc0" parent="a70bc6e5396ec392d7bb113a2bb3f131" type="folder">16</container></did><accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="02fc378d7f3b4b93e45c3eef89379858" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="d5cace8f15409ce493952cf65f96bfa9" label="Mixed Materials [A0000000075902]" type="box">60</container><container id="6da475fe0fed93b9ec47a8da11bc31dd" parent="d5cace8f15409ce493952cf65f96bfa9" type="folder">17-18</container></did><accessrestrict id="a1e5c73ef6115e61a317948cb85a9927"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c6bff42d1f14c6a829324e9782c498a" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="931704d944b5f51f07573de4851e57d7" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="f5e5bfa2b1b90d47de3da246aebbb52e" parent="931704d944b5f51f07573de4851e57d7" type="folder">1-3</container></did><accessrestrict id="5b52a18cd7491854824957b6528aa161"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6bf6928a0695a21bf35c621f43a5b338" level="file"><did><unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="48a43aa368a60d840933431b4b2bb29e" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="7c935f22ef0f67a81375f8ddf7322b42" parent="48a43aa368a60d840933431b4b2bb29e" type="folder">4-6</container></did><accessrestrict id="7c855f662c00758a77e6169900e656ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file"><did><unittitle>TML - AIDS - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="39789afabf697afe7c53678c201785ea" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="41f0f113136289c2e82d7db664475950" parent="39789afabf697afe7c53678c201785ea" type="folder">7-11</container></did><accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file"><did><unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="addb398ad8988448a19aff033c22cb34" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="77332711b459b793d4d95fe17c87c76a" parent="addb398ad8988448a19aff033c22cb34" type="folder">12-13</container></did><accessrestrict id="c107fed35cdd31085f732308990ad842"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41aa0763a7e36f6ce380706ce01181e3" level="file"><did><unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="3c30b0b93819e1b7fccd756c1ac2c567" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="98ef307c99210587853862aabd1e3418" parent="3c30b0b93819e1b7fccd756c1ac2c567" type="folder">14-16</container></did><accessrestrict id="10b78f31b326647359759629918503ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21f79f7c6b4acd8a596b33dacb48841b" level="file"><did><unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="1dec00d8f043234a72d0cf46c635d6cb" label="Mixed Materials [A0000000075903]" type="box">61</container><container id="3bf0ee0443f5e76d46df544b3d02115b" parent="1dec00d8f043234a72d0cf46c635d6cb" type="folder">17-19</container></did><accessrestrict id="ce544613fec94a632b764ccaa6155e27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2eed515acb400c24339036029a7a8f49" level="file"><did><unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="e803eba586f3327962abb50815832510" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="2db5b2921794a8bb9019641b7b6563ad" parent="e803eba586f3327962abb50815832510" type="folder">1-3</container></did><accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ccba2cedcccf56cdefa0e205fc19e877" level="file"><did><unittitle>TML - Drugs of Choice - Cancer</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="5f5c13257ed03a2acd48e935d30db528" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="7be9410d8da3703eb226715c4a438a21" parent="5f5c13257ed03a2acd48e935d30db528" type="folder">4-5</container></did><accessrestrict id="d687a473729a78247a1c380123065159"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file"><did><unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="3f55a01e0d7a02f9953e77b6d639aaf4" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="d6165119eb0b16466f8b1186069cff08" parent="3f55a01e0d7a02f9953e77b6d639aaf4" type="folder">6-9</container></did><accessrestrict id="60722a1253dc5c989a1fb84363bf8347"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file"><did><unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="b67428dc33e94d59c80af2b7d7926f22" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="c400c1fddc532f5d3911bbc59d7a9c39" parent="b67428dc33e94d59c80af2b7d7926f22" type="folder">10-13</container></did><accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file"><did><unittitle>TML, 43-17 - Drugs for hypertension</unittitle><unitdate type="inclusive">2001 March 5</unitdate><container altrender="Record Storage Box (Paige)" id="326ca4e901839df7833db5f0946292ef" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="a1747e3566c5100afaa232ce8b3cff29" parent="326ca4e901839df7833db5f0946292ef" type="folder">14-18</container></did><accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="087f594ada07595025666afe5418c016" label="Mixed Materials [A0000000075904]" type="box">62</container><container id="ee07ad042ffbe1cc28f000e7a00bb9c6" parent="087f594ada07595025666afe5418c016" type="folder">19</container></did><accessrestrict id="bedf8436e8ecc88cef43b4466703321f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2a3e11c7291578855058677f583ba4cc" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="337689464831a0ae5b762a0e802158dd" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="ad1acb57363f22f334e162efd58afc19" parent="337689464831a0ae5b762a0e802158dd" type="folder">1-2</container></did><accessrestrict id="1faf2fbe4c747499b17f777c7da8d367"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="7aeba34ec44547fe9581d43a0fc4043e" level="file"><did><unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle><unitdate type="inclusive">2001 January 27</unitdate><container altrender="Record Storage Box (Paige)" id="e4be8583c2b5bd6ef53e9a6753126f8b" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="fa18e0ac6b2b704d70446e6967d34c25" parent="e4be8583c2b5bd6ef53e9a6753126f8b" type="folder">3-7</container></did><accessrestrict id="d1f83bcd9d1dba630ab83fe624589365"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9011b2319d9d385461bdca83ff03a269" level="file"><did><unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="c2d693f4336fdf87f8bd7d09c334578a" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="f3a4a4efeb33997213c989fd73c7bcab" parent="c2d693f4336fdf87f8bd7d09c334578a" type="folder">8-10</container></did><accessrestrict id="d1142cfc576dc71445c5513786f60e47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="43f128e719abd7716a8b552dab41b4ca" level="file"><did><unittitle>TML, 43-84 - Cord Blood Banks</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="440b3814a7c0af372c1fc22450ce29e9" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="50a149156abba5162c5bb88afa44b033" parent="440b3814a7c0af372c1fc22450ce29e9" type="folder">11-14</container></did><accessrestrict id="d355e32a24f6cffb35162f5a565f8aad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2ca4ec46f32a50a21f55760304d5080b" level="file"><did><unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="9b8c99e4179e1fe1a595d4815b886293" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="3b687bc727750382e1e86721208e441a" parent="9b8c99e4179e1fe1a595d4815b886293" type="folder">15-16</container></did><accessrestrict id="12449f363aa33b967622999d1c656f25"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f4881e412a79293a02fce06ab7ada62d" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="0c1df0095e68b9100de4088e1123cbc0" label="Mixed Materials [A0000000075905]" type="box">63</container><container id="c6d59081ef6450e4caaa9a37c3f3174d" parent="0c1df0095e68b9100de4088e1123cbc0" type="folder">17-20</container></did><accessrestrict id="762520a711ae5cf2f881c37d75c585e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="076a7f8b55c4644de3dc62c6db843a72" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="b849f4016679674128ea96eecbdd99ec" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="43321439a8875005aee6c264d1e88a42" parent="b849f4016679674128ea96eecbdd99ec" type="folder">1-2</container></did><accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="98d5e522f0e12ef676f68b6296b375c4" level="file"><did><unittitle>TML, 43-61 - Lung Cancer screening</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="e54da3ba2867828060a9d2216a77154c" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="e9a9abdbe4d3e202dfc72d0fd7aac9b8" parent="e54da3ba2867828060a9d2216a77154c" type="folder">3-5</container></did><accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bbfbf04fd92af083cfe5f2803138df54" level="file"><did><unittitle>TML, 43-7 - Mirena</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="f4ac725d3ed1bafa044e5722de630cce" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="a8a93271bcf3843395115bd7805a326a" parent="f4ac725d3ed1bafa044e5722de630cce" type="folder">6-8</container></did><accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b86dfd5896dc8ed385111ad16cbd218" level="file"><did><unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="afd46c11e11915067c7480fbe4bbf06a" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="3ba5afb52f1eb9e6d1cf8ea4e6be0d30" parent="afd46c11e11915067c7480fbe4bbf06a" type="folder">9-10</container></did><accessrestrict id="f505d3982f99b3e642ccbf40fbd75883"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0f9927bdf850374dd901cc030c68dc7c" level="file"><did><unittitle>TML - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="5a852a1129930b66b2f5ed83235f7aea" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="947c356a3b2734dc62f5e5b1c9172739" parent="5a852a1129930b66b2f5ed83235f7aea" type="folder">11-14</container></did><accessrestrict id="6be4b2a90096d23f4c7270994aa74f17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="97fc093a6a8e4909bb2c604168b0b754" level="file"><did><unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="74f2abae8c9fec91dbc56c6f9bf1b53c" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="4b58f555e7fd136c1d7f4270fa4de60c" parent="74f2abae8c9fec91dbc56c6f9bf1b53c" type="folder">15-18</container></did><accessrestrict id="f836855e02f4d6fe9f63b628886a4c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6da20ff4a72dc0604ae511c5634291e7" level="file"><did><unittitle>TML, 43-55 - A new snake antivenin</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="f03ccbfe86037b225274c7befc30984b" label="Mixed Materials [A0000000075906]" type="box">64</container><container id="9cb765ace8040e0feb3e29dfac64ebfe" parent="f03ccbfe86037b225274c7befc30984b" type="folder">19-20</container></did><accessrestrict id="f08173f37c2607c4d273372be7fedab1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ede8d569017eb650ffb86947aa817ebe" level="file"><did><unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="228c8c4bb326581c2dad8abbc410d247" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="2ff068c24bc248dbf1275c0f6aa7d6f4" parent="228c8c4bb326581c2dad8abbc410d247" type="folder">1-3</container></did><accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file"><did><unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="bd94f7fdbda434b9459f95506e76f8f0" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="a3b44665f47a2239cdc5356a1ef714b6" parent="bd94f7fdbda434b9459f95506e76f8f0" type="folder">4-7</container></did><accessrestrict id="810ad5d825ba01f69c55af09b52e33af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8068f52546b65b321ac2f5fa6a731f4c" level="file"><did><unittitle>TML, - Drugs for depression and anxiety</unittitle><unitdate type="inclusive">2001 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="c26466883f3446f7d6a6b20a484be960" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="725d717fe187ce2dba7ffb51979e2bdd" parent="c26466883f3446f7d6a6b20a484be960" type="folder">8-10</container></did><accessrestrict id="67940cb71724cb07bb1c047808a223cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="55a8ca16b598343eb87537a2d296ecd1" level="file"><did><unittitle>TML, 43-15 - PC-Spes</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="cad6d53ebabf091d0b9fa95820e33532" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="6808fc2c594912725363632c990bf49a" parent="cad6d53ebabf091d0b9fa95820e33532" type="folder">11-12</container></did><accessrestrict id="75c2794ebd1f11660bcef03019daccd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file"><did><unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="db4a60e3f8cfdf67356ed43e3f4bc3af" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="a2c3f3c9b88c76c671f225d11afb35f5" parent="db4a60e3f8cfdf67356ed43e3f4bc3af" type="folder">13-16</container></did><accessrestrict id="07f8b933648e23ed47138c1bef096df8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="833ebff3fb7c7c45c0c064414304d04f" level="file"><did><unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="b1191109477b73235ce59e133bb11c51" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="df7e4b7a04ce2628bf2c292b13067162" parent="b1191109477b73235ce59e133bb11c51" type="folder">17-18</container></did><accessrestrict id="8a48c9bb323707808cd2699c098b90df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="e8d7c8ed9be08a00e9066b3c2f2e5f7e" label="Mixed Materials [A0000000075907]" type="box">65</container><container id="2550e667bfa03242bbfd244dfc2fcc69" parent="e8d7c8ed9be08a00e9066b3c2f2e5f7e" type="folder">19</container></did><accessrestrict id="5b72b0c715fd854e87ba957e71353a88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="e365c927adad779c6fcb702dd08759b3" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="9d97924fec08c0e471798eec542b0850" parent="e365c927adad779c6fcb702dd08759b3" type="folder">1</container></did><accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a3e98844edbadfd1126f96dcee9fa072" level="file"><did><unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle><unitdate type="inclusive">2001 October 15</unitdate><container altrender="Record Storage Box (Paige)" id="6ec81107e5bc080d4edd7205c6d40465" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="3602b96e45d284b557d381fa1bb63219" parent="6ec81107e5bc080d4edd7205c6d40465" type="folder">2-3</container></did><accessrestrict id="95db9e419544c222951aae12dd139e45"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2330e815d4bdfd9c12c459306864dcca" level="file"><did><unittitle>TML, 43-103 - Drugs for HIV infection</unittitle><unitdate type="inclusive">2001 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="866012ae011c4dfe25bdad861bed988d" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="3d9b3bdae30fe3b272ff6a2300e498ba" parent="866012ae011c4dfe25bdad861bed988d" type="folder">4-7</container></did><accessrestrict id="ba5d1519c239af0bb83357cd9431cc00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file"><did><unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="142aeb819b18ee022a5fa4656a71e2cd" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="44bda117de03b2ed9baca222af916f75" parent="142aeb819b18ee022a5fa4656a71e2cd" type="folder">8</container></did><accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9f44342b0f523de0bfcb639e0134e8" level="file"><did><unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="7a28f6615dbdfa55d8d60248632edc4f" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="4438ca1d78a1cf6ab3628c5b055f1ca3" parent="7a28f6615dbdfa55d8d60248632edc4f" type="folder">9-10</container></did><accessrestrict id="9d4ad8765f4f79883181f256eb7f9879"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file"><did><unittitle>TML, Drugs of Choice - Pain</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d9b6af4f2410e91b166a35dad80c6ae1" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="2b66f1c5d03b0f0206e704488884e081" parent="d9b6af4f2410e91b166a35dad80c6ae1" type="folder">11</container></did><accessrestrict id="3b2728fff814b6aa47a93b6386e34381"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="468e734f765a9be3853dd86c21c17c5d" level="file"><did><unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="a4030236e23601290a97870a9338dd10" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="92989257d2c8d4c05c18373714f893a5" parent="a4030236e23601290a97870a9338dd10" type="folder">12</container></did><accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d63b61dd440fbe48748ed3adaaa153a3" level="file"><did><unittitle>TML, 43-13 - Palivizumab update</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="8cae638e10950d0e8aad077fb0fc877b" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="ebbea543fca5602df141c0451cfdaf62" parent="8cae638e10950d0e8aad077fb0fc877b" type="folder">13-14</container></did><accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="07c5a88addbecee925056539789a95ce" level="file"><did><unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="d0fd248ed66ee993fc5fa23111f6e52b" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="8d928ade84d7cdf6fc7a1c96b726620c" parent="d0fd248ed66ee993fc5fa23111f6e52b" type="folder">15-17</container></did><accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3c99102c3cbe6573776800745f8ae469" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="ae30beb660c22aaf34728166bba9187e" label="Mixed Materials [A0000000075908]" type="box">66</container><container id="829bc122d823379311f0aef3630d3c8f" parent="ae30beb660c22aaf34728166bba9187e" type="folder">18-20</container></did><accessrestrict id="0e83e8dd8e86709df7f972ac81515598"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6baca4f86fe997597684780a50afb04" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="6ba29e61c39c7e1074552d8250344098" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="30f012ae3fa6a849fab9a313fe23242f" parent="6ba29e61c39c7e1074552d8250344098" type="folder">1</container></did><accessrestrict id="a04d9293e94b60a9e39c9b4189abc925"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21563c371ed6d15964e3cc6b122e8325" level="file"><did><unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="9a416d01f1852836cc0302936f8fbe6c" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="021da2f9a18b9b0d0725ca0f0235bd37" parent="9a416d01f1852836cc0302936f8fbe6c" type="folder">2-5</container></did><accessrestrict id="591f5ce0464ac805e58c930e1f206114"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a56fc8ba008f5ec96cb059f94525d216" level="file"><did><unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="6e5e7eb2fbf03a3355186e33fea183c5" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="0655a1bf34a4819cb8f551e3ba30a564" parent="6e5e7eb2fbf03a3355186e33fea183c5" type="folder">6-8</container></did><accessrestrict id="516c40c3c42f23a1ef834fac3280423d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file"><did><unittitle>TML, 43-57 - Levothyroxine</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="23063846ba5e76d516fae19bd1793e10" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="d840230955e782be645358c70a5e0fa4" parent="23063846ba5e76d516fae19bd1793e10" type="folder">9-11</container></did><accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d2d95b76affb3a4c9b22a381ae08576d" level="file"><did><unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="fb50c6551bdf6ae9968197d65264c876" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="4e6713a66f8d892c3734d0a408c99217" parent="fb50c6551bdf6ae9968197d65264c876" type="folder">12-13</container></did><accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file"><did><unittitle>TML, 43-27 - Prozac Weekly</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="c873bc58a165b45aad92e03e35de8a87" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="d1d6d086dba528b8fa25d001ece0c8ec" parent="c873bc58a165b45aad92e03e35de8a87" type="folder">14</container></did><accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="67c3e23b5d12d8534868e8715ee6834b" label="Mixed Materials [A0000000075909]" type="box">67</container><container id="d8ee03a08484ee76e4333ee40e1036b5" parent="67c3e23b5d12d8534868e8715ee6834b" type="folder">15-17</container></did><accessrestrict id="81584269571599c2534c39747bee7f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d66d152546faaaff8951fbc78b68163b" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="b73c7b70f45011298c765bbf2a15ba72" parent="d66d152546faaaff8951fbc78b68163b" type="folder">1</container></did><accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file"><did><unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="70fd86b477dd531db8637dc4eef2b67b" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="e08d0d8bec6b8de74e7bfddda58176aa" parent="70fd86b477dd531db8637dc4eef2b67b" type="folder">2-4</container></did><accessrestrict id="c860c07bca67d0f682cba26ca6577767"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="50348bc86f79794dd7d3880f772dc9fb" level="file"><did><unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="45b041f8b3c9d20e7b36ff18719e0978" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="d7dbc453a6ab7b8ffa586c37577a87a2" parent="45b041f8b3c9d20e7b36ff18719e0978" type="folder">5-8</container></did><accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file"><did><unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle><unitdate type="inclusive">2001 April 16</unitdate><container altrender="Record Storage Box (Paige)" id="c234773c7ad8ec71c1281b7e2a584150" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="f49a23b466a6291334b1555255866279" parent="c234773c7ad8ec71c1281b7e2a584150" type="folder">9-12</container></did><accessrestrict id="524857adc52fa0f183b069d3ae7050b5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41122ea5a6e7981f0132dc387c47d526" level="file"><did><unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="04fee170f3cfacf30930d689148a56df" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="1a2a1bdc9a3edd687510db23479de56a" parent="04fee170f3cfacf30930d689148a56df" type="folder">13-14</container></did><accessrestrict id="8a2f04b8e85fd19c93d31127f994912c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file"><did><unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="38f2b27ca3a3556c54260093f3c2cd52" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="3ff4592eb3d803b004a20c231555318d" parent="38f2b27ca3a3556c54260093f3c2cd52" type="folder">15-17</container></did><accessrestrict id="ed26092ce8449e46cf63b80b2a291816"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c5905505fca4831e512fb2648100be7" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="ab025cdde4324e50beb269986aca8e48" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="86e3dc87cd4bcaa4b0c2f545ebbd5371" parent="ab025cdde4324e50beb269986aca8e48" type="folder">18</container></did><accessrestrict id="75c6bb282a1bebd46a6a30af50403e35"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d83158c1d6d2339140e8e837daa705b4" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="0cecfa2fc488eab3ef023574e5d0a79e" label="Mixed Materials [A0000000075910]" type="box">68</container><container id="ca12feb028ffb7836ef21b174cddeb56" parent="0cecfa2fc488eab3ef023574e5d0a79e" type="folder">19-21</container></did><accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="133e4e9a4ea21ca1b28e4ab4c1cd775b" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="b2f5b5cc01c6efeac27ff8e63c16a528" parent="133e4e9a4ea21ca1b28e4ab4c1cd775b" type="folder">1</container></did><accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="4cdec89511203afd4fe2dc98bb7107a3" level="file"><did><unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="8e95d3518f1c766fb75b291f242794f1" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="d5372003b321f80758dcbd6ce32cf5fb" parent="8e95d3518f1c766fb75b291f242794f1" type="folder">2-4</container></did><accessrestrict id="721d15062edf16474f8c9615e7343c9b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c93f14bdbe03244367dc9260f841c8a" level="file"><did><unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="53be3e83607b9da197dac1b63c0ed9dc" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="4356b42c6c1bac39b5e8372816762dec" parent="53be3e83607b9da197dac1b63c0ed9dc" type="folder">5-8</container></did><accessrestrict id="0834865471315b83cd87445af0b5d964"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c1db8b64ee78c1dea2315fd90476615" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a110624af35bd6e51d5a5e77cfc7de29" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="9d505e3fc5539c01f8be0dbe0172b010" parent="a110624af35bd6e51d5a5e77cfc7de29" type="folder">9-12</container></did><accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file"><did><unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="52b9088f446ee30cfb2f1331c9ba71ef" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="4782d0bdd7a59544ed978affc2daee59" parent="52b9088f446ee30cfb2f1331c9ba71ef" type="folder">13-14</container></did><accessrestrict id="cc2db5a946dc97445662edf403135cfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dde7a8f4a1c15dd762a0160728804b73" level="file"><did><unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="e1f02d77cb3339e7c03188c2232817e8" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="590a55cd32b35bf007f4de0215f9d5d2" parent="e1f02d77cb3339e7c03188c2232817e8" type="folder">15-17</container></did><accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9666394f9b7e1594ab6d9d740833bf6d" level="file"><did><unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="51fed71d9d362131de80e7be0c094559" label="Mixed Materials [A0000000075911]" type="box">69</container><container id="894e9761f01dc5fc938c5025fe60ce13" parent="51fed71d9d362131de80e7be0c094559" type="folder">18-20</container></did><accessrestrict id="64351c947d34d22cef39ad4007296824"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9e514faa1eb026a69873e6b610137535" level="file"><did><unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="35cfcb714e2e33f178a7ec9d5eaab573" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="db3d24b6c4b63e3e9efa1f40704dc566" parent="35cfcb714e2e33f178a7ec9d5eaab573" type="folder">1-4</container></did><accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file"><did><unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="79dbc9688ff15bd82a710f1818871170" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="f14c3a8a9c70e2b48280020e2e1cebdf" parent="79dbc9688ff15bd82a710f1818871170" type="folder">5-7</container></did><accessrestrict id="753a55d97a80d113ee2476718a3d1661"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="094c201158dc4594db833aa331f44d92" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="7ae2842e2a60ad62c523c4bf69588b86" parent="094c201158dc4594db833aa331f44d92" type="folder">8-10</container></did><accessrestrict id="d504ebc62c5421f5e1d907042650019a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="28985057e383ceb12ff871b5d26e61da" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="33c88162624b803f63b99ff80d07d7d8" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="789013c8f78a5024cc506eab49862645" parent="33c88162624b803f63b99ff80d07d7d8" type="folder">11-13</container></did><accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file"><did><unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="5968a30129017f2a485c25d8338772a0" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="78814d1f3523b1b6b4cb0bb31a1ac597" parent="5968a30129017f2a485c25d8338772a0" type="folder">14-15</container></did><accessrestrict id="b5d06faa04330361ca1ca75b21c017fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a8579ee641a8d372e5b92c341780d2f0" level="file"><did><unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="628b6f806d240775c3210120ebe54617" label="Mixed Materials [A0000000075912]" type="box">70</container><container id="d9a0af73e53b4ba5b2f811946577d43a" parent="628b6f806d240775c3210120ebe54617" type="folder">16-17</container></did><accessrestrict id="85e3914a93c77fea32c035bd079cdf38"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file"><did><unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="624ab9a5ee50c6c8f0be172dace2695a" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="0749214bedddb93fcb363298e9bd188c" parent="624ab9a5ee50c6c8f0be172dace2695a" type="folder">1-4</container></did><accessrestrict id="5e9a358af553725b2b7a0e754e583db4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a52ad11ec1e3f4d9273267e959212194" level="file"><did><unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="4d0d4182f18eb15509a789909f52713d" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="b2e75283c195110e3d658fd01fb0ffb8" parent="4d0d4182f18eb15509a789909f52713d" type="folder">5-8</container></did><accessrestrict id="44f937981b03e47fe5b48832e2bc3c06"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="524bcd1ef0983fc228db57fdceccbd8a" level="file"><did><unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle><unitdate type="inclusive">2002 January 7</unitdate><container altrender="Record Storage Box (Paige)" id="4ed56a30cb2a76e7d57a8ae5a8d958a8" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="d90687f520f74f69f466de1374cd5a88" parent="4ed56a30cb2a76e7d57a8ae5a8d958a8" type="folder">9-11</container></did><accessrestrict id="41a008738c8b0cf8972cf6b24432d838"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bad1e6f9e4ec0f760e77c31253787c34" level="file"><did><unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="2df4d9a68df04b8810f58ee713608b29" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="940252b0c288fac03a0eea155d486c9f" parent="2df4d9a68df04b8810f58ee713608b29" type="folder">12-13</container></did><accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ba78803aaafb030f1962308400163490" level="file"><did><unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="070f35c62d793b5904a6d2a46e4fc205" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="8167a5649cb4890fe768c26fe2248fdd" parent="070f35c62d793b5904a6d2a46e4fc205" type="folder">14-16</container></did><accessrestrict id="261eac7e701cc4253a133eadd4895b0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file"><did><unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="6189b0eda5372f3155c6a4b434a9e8e5" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="1675eb7c83426c0495bd19e6cab3a09d" parent="6189b0eda5372f3155c6a4b434a9e8e5" type="folder">17-19</container></did><accessrestrict id="06663a53b51c9f32469146874e6a53fd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a4e45a144c74f16ab14378047e5576f1" level="file"><did><unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="eed51a1a5275eb3836c71725c9e04999" label="Mixed Materials [A0000000075913]" type="box">71</container><container id="b5546cedf2b194df1af1d57f5544705c" parent="eed51a1a5275eb3836c71725c9e04999" type="folder">20-21</container></did><accessrestrict id="344623fd522ad204005bd4713a3a7eaa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9f13d0adec34e41920a5e68ddd64292c" level="file"><did><unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="d041e1740ed2c7b6e588126a6fe91a0a" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="eb85887fb2df0cc3593486867d18409d" parent="d041e1740ed2c7b6e588126a6fe91a0a" type="folder">1</container></did><accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9263ee3a396996d1f6c92f91c990e8b4" level="file"><did><unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="5e37caf11cff4903dbd2307276563c45" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="7f596fc29e2e3a334614a2fab08e7762" parent="5e37caf11cff4903dbd2307276563c45" type="folder">2-7</container></did><accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fec2a29720e66cc581b066877ffa632d" level="file"><did><unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="65e508854044c62b8a35c9dda23dc724" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="f460fa3515edfb859f145258d635f57a" parent="65e508854044c62b8a35c9dda23dc724" type="folder">8-9</container></did><accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ea19cfea9c41aa789e87a27139849cc9" level="file"><did><unittitle>TML, 44-42 - Copyright violations</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="2ef53c2cf2b0be7bfbdd7402b433a4bd" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="e751acb27ac1e77d1eb5fccf230dbf4d" parent="2ef53c2cf2b0be7bfbdd7402b433a4bd" type="folder">10</container></did><accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="573b9aa7949c2b6064549d58f22d1ef4" level="file"><did><unittitle>TML, 44-89 - Generic drugs</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="a7d0629d8de4e3fe176886b816c14b49" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="13c398b54ae179bf02e710c8b06f707a" parent="a7d0629d8de4e3fe176886b816c14b49" type="folder">11-13</container></did><accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="eca6e6e8880da77ade266c114c4c3ef8" level="file"><did><unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="47b695b0e14afba2cd2806841fb118ed" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="3e5dc3067980021952102c3272056633" parent="47b695b0e14afba2cd2806841fb118ed" type="folder">14-16</container></did><accessrestrict id="e52979497dde6f1c31a59d9d3764a403"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file"><did><unittitle>TML, 44-103 - GHB for nacolepsy</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="2b5928186deb5402d5ecf67a2d2b744b" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="efa09263461af70edfcdbd0cfa2e969e" parent="2b5928186deb5402d5ecf67a2d2b744b" type="folder">17-19</container></did><accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="5f1f43a60e3a918e61f1524dd78e1670" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b65ce1a9cd9d208b6a8b14f962bf9fbb" label="Mixed Materials [A0000000075914]" type="box">72</container><container id="1ea4d1363a4983cf43a3f73f0a1ad8dd" parent="b65ce1a9cd9d208b6a8b14f962bf9fbb" type="folder">20</container></did><accessrestrict id="43b31e9dd0e56b4393c587638541da8a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d0277fd8830f2d769496c88f15bb859c" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="e683eb3c726580f52c470d23bde65bef" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="0e39e5f1ebcd51f8240e8ae67f0e98c6" parent="e683eb3c726580f52c470d23bde65bef" type="folder">1</container></did><accessrestrict id="0374c695f899676ae2f0f4ab46c32079"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="38f15317a1ab04ccab7ddf87c59865ca" level="file"><did><unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="eef3b12755514312f535a1fd51bd939a" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="164fd4a76584355366c25eff524e8923" parent="eef3b12755514312f535a1fd51bd939a" type="folder">2-4</container></did><accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c2dd44962d67176662e4db78dd0a66d1" level="file"><did><unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="e37c9e2f04c92d6f87c1bf3ac5b6744a" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="649c231a4ffdd9561f812a3850be61c7" parent="e37c9e2f04c92d6f87c1bf3ac5b6744a" type="folder">5-7</container></did><accessrestrict id="a137a040fd97e7017313ae9a82d2fe86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="70993f6f906adca6d28b7cec87c5cbab" level="file"><did><unittitle>TML, 44-93 - Drugs past their expiration date</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="d2954b6b56362b62cbfbe0590c10655e" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="09f207d0348e68dfa63616867bc37a20" parent="d2954b6b56362b62cbfbe0590c10655e" type="folder">8-10</container></did><accessrestrict id="e06690c5813977cdcc6c8a5a7653718f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f9bc602671296cc3d2de922401f1986e" level="file"><did><unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="1e5271525168be512bd78ee82e8cf242" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="1a81df9fb4fe5ce078c5b3f99273d6cb" parent="1e5271525168be512bd78ee82e8cf242" type="folder">11-12</container></did><accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="88bf2c423e244a87d79645badbf2e9f3" level="file"><did><unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="218babbe7db60e2e4b9944c865d200ca" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="b1ec3d246e597d79f3c1fc70cc1c1151" parent="218babbe7db60e2e4b9944c865d200ca" type="folder">13-15</container></did><accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="05b64e3022467a23598c9201bc74dfdf" level="file"><did><unittitle>TML - Cefepime</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="80c4f3f87ba9833f56e3f8ce362f2e9e" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="d8961dbb61f685539b3b45bfc7fa8eb4" parent="80c4f3f87ba9833f56e3f8ce362f2e9e" type="folder">16-18</container></did><accessrestrict id="394b3115bcff39760eac5c39dc81bdb6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0b79a2b45ac5a48beb03988b3255f34c" level="file"><did><unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="7da2a58769525594eeece6b373879eee" label="Mixed Materials [A0000000075915]" type="box">73</container><container id="c593b198c4e7b704cd997f9abecf8422" parent="7da2a58769525594eeece6b373879eee" type="folder">19-21</container></did><accessrestrict id="556a688586b09ef7523a269879e4d606"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file"><did><unittitle>TML - Echinacea</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="88a3d7e86d2f1a1cfac72d5bd976f808" label="Mixed Materials [A0000000075916]" type="box">74</container><container id="5bd28a27e8f21eca5783fcb57ffbb46e" parent="88a3d7e86d2f1a1cfac72d5bd976f808" type="folder">1-3</container></did><accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="af85bd11efe07fd729751c8c218f32d2" level="file"><did><unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="9d90a0231283c41d3010b847eb7a0021" label="Mixed Materials [A0000000075916]" type="box">74</container><container id="b8874aaebd0df1ac26d0885eda1fe3e1" parent="9d90a0231283c41d3010b847eb7a0021" type="folder">4-6</container></did><accessrestrict id="e67c688500af00baeca0146003fa4b6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45aa8fe42fd0ddc4536be77350df4b57" level="file"><did><unittitle>TML - Fungal Infections - Reprints</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="e8a83946e5fb566f3452a5b5ea813955" label="Mixed Materials [A0000000075916]" type="box">74</container><container id="f0bcd61de1b9bb5eb104fb4f39612096" parent="e8a83946e5fb566f3452a5b5ea813955" type="folder">7</container></did><accessrestrict id="1f1099e38699970b363bae0c6975a70b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2e47b4ee1607009a90bcdea23b07a404" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="4453c4e47e6091c2861cf30ae741d6b2" label="Mixed Materials [A0000000075916]" type="box">74</container><container id="0c7221557ac64f09bd8abad7cd606a47" parent="4453c4e47e6091c2861cf30ae741d6b2" type="folder">8-19</container></did><accessrestrict id="831283e78ef78563e6f6b9e3060a60fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1b3c5e9f90a08c6b3089d19d45831771" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="26f8a732ad5b9b7059f60987486f48fe" parent="1b3c5e9f90a08c6b3089d19d45831771" type="folder">1-2</container></did><accessrestrict id="37075cc131616efa32d821ddec70e19a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0785dbde88fe25acb019e68e53796851" level="file"><did><unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="9f12df2fb1e9430db84c1b8900bde45b" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="7ecd80e838b3bdd38127a5e421c0a3f3" parent="9f12df2fb1e9430db84c1b8900bde45b" type="folder">3-4</container></did><accessrestrict id="423a699022dfc41e5a19356b8ede358f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daec721a5877ed667e3be025c5b3972b" level="file"><did><unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="c7bcd7c2c95f032eb75fb900dec7860c" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="e54e1705c83e403cdc7fe9818518a82c" parent="c7bcd7c2c95f032eb75fb900dec7860c" type="folder">5-6</container></did><accessrestrict id="65275a0edfafc2779f6f3b12b167613d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file"><did><unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="4c27655da46473d89c0f352929f4bda8" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="4753092c42d22e3de460039b1c34a88a" parent="4c27655da46473d89c0f352929f4bda8" type="folder">7-10</container></did><accessrestrict id="66fca14cfc643877b243d938549ef683"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6c5c80d095e7afd1c721854326e0f8cc" level="file"><did><unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle><unitdate type="inclusive">2002 February 4</unitdate><container altrender="Record Storage Box (Paige)" id="34c9a402b40db050661121f585349d61" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="ed0cab71693653b48fd5d800faf72d98" parent="34c9a402b40db050661121f585349d61" type="folder">11-17</container></did><accessrestrict id="bdf05fc38d86db9b72f37658b33c4730"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bcfed60146a9353c15a7810e066eb562" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="22a2e346a09e3c63a04f608912805f8d" label="Mixed Materials [A0000000075917]" type="box">75</container><container id="b18554487e3ebe5b3b3c23da589bac37" parent="22a2e346a09e3c63a04f608912805f8d" type="folder">18-19</container></did><accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="26f9f680797154013e700d36b1ee02cc" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="c1442e7579ab1a4e25e122c36fe1230a" label="Mixed Materials [A0000000075918]" type="box">76</container><container id="7cb70f71e8cd1f78c224f62bf6bc8df4" parent="c1442e7579ab1a4e25e122c36fe1230a" type="folder">1-2</container></did><accessrestrict id="538e6db36155fc336b5cd7453b267830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file"><did><unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="01cbcaec634cf1fda432e64d70a1cf53" label="Mixed Materials [A0000000075918]" type="box">76</container><container id="44b4552c2c4cac913c6115a6c64ea06c" parent="01cbcaec634cf1fda432e64d70a1cf53" type="folder">3-5</container></did><accessrestrict id="009827e7a43d5b337cbe6459416c7913"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4e2f11c3afbd278cc01889db51cc3594" level="file"><did><unittitle>TML - Safety of antimicrobials in pregnancy</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="546d3827cded78da9080767fab02603a" label="Mixed Materials [A0000000075918]" type="box">76</container><container id="8578d3b9081e6b11209abbab9d6466c4" parent="546d3827cded78da9080767fab02603a" type="folder">6-9</container></did><accessrestrict id="4077280e1fc84a55fa2f33342e312820"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d9af5da201c75753edd17152b98006c9" level="file"><did><unittitle>TML, 44-63 - Voriconazole</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="817e937eb496d977985af37159257fce" label="Mixed Materials [A0000000075918]" type="box">76</container><container id="a884e4bcdb883822e2ba87f7a27bb322" parent="817e937eb496d977985af37159257fce" type="folder">10-14</container></did><accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file"><did><unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 December</unitdate><container altrender="Record Storage Box (Paige)" id="afec746e0eaa15b42d3cbd866edebf90" label="Mixed Materials [A0000000075918]" type="box">76</container><container id="2c7582753644b74cada75e9cdb840c25" parent="afec746e0eaa15b42d3cbd866edebf90" type="folder">15-20</container></did><accessrestrict id="d78727a12815fb45316cee4c1bb66369"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4536f53d88709a34f9764f238002f522" level="file"><did><unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="bb45604b663b6ab4a75dd1dbfefffb13" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="e79be95423ca7376a587fcc073671f40" parent="bb45604b663b6ab4a75dd1dbfefffb13" type="folder">1-4</container></did><accessrestrict id="3f564956f49faf84f827624973a86572"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8319ac1e74f3772c55f953d49d1fe802" level="file"><did><unittitle>TML - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="609f8e34b2d8efa0984b44ee3577c530" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="26e97aa75bad8f2bb38bdc7e4766a836" parent="609f8e34b2d8efa0984b44ee3577c530" type="folder">5-8</container></did><accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c61123a9a767eb2a2f0665b7e710f056" level="file"><did><unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="395e96b72260e8998b4ec8c24253d446" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="2e4b2ebd9dd7f09a83e8cf986a4723a3" parent="395e96b72260e8998b4ec8c24253d446" type="folder">9-11</container></did><accessrestrict id="96d0a14409c624606417824206c572f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file"><did><unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle><unitdate type="inclusive">2002 July 8</unitdate><container altrender="Record Storage Box (Paige)" id="189e2b42e897a4c1aac58352d3692224" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="b78e1767c530d82ec6285cd571c79058" parent="189e2b42e897a4c1aac58352d3692224" type="folder">12-16</container></did><accessrestrict id="049b266831555277c80bf92411b09f0b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file"><did><unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="7e84d59cbe98e10929fdb5f8051d1a99" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="ce178e6214b61047851e3c1918aaa03f" parent="7e84d59cbe98e10929fdb5f8051d1a99" type="folder">17-19</container></did><accessrestrict id="6b6e7ca2998642d620f912e4ae273e58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="702df7b3933e28f25249b7010b1efc23" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1d0724cf767d7c19796e95626eac02e6" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="9d0a3cb5f3f354e123bb958bd644593e" parent="1d0724cf767d7c19796e95626eac02e6" type="folder">20</container></did><accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="4d55a08c108da57f44493e47168de204" label="Mixed Materials [A0000000075919]" type="box">77</container><container id="ce4aee841908ab4b8f3b5f01dca9af2c" parent="4d55a08c108da57f44493e47168de204" type="folder">21</container></did><accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="3238875c71befee0c843bfb578b0af6f" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="99a8d9918cccc337d016c3ebd97136f8" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="ea573b009644fd634af59ebae5732607" parent="99a8d9918cccc337d016c3ebd97136f8" type="folder">1-3</container></did><accessrestrict id="f07baa851539686de763d2f786c2177e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0f73f901dbd4ead91b01d80ceed67c30" level="file"><did><unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="e296fbd5ecf07e3af14b0f26fcc75cf7" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="c7888b462616980fd290e99991913cf0" parent="e296fbd5ecf07e3af14b0f26fcc75cf7" type="folder">4-6</container></did><accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="23ee674858aa228c8597cb11a5363b5d" level="file"><did><unittitle>TML, 44-33 - Advice for travelers</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="5b5a68ed4b5eff2be2673ac3ee994d9d" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="b20ef2e924fc5d52c1ca31f44e4eeb27" parent="5b5a68ed4b5eff2be2673ac3ee994d9d" type="folder">7-9</container></did><accessrestrict id="687d9c16855007cc90b89408873e9116"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c3ff86733b644974c019ea29b403f49f" level="file"><did><unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="8169b7089ad7ffe5cfa5ee598608a822" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="335330a08fccc6edd1380881ddb8e2a4" parent="8169b7089ad7ffe5cfa5ee598608a822" type="folder">10-11</container></did><accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="24af9a9128ef19b87942303f71c93a4b" level="file"><did><unittitle>TML, 44-91 - Acetaminophen safety</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="d76329c961322f91a4d3ba917c56f6f4" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="a1a57811bd8ceaafab38af8f7788bea3" parent="d76329c961322f91a4d3ba917c56f6f4" type="folder">12-16</container></did><accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="ef1e6a8df97f381947f0780fcf16db5a" label="Mixed Materials [A0000000075920]" type="box">78</container><container id="e6e2204652f8d841d15f90a5fc0e5e43" parent="ef1e6a8df97f381947f0780fcf16db5a" type="folder">17-19</container></did><accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8104e8da1a3aff8455ce0008f38fee5a" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="3963f1bef1b9073b0d78a03c4b05ae40" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="f412832a7783a083663ba529c7e447b3" parent="3963f1bef1b9073b0d78a03c4b05ae40" type="folder">1-2</container></did><accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="02479e2c1173076c05f34aa17007ba49" level="file"><did><unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle><unitdate type="inclusive">2002 March 4</unitdate><container altrender="Record Storage Box (Paige)" id="0f180dc2a6d002dd74afa55ffd59884f" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="300447cce1dacae4e07f7c64a8ddad86" parent="0f180dc2a6d002dd74afa55ffd59884f" type="folder">3-6</container></did><accessrestrict id="c95f7f827b4be73752d104280c14ae0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d1098818233489d81f3ee9a35c491fda" level="file"><did><unittitle>TML, 44-71 - Tests for drug abuse</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="8d2d7ead998f67b4034fad8c487ca720" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="47b872a900603d60a7b32e264cb83be8" parent="8d2d7ead998f67b4034fad8c487ca720" type="folder">7-10</container></did><accessrestrict id="6b5deed194656d7a78e4584eaf23da1c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a2d97df9926c22348169dc85fc2da466" level="file"><did><unittitle>TML, 44-82 - Accutane</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="77fe58a7fb3f4809593bb045cf5c8bf9" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="b4da398e2e1f561425aa14e8a3bb2a02" parent="77fe58a7fb3f4809593bb045cf5c8bf9" type="folder">11-12</container></did><accessrestrict id="811a73112a0f3db0c61460c6f50c3a83"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="77f6dda8f57e4d024c751d9255cb8084" level="file"><did><unittitle>TML, 44-50 - Spinal Manipulation</unittitle><unitdate type="inclusive">2002 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="e81cbd210687ca80f28d91b2ad115a72" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="a2a078da7d0be8dd0553d0a461d58964" parent="e81cbd210687ca80f28d91b2ad115a72" type="folder">13-15</container></did><accessrestrict id="c6a5678b6a97ed4390bd98a720535a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="9c78e8a3a064e7ca61e5777b69076479" label="Mixed Materials [A0000000075921]" type="box">79</container><container id="46f3b8a21beaf2882895d5b8b72f1772" parent="9c78e8a3a064e7ca61e5777b69076479" type="folder">16-17</container></did><accessrestrict id="1fde5116b8525bf37872775d4c998b9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2af7784d4333e1386ceb5387b0141573" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="6efbae2b0e33eb98d9b7544d3ba45bf1" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="ef1f344cf00b07e328fea6de0921da90" parent="6efbae2b0e33eb98d9b7544d3ba45bf1" type="folder">1-2</container></did><accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45b86f5c46903225f479639e02061c91" level="file"><did><unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="4876a193ff9c15694e91a627c3842172" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="66fd5160bebb278a2cd1d848fd91b219" parent="4876a193ff9c15694e91a627c3842172" type="folder">3-7</container></did><accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file"><did><unittitle>TML, 44-78 - Hormone replacement therapy</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="5540710126fffd75e43b3d20a01e410f" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="1d07ee3d9c0c2309b09fb7e7ca3db73c" parent="5540710126fffd75e43b3d20a01e410f" type="folder">8-9</container></did><accessrestrict id="25fbac45d92806e8263c700a8600b817"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="79ecc959704f5a99033f6383c71d5e2b" level="file"><did><unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="dbbdf1249645919b0757af517074a04b" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="16e06f91c1c3079bdfbec7416c88ef3f" parent="dbbdf1249645919b0757af517074a04b" type="folder">10-12</container></did><accessrestrict id="c218a513a6535a5ceb72241f53f1083c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file"><did><unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="85066bb7c607ab76e9a00650629c6cf7" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="8f34ad2c082b49022512142e7da5c4e2" parent="85066bb7c607ab76e9a00650629c6cf7" type="folder">13-14</container></did><accessrestrict id="daa9fc43588271721e9668e6387b1ecc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9cf28c7502d38a3253794dc0aff81d12" level="file"><did><unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="9284f598a6b529aa4e20fca50579ee99" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="7d7e182c051147823fa0a8f34da09762" parent="9284f598a6b529aa4e20fca50579ee99" type="folder">15-16</container></did><accessrestrict id="9343665bbaab14cdc391de9fbda39aab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="037a4523e063f09b403c4b86b056b0b9" level="file"><did><unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="1fe2917465538c36a49b6acd68923449" label="Mixed Materials [A0000000075922]" type="box">80</container><container id="d637a9fa606ae1082c27e0a1e39d113f" parent="1fe2917465538c36a49b6acd68923449" type="folder">17-19</container></did><accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file"><did><unittitle>TML, 44-96 - Rasburicase</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="cfb5791f884fde676664831303aed830" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="fec31e65a2bba4ce6d9b027724e2c1bb" parent="cfb5791f884fde676664831303aed830" type="folder">1-2</container></did><accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file"><did><unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="d879fa47f1d9fd479b22321cc2690abf" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="85e56664137fb6a181a1447fce02844a" parent="d879fa47f1d9fd479b22321cc2690abf" type="folder">3-6</container></did><accessrestrict id="de5073ebce08ff223cdc3bac4b44096d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="cd35b74adb66fbee3caa77d502914319" level="file"><did><unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="9d4a600d5743e5a313c30cec2d9b7637" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="68bc10a2207f483a00b4bee9f1d3fb85" parent="9d4a600d5743e5a313c30cec2d9b7637" type="folder">7-9</container></did><accessrestrict id="44a756d7626a6484624c170f3c9fe601"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file"><did><unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="d79a4d2fe1d2871cf6a735163ded96e1" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="c3085301f0bb31e86325c4b57fbb49c3" parent="d79a4d2fe1d2871cf6a735163ded96e1" type="folder">10-13</container></did><accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0cdc8024ee854934a00a2e6cc658127c" level="file"><did><unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="83b22532421a3ecc8b4a412bacec6a76" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="8863abcec19122bdba7730f22234f425" parent="83b22532421a3ecc8b4a412bacec6a76" type="folder">14-15</container></did><accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6373e1ea574b03380381b604f8f317ea" level="file"><did><unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="1545bed0535f25c24e429e98632ed908" label="Mixed Materials [A0000000075923]" type="box">81</container><container id="a4834f33aa547de7572c2512716db06f" parent="1545bed0535f25c24e429e98632ed908" type="folder">16-17</container></did><accessrestrict id="c8982cc8907e5273994dc146b1a74168"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file"><did><unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="31bea3352936a4d8e0b3ed6e27d844e0" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="b378b5214b6d66a6422e3870e07caf33" parent="31bea3352936a4d8e0b3ed6e27d844e0" type="folder">1-3</container></did><accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file"><did><unittitle>TML, 44-27 - Desloratadine</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="06b7ba7869faf2d10a8a91deb1a8397f" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="584a4c2b17e188abf90fc92ac0333e8f" parent="06b7ba7869faf2d10a8a91deb1a8397f" type="folder">4-6</container></did><accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b7991b9a56fe105d30e6587c04553698" level="file"><did><unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="a94a322f1eb5a7a9abadd989ddb5df87" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="53c8d900e11377f5e5203c41f0e28bf2" parent="a94a322f1eb5a7a9abadd989ddb5df87" type="folder">7-8</container></did><accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="e886d7140f04a51e798f5685595d8a64" level="file"><did><unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="9fba3bafd2009bb57ebbe14df2837e24" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="28a32c26a857ac7bc153b6d62de4fad5" parent="9fba3bafd2009bb57ebbe14df2837e24" type="folder">9-12</container></did><accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="455d2fc328328796d58ba48926cfc74c" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="42d443a9aa8e2923d883d7add93548b5" parent="455d2fc328328796d58ba48926cfc74c" type="folder">13-16</container></did><accessrestrict id="a1761f494a6aadd735240b5f6234da0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file"><did><unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="193e87504501a4cd6be3c1bb448ef77b" label="Mixed Materials [A0000000075924]" type="box">82</container><container id="419afaa2dbc1d2f2907177f9e9ff349c" parent="193e87504501a4cd6be3c1bb448ef77b" type="folder">17-19</container></did><accessrestrict id="a69e5af2889f08c295264781d0dc1080"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f777550cceb72905734014265970ba2d" level="file"><did><unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="b63a2150e389de00a0e0aa182113431f" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="2912c8f6f2afcbf00f268eb508397efd" parent="b63a2150e389de00a0e0aa182113431f" type="folder">1-3</container></did><accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="755a5cb278c5674c278d62217583d0dc" level="file"><did><unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="425d3e51d7e8be95512f275827107221" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="1adc0b59f8375661ab84f3d28b7b01c8" parent="425d3e51d7e8be95512f275827107221" type="folder">4-6</container></did><accessrestrict id="a72cbce0a6c64d80126a119167b5dc50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file"><did><unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="b78036208f777a9bd3852ea879d152ed" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="df942c9149602d619aee4d2ed34912b3" parent="b78036208f777a9bd3852ea879d152ed" type="folder">7</container></did><accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="32827b05df08c432fb2cbb3d952c316a" level="file"><did><unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle><unitdate type="inclusive">2003 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="f45d5df388820fd8f27c3b7c9fab20c2" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="d8b8a6ee3842dc83fa68780a9215b021" parent="f45d5df388820fd8f27c3b7c9fab20c2" type="folder">8-10</container></did><accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2dcb5260bf184933786c79514811276a" level="file"><did><unittitle>TML, 45-5 - Augmentin XR</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="3ad371d07e6d46bc087eae301d85b0df" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="18dd8a92853a82b18ff275484ce0326d" parent="3ad371d07e6d46bc087eae301d85b0df" type="folder">11-13</container></did><accessrestrict id="352c7f8bef5faa523d50be8830568d03"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="6719542efa0dd7e6ff2199fb0fc45784" level="file"><did><unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="765ff483462653f632baa330e62c6b7c" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="ca303b7ede9260c8b43b9f33df1eb1b5" parent="765ff483462653f632baa330e62c6b7c" type="folder">14-15</container></did><accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="face99254c656f96b64bf580e5f85bcf" level="file"><did><unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="68a67a9e634d3251dfb545fe3b2791b7" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="9144ce6f9620ee9bf10196291981df55" parent="68a67a9e634d3251dfb545fe3b2791b7" type="folder">16-18</container></did><accessrestrict id="5b737b9395121e3828a6f6fa407666da"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9ec231ed3611900061caae3128c95513" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="3d5dfa4446254e4e8151147fa9508bf1" label="Mixed Materials [A0000000075925]" type="box">83</container><container id="be110ba71dd01353adb09f6c9789ebcb" parent="3d5dfa4446254e4e8151147fa9508bf1" type="folder">19</container></did><accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c6404194bb02ecf2496bacd146a0cc60" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="1ebe970ef1d6234ef496fc58ac577843" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="45318ad2c2568003fd6e1535d9394a53" parent="1ebe970ef1d6234ef496fc58ac577843" type="folder">1-3</container></did><accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2ddbc741772355d7dce54b4b63ef6749" level="file"><did><unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="f16ad1e8e066c161520746c6d239ca4f" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="3d9fb213a4d10221142ea10cf2c30efe" parent="f16ad1e8e066c161520746c6d239ca4f" type="folder">4-5</container></did><accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0f45b082b3a08c7cce74229a00644b02" level="file"><did><unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="8809dae8e0e4dd081e44540da279408a" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="bec2952f1920144e39758e92669a7dcf" parent="8809dae8e0e4dd081e44540da279408a" type="folder">6-8</container></did><accessrestrict id="f517a35e209156fcce5cddbc43b68b14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="94948e6e42424f89ec840de91511a768" level="file"><did><unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="76628e508cc80062111ff04bbd8cb9b8" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="01f67c9b470e1b6951518565e799f9dc" parent="76628e508cc80062111ff04bbd8cb9b8" type="folder">9-11</container></did><accessrestrict id="a3551a188d335a0b903727fcd2a48fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="48f4b3c522fa705a3ae202735e45ac3b" level="file"><did><unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="745c35289c0cec6658ed4ded3e751326" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="2d55279037b5db2d9a9d08fb4b22f129" parent="745c35289c0cec6658ed4ded3e751326" type="folder">12-14</container></did><accessrestrict id="3229644ce53e8795f97a65d5d61f18e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="780d425bdbd53ceafd83133223d279a7" level="file"><did><unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="c4e82bfd4b98c8854da288ffbde14f75" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="379db21206120f50581ff158f61ce6cf" parent="c4e82bfd4b98c8854da288ffbde14f75" type="folder">15-18</container></did><accessrestrict id="12994eea68e1f09108df54e255ae8cff"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e27a4c127b0269848618ade1805962f" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="adf002cb60b26a19a6ed4c5bc56c7f95" label="Mixed Materials [A0000000075926]" type="box">84</container><container id="e4e350c7b968cf306fd5fc66aca04790" parent="adf002cb60b26a19a6ed4c5bc56c7f95" type="folder">19</container></did><accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="732aaf61ce82ace45c4354ea0038b752" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="ab7ed7b98b88ed52b274010516fd6b4f" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="c6044d21d9a12a963ff8894ffc7a29df" parent="ab7ed7b98b88ed52b274010516fd6b4f" type="folder">1-2</container></did><accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c4617feb74a721aa21a7112babed977f" level="file"><did><unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="b2a0f5e02724838ad870d7648727c4ca" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="8149c2cdeaab357869e1ae4b12dd8992" parent="b2a0f5e02724838ad870d7648727c4ca" type="folder">3-4</container></did><accessrestrict id="09ded828b852ae6c86297bc23c88adc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file"><did><unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="53724e1cb3dda08ee5d8aba27f4b1ae7" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="19d8048d312cf82969121b94f34e137b" parent="53724e1cb3dda08ee5d8aba27f4b1ae7" type="folder">5-8</container></did><accessrestrict id="9d74192e21e6502b4dff990dec4cbb50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file"><did><unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="d72efc6abb92d73652dac407eaab0c82" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="19a8d5c1fa07d0ff1b53bdb3f094fb21" parent="d72efc6abb92d73652dac407eaab0c82" type="folder">9-12</container></did><accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fdd62d893c6f422fd7c183e65efa7835" level="file"><did><unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="2a645c7b773d8e2a9ca800859023d473" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="2e1f1a44b0869f1ba11d6d2a0f6de788" parent="2a645c7b773d8e2a9ca800859023d473" type="folder">13-15</container></did><accessrestrict id="36610a7149adbc1f92cfdc7751128db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="35402d0a4356ba61f6f491a96f89217a" level="file"><did><unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle><unitdate type="inclusive">2013 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="e1191395c423fb5479a730831f4be546" label="Mixed Materials [A0000000075927]" type="box">85</container><container id="f8b2102c93a78f0bfa5dfacc7f0d9927" parent="e1191395c423fb5479a730831f4be546" type="folder">16-20</container></did><accessrestrict id="136a1315a2303fa111e5d01cb0517e7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file"><did><unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="5b862a550596e0df186126ba1975c30f" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="5ba590533f1cd98e59de6b22fe7f3546" parent="5b862a550596e0df186126ba1975c30f" type="folder">1-3</container></did><accessrestrict id="aab1089a7327f8fc78a2fc319190599a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file"><did><unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="d5a1ad7cc15aaa4917be0c767bd1ec32" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="18f729bd81d7e8c8b39babba37a199d5" parent="d5a1ad7cc15aaa4917be0c767bd1ec32" type="folder">4-6</container></did><accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="19fc064c09e3806caaddbb51b70e4090" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="14b2b034b8ca4ce5ad68b0874fb6efcc" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="636acc32d9cd06015dd6ba1ec58ab7ab" parent="14b2b034b8ca4ce5ad68b0874fb6efcc" type="folder">5A-6A</container></did><accessrestrict id="60b6213d43e89633056c4a067f8c54e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="9c43525145f1420684cd564de0ead256" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="148e58080be092860895a962506a3c36" parent="9c43525145f1420684cd564de0ead256" type="folder">7-9</container></did><accessrestrict id="7a45da012d9d8375ab9c62d057d20b13"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d1e93fdc68ebf64e073b0d53c908f073" level="file"><did><unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="1f9b1a0a7c15ba76f1564745ccbc29f5" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="806f2ba3c0d663eea553fe43075fbcb8" parent="1f9b1a0a7c15ba76f1564745ccbc29f5" type="folder">10-11</container></did><accessrestrict id="a187e298156d35ecb24bf62acbaa2162"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file"><did><unittitle>TML, 45-95 - Tattoo Removal</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="b53aa6c80d7d74098ab755f12a571dce" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="39502defc81144658443128720dc9826" parent="b53aa6c80d7d74098ab755f12a571dce" type="folder">12-13</container></did><accessrestrict id="1cb8774dfbec0195c1be0234b77205c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a857cbd537b23d5351b0c89499d70d8e" level="file"><did><unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="8a9dc32780c329241e8a96bfbf922db1" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="68dcb35850908e7e6a264983a46a34c6" parent="8a9dc32780c329241e8a96bfbf922db1" type="folder">14</container></did><accessrestrict id="4b2308536bb701384ee28edb8995985a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1ed11b7c73752bdb0689383a30c1baf5" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="1b24cc6367e3c094857838081b932063" label="Mixed Materials [A0000000075928]" type="box">86</container><container id="83b62de5074b84fa590452ad5bca10ad" parent="1b24cc6367e3c094857838081b932063" type="folder">15-16</container></did><accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c48f05a528d95bdfee4855de30cb54e2" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="00db15dcb917848a541e5f75e2fdebe4" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="b7fe0b15846ec4b99f74ae12c0b3ca3a" parent="00db15dcb917848a541e5f75e2fdebe4" type="folder">1</container></did><accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file"><did><unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="2e69c3901666a81db9e5834b7ca462fa" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="d68d693b5c5c41b8a114d76591dd69dc" parent="2e69c3901666a81db9e5834b7ca462fa" type="folder">2-4</container></did><accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7d40fbe976113721e79b64dd1d00e27d" level="file"><did><unittitle>TML, 45-3 - OTC Loratadine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="707bc95236181e39dd30c1b00b2f8aff" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="3b2466a2515e75939a6b26c0ef82ef9f" parent="707bc95236181e39dd30c1b00b2f8aff" type="folder">5</container></did><accessrestrict id="68d83db5324a44659c1dd3f51c2e2864"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1823eedc9d0074c8a4265ac61efdfda5" level="file"><did><unittitle>TML, 45-41 - Insect repellents</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="c30b374f052d589d127e2fb06ac3c2b3" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="90421ebd922aef2c3fe59ffabdf9270a" parent="c30b374f052d589d127e2fb06ac3c2b3" type="folder">6-8</container></did><accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2f3bcea3a484b983f63233e648e58d71" level="file"><did><unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="853522510f88dfccccbe39ff8e100ca9" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="eaee47fd3d7fd68990b170b6a730fe5c" parent="853522510f88dfccccbe39ff8e100ca9" type="folder">9-12</container></did><accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file"><did><unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="bee080cd83999f1b3b78b831c6ff2574" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="dfba1d83089769fe2c6693ca9051ebb4" parent="bee080cd83999f1b3b78b831c6ff2574" type="folder">13-15</container></did><accessrestrict id="68c074ca5c7b85d99e37109be8f03f26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file"><did><unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="ecd27226e262943dec3efe34ac58bfcd" label="Mixed Materials [A0000000075929]" type="box">87</container><container id="53a2bc01287d6818fb75576cdda755ac" parent="ecd27226e262943dec3efe34ac58bfcd" type="folder">16-18</container></did><accessrestrict id="349dea74056b705fe12a6e58b6be4a61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="11bdec471c430a38763f1ea9a86eab38" level="file"><did><unittitle>TML, 45-58 - Treatment of heat injury</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="f5365cb2076a93c963e070705e4bdf2a" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="eb9c80a50bce2d52b505530658ca5d80" parent="f5365cb2076a93c963e070705e4bdf2a" type="folder">1-2</container></did><accessrestrict id="b32e89185eafe8ec72db09448de5ce28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="806d8942533d66de734e65e88b3304ee" level="file"><did><unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="0066b91d3565b22ed29f9e345405f730" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="1fae7f95db4a71f6f979d868d6109f10" parent="0066b91d3565b22ed29f9e345405f730" type="folder">3-6</container></did><accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="04dee614a81cacb32c43ef5b0a88af03" level="file"><did><unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="0f269d497b5756293fb1deb2ef13a5da" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="c0f923409abe375ae6dec12432da78a0" parent="0f269d497b5756293fb1deb2ef13a5da" type="folder">7-8</container></did><accessrestrict id="b53a56596e6cd54c520d93ec764edd68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9233509af152396c7a0be4f4a4690cec" level="file"><did><unittitle>TML, 45-46 - Drug Interactions</unittitle><unitdate type="inclusive">2003 June 9</unitdate><container altrender="Record Storage Box (Paige)" id="0f39d764f72c2e5c7ec01b13aa0371e7" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="6daaa898a8d9a4cdf8afa89a102a4b37" parent="0f39d764f72c2e5c7ec01b13aa0371e7" type="folder">9-12</container></did><accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="95a2b9eb73be12648888070a03ead474" level="file"><did><unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="f0e387672a6110f87f654f59bf12bdbd" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="1fa20f2abb75a31ba207b7c8ec1ab88f" parent="f0e387672a6110f87f654f59bf12bdbd" type="folder">13-17</container></did><accessrestrict id="150bc9e4636bdbb6ef444d31120758f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dad27947e40b662edd3cc5a90a0be625" level="file"><did><unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="66b331ce930c8fdcd8876f75219ae6f6" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="3b5bf729c21e59d6498c8060e94d671e" parent="66b331ce930c8fdcd8876f75219ae6f6" type="folder">18-19</container></did><accessrestrict id="7bacb749d5cace7b77c6d20686088469"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e617e6eea5f9996628c705dd200e1ffa" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="86e975d45a525885aadb12c4505237e6" label="Mixed Materials [A0000000075930]" type="box">88</container><container id="4fe95e3930a7e5164d9ca84973cd85b3" parent="86e975d45a525885aadb12c4505237e6" type="folder">20</container></did><accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="dc9a4da27813863ae8f835d75f9e65d3" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="c73873c5fe09ab8af4e144f130207256" parent="dc9a4da27813863ae8f835d75f9e65d3" type="folder">1-4</container></did><accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="edaf8bc319227fe95dce9ce1973f3621" level="file"><did><unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="c33e53584ec03d033151d0d7c2b6f30d" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="ee90a8f105f1870e45c4a06482d91533" parent="c33e53584ec03d033151d0d7c2b6f30d" type="folder">5-9</container></did><accessrestrict id="a9e5f083314a82f3692a841eac51a5ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f8dc69e4bf109c9986cc722051633070" level="file"><did><unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="e8dcb2da0ee9095e4f459f00297b47f6" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="1b67273047cb195096680f9ceb8a463f" parent="e8dcb2da0ee9095e4f459f00297b47f6" type="folder">10-11</container></did><accessrestrict id="e59f218612780c21cd1831f3c38ec08e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="cc9f06be346fedef1f6102477bee9cb2" level="file"><did><unittitle>TML, 45-78 - Influenza Prevention</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="1f6cd14d3b6bcd5313985c9f7e134f51" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="d0ecb3634722e531ed9538770387310c" parent="1f6cd14d3b6bcd5313985c9f7e134f51" type="folder">12-14</container></did><accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="39d9d76dedec7d6057d3eb65d8744ded" level="file"><did><unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="055b7fa19320f4364d0c1a4f8c883440" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="4ccc487c150df854146420261f448763" parent="055b7fa19320f4364d0c1a4f8c883440" type="folder">15-16</container></did><accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file"><did><unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="ea63a9a29b8d4293edd935c24b26be28" label="Mixed Materials [A0000000075931]" type="box">89</container><container id="6c900ceffc79e3bbec6eb11001f96ceb" parent="ea63a9a29b8d4293edd935c24b26be28" type="folder">17-20</container></did><accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e809ce901af88811ad1fd0cb5bc5882c" level="file"><did><unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="0b07adbc4fbf112379dcb26b76ed5236" label="Mixed Materials [A0000000075932]" type="box">90</container><container id="3982543227a2a495fa4b9717568ba6ee" parent="0b07adbc4fbf112379dcb26b76ed5236" type="folder">1-4</container></did><accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="acd944256fa6e191f50b1c636b7b7bf4" level="file"><did><unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="82baaa16eb604ee053f20ba8d041df54" label="Mixed Materials [A0000000075932]" type="box">90</container><container id="b77387aa69895943741e3048e39ee6b8" parent="82baaa16eb604ee053f20ba8d041df54" type="folder">5-8</container></did><accessrestrict id="56655a641344d4055a005097ec27c5cb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file"><did><unittitle>TML, 45-1 - Smallpox vaccine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="a6da625ebc14eed449134e1a0b92a6da" label="Mixed Materials [A0000000075932]" type="box">90</container><container id="32d96a36cd31728209e649605cf78636" parent="a6da625ebc14eed449134e1a0b92a6da" type="folder">9-12</container></did><accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d9642438ec124cd82d8e135b0198ede7" level="file"><did><unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="172a74722a6cf5fe5e028b3e1d8f3a9b" label="Mixed Materials [A0000000075932]" type="box">90</container><container id="3c93dab0800f74d62c87042fb143860c" parent="172a74722a6cf5fe5e028b3e1d8f3a9b" type="folder">13-16</container></did><accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="e2bb75c2ec558e375b2ed8ee0cb117d4" label="Mixed Materials [A0000000075932]" type="box">90</container><container id="7ac17bca6b738c8c0af7d1b8ceae8adb" parent="e2bb75c2ec558e375b2ed8ee0cb117d4" type="folder">17-19</container></did><accessrestrict id="91472bcb765db5980f76960bca69f7bb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="6293bb7a968aeb668a4e49baac370e51" label="Mixed Materials [A0000000075933]" type="box">91</container><container id="e46ca2809c8cc76973a685540e071c21" parent="6293bb7a968aeb668a4e49baac370e51" type="folder">1</container></did><accessrestrict id="ad37cdcd99a2044624e749e1cd39779d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f9a9c4fc1896553a888be142b1758016" level="file"><did><unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle><unitdate type="inclusive">2003 August 4</unitdate><container altrender="Record Storage Box (Paige)" id="b5fbc8564dcff3991936dcb3fb659cd9" label="Mixed Materials [A0000000075933]" type="box">91</container><container id="c0bb23c3a55bd6f299a61ff39304e333" parent="b5fbc8564dcff3991936dcb3fb659cd9" type="folder">2-3</container></did><accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="839fb8691411f959bd1aac5c4ebf7d26" level="file"><did><unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="4b5b659d94443127232783357a8ed285" label="Mixed Materials [A0000000075933]" type="box">91</container><container id="9862e5ad68c491c18fc1ccdc7689acd5" parent="4b5b659d94443127232783357a8ed285" type="folder">4-5</container></did><accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="55365ce4b3ea2d58db64e9416965cb4e" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="de1f0fdc4c4ded1db3384cee741d2789" label="Mixed Materials [A0000000075933]" type="box">91</container><container id="b2217c95e4166b4d25535ac04c6ac96e" parent="de1f0fdc4c4ded1db3384cee741d2789" type="folder">6-17</container></did><accessrestrict id="0ed20f41fac45d1a638a3740752cb703"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="668d7e7e07b5750eb2c823e11c095964" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="08460d7fadd818237960227966217b0b" label="Mixed Materials [A0000000075934]" type="box">92</container><container id="55b9b13e91930f5cb4f04e7b02868eb1" parent="08460d7fadd818237960227966217b0b" type="folder">1-4</container></did><accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file"><did><unittitle>TML - Weight Loss - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 December</unitdate><container altrender="Record Storage Box (Paige)" id="12b4683bc762a6718ffb3089413fa51c" label="Mixed Materials [A0000000075934]" type="box">92</container><container id="075e6bbeafe6fd578ded364544bb609e" parent="12b4683bc762a6718ffb3089413fa51c" type="folder">5-13</container></did><accessrestrict id="6dd9eece4a3c89e40bca2442781a600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ee60c4bf66a25475983425024da14c39" level="file"><did><unittitle>TML - Heart Failure - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 April</unitdate><container altrender="Record Storage Box (Paige)" id="4b5d2baebd5f3dffdaec2c55d7ce8f2c" label="Mixed Materials [A0000000075934]" type="box">92</container><container id="a17f4a9b49cf470f123f0a3d2286ae89" parent="4b5d2baebd5f3dffdaec2c55d7ce8f2c" type="folder">14-18</container></did><accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file"><did><unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="a9fd9fc6b03e709a39be9daa3201a81a" label="Mixed Materials [A0000000075935]" type="box">93</container><container id="53db31030d01e86fd3a888c3d6a6966b" parent="a9fd9fc6b03e709a39be9daa3201a81a" type="folder">1-7</container></did><accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c0978c508033828e366f1d55950a308e" level="file"><did><unittitle>TML - Drugs for Psychiatric Disorders</unittitle><unitdate type="inclusive">2003 July</unitdate><container altrender="Record Storage Box (Paige)" id="2fa3dcec5b6f8c9bf033fa629570ee81" label="Mixed Materials [A0000000075935]" type="box">93</container><container id="9df0d1f82393d33123421695badf4936" parent="2fa3dcec5b6f8c9bf033fa629570ee81" type="folder">8-18</container></did><accessrestrict id="03781a219ff982acf63e0290b3b87f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a9906d72f32382fa1bb39c1ccd388091" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="c6910f58ac2daad64a2066c2976bc210" label="Mixed Materials [A0000000075935]" type="box">93</container><container id="bdb310194bb4985c32965c7238e8f4b1" parent="c6910f58ac2daad64a2066c2976bc210" type="folder">19</container></did><accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="5acb370a1381e28ba37f8bb84411c2a1" label="Mixed Materials [A0000000075936]" type="box">94</container><container id="c927b3739981fb33c5c87d28705dcad2" parent="5acb370a1381e28ba37f8bb84411c2a1" type="folder">1-4</container></did><accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="380c664090534851fbc806e0558fde2f" level="file"><did><unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 October</unitdate><container altrender="Record Storage Box (Paige)" id="1b128050057b4c981f8d5e8c24740ec2" label="Mixed Materials [A0000000075936]" type="box">94</container><container id="27130be4bd536dc3ebbc6acf75489d5c" parent="1b128050057b4c981f8d5e8c24740ec2" type="folder">5-13</container></did><accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dfe820ca0d9eb165533f652cbc41ee32" level="file"><did><unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 February</unitdate><container altrender="Record Storage Box (Paige)" id="3f1119014688311e9d0bd3a76db0944e" label="Mixed Materials [A0000000075936]" type="box">94</container><container id="2623ba0008062f8104b175380c7a2e46" parent="3f1119014688311e9d0bd3a76db0944e" type="folder">14-17</container></did><accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3ce9ce08c457fba44042e2deea5066f7" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="c7a1185b46471ced83ed814355be5905" label="Mixed Materials [A0000000075936]" type="box">94</container><container id="f61bbce20bccd72704e5346a5bde4489" parent="c7a1185b46471ced83ed814355be5905" type="folder">18</container></did><accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d475b54c5095880adce7b8263966fe2d" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="72b95dc523b53dc83f07fa2c52be2091" label="Mixed Materials [A0000000075937]" type="box">95</container><container id="21bb45c67f3950df5bbb30a17566f082" parent="72b95dc523b53dc83f07fa2c52be2091" type="folder">1-8</container></did><accessrestrict id="d727ecc0d3636f553591f418559bc721"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file"><did><unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 May</unitdate><container altrender="Record Storage Box (Paige)" id="8acb62059e078d9601421e0720a1526d" label="Mixed Materials [A0000000075937]" type="box">95</container><container id="4ea387d96eb1beb515bb2db694e9ce45" parent="8acb62059e078d9601421e0720a1526d" type="folder">9-14</container></did><accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file"><did><unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 August</unitdate><container altrender="Record Storage Box (Paige)" id="11ef8e8ad4ee32b302797ccbaff81af7" label="Mixed Materials [A0000000075937]" type="box">95</container><container id="d54ae4b8c490f03a255a4a5e540064ad" parent="11ef8e8ad4ee32b302797ccbaff81af7" type="folder">15-18</container></did><accessrestrict id="334e64660b4fc298f4d1c26e9a76a343"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="ca57b6e25abf53c54ee091286d238b70" label="Mixed Materials [A0000000075937]" type="box">95</container><container id="92b2bc3d9c379071a0ae71df3012474b" parent="ca57b6e25abf53c54ee091286d238b70" type="folder">19</container></did><accessrestrict id="7cdf942787e0cbed8326189a2020f299"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ddf6b73987ce0637989f66584610c6ea" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="46e6a531d03610dce08d33a780c09e7f" label="Mixed Materials [A0000000075938]" type="box">96</container><container id="a506de2ba671b99c7a6ee38bae9a26f7" parent="46e6a531d03610dce08d33a780c09e7f" type="folder">1</container></did><accessrestrict id="2b960cecbba771988110df8a9cd33742"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file"><did><unittitle>TML, 45-93 - Which SSRI</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="5a602fbba750e5a1f23c45b4b8764b46" label="Mixed Materials [A0000000075938]" type="box">96</container><container id="03ea8ce5ef7e3dd3b4cd7d701feb7b31" parent="5a602fbba750e5a1f23c45b4b8764b46" type="folder">2-5</container></did><accessrestrict id="72e10bfbf01df945876de61f8480a08b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1e5a72f232d4e116685aff32e9ed9f87" level="file"><did><unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 November</unitdate><container altrender="Record Storage Box (Paige)" id="a35819d6c62b4285c32d061d4212663f" label="Mixed Materials [A0000000075938]" type="box">96</container><container id="de0a8e583b9aca9b97c823803ceb337f" parent="a35819d6c62b4285c32d061d4212663f" type="folder">6-9</container></did><accessrestrict id="ce922dcf8bde445758a34a54106e0ec6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7621ca9e85272fb03e367f6102650bf9" level="file"><did><unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 September</unitdate><container altrender="Record Storage Box (Paige)" id="9d1bac34a266f69248906be4da3b3a5a" label="Mixed Materials [A0000000075938]" type="box">96</container><container id="9c6af7f6612e787a7d03331d809b6680" parent="9d1bac34a266f69248906be4da3b3a5a" type="folder">10-17</container></did><accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="68e729c691bb49c8be35f332fbb1e32b" level="file"><did><unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="3e9c3c9d9a0f579e076edf7e4b9925df" label="Mixed Materials [A0000000075939]" type="box">97</container><container id="ae35f915900fea8d52ff11fe6a0c16b7" parent="3e9c3c9d9a0f579e076edf7e4b9925df" type="folder">1-10</container></did><accessrestrict id="084a4278da0f4581918db07f8eb825b4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="07f19737b5f6d3009e9e85a8b0528533" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="6db4cd19eb00a0421f37ec24ce702138" label="Mixed Materials [A0000000075939]" type="box">97</container><container id="e7237265c1f6ab190ceb385cea8f00bf" parent="6db4cd19eb00a0421f37ec24ce702138" type="folder">11-18</container></did><accessrestrict id="8f26a61c71898392ee05f246c39c61b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="c099bb967206188345dcdbf9c2975e6d" level="file"><did><unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="615feb2a3ee51d1fc4d16589894d3e70" label="Mixed Materials [A0000000075940]" type="box">98</container><container id="ef0c26b27cf9257086f429af7f770609" parent="615feb2a3ee51d1fc4d16589894d3e70" type="folder">1-9</container></did><accessrestrict id="e0b7814bc924716eb27275e9522cf9ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="237497500e700200226282634e319af9" level="file"><did><unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="31d11d7bc2c60481d1283c2738a9e29e" label="Mixed Materials [A0000000075940]" type="box">98</container><container id="cc8a9635a43be347efb6705ccec54f70" parent="31d11d7bc2c60481d1283c2738a9e29e" type="folder">10-15</container></did><accessrestrict id="00d75b64dab2398628516bc88ce53406"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="423b8c383be805c9a485a8fecfe9ddb1" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="280325bc014475c9aa7e25c448278323" label="Mixed Materials [A0000000075940]" type="box">98</container><container id="39f2eefc1a29cf4367d2bc9d1af5ee92" parent="280325bc014475c9aa7e25c448278323" type="folder">16</container></did><accessrestrict id="98f8b37e529ccb193a51c645e7d19af9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="26700edc7d4dff9bb83e29c005e8dedd" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="6f6677780abcc789b8c39692b3e621da" label="Mixed Materials [A0000000075941]" type="box">99</container><container id="4d02ba2c037fe12af791ed5e06e14d4b" parent="6f6677780abcc789b8c39692b3e621da" type="folder">1-5</container></did><accessrestrict id="ff906c4305f7b289ec47141f34c41d10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file"><did><unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 October</unitdate><container altrender="Record Storage Box (Paige)" id="6e40f694726fbce6d033d966b8e9ec40" label="Mixed Materials [A0000000075941]" type="box">99</container><container id="35e0e60772cd9ee397b95bdb67095a3e" parent="6e40f694726fbce6d033d966b8e9ec40" type="folder">6-12</container></did><accessrestrict id="6db6900a0738aa418a1db1239ba995f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="ef8b77a4a9168df66dbaa1d35328f051" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="ef70cb0d58dc0aa2effc1a8550fed3e7" label="Mixed Materials [A0000000075941]" type="box">99</container><container id="dff40c9bd753595c9a91b184aed021b9" parent="ef70cb0d58dc0aa2effc1a8550fed3e7" type="folder">13-18</container></did><accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="4122c98e47eb1d53ed958233e91ca5d6" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="24ad49f502cb921ac34fd825fc3b702b" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="076f8eef59b232ff4ef61167512e37ee" parent="24ad49f502cb921ac34fd825fc3b702b" type="folder">1-3</container></did><accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="1db0c21858cc9e616d5906c203e6860d" level="file"><did><unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle><unitdate type="inclusive">2004 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="53004b80e5fe4e2626a2d73f75d77594" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="caf04c50fe709ca1d2fc8bb995135808" parent="53004b80e5fe4e2626a2d73f75d77594" type="folder">4-5</container></did><accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file"><did><unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="868c4b74f13d5175ff13add2b1f01aa2" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="da398f233066f154856f213213fcda47" parent="868c4b74f13d5175ff13add2b1f01aa2" type="folder">6-8</container></did><accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file"><did><unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="f12ba5879abe213e774f749ff1f1fb00" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="20c269ea4735a8facd4f1af934f4bfd8" parent="f12ba5879abe213e774f749ff1f1fb00" type="folder">9-10</container></did><accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="9ea3892837eec8429d01fe1dc14e6b41" level="file"><did><unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle><unitdate type="inclusive">2004 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="c45057387f958d331533ccff7809ac04" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="eec24bd7f46b8f6e3f00187e24b45584" parent="c45057387f958d331533ccff7809ac04" type="folder">11-14</container></did><accessrestrict id="7815c3c9e1b402b4a02ed5022e168609"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1703fc66140060139d86d70ac0c3846" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="96976378faa1876ea9deffb4c23c5016" label="Mixed Materials [A0000000075942]" type="box">100</container><container id="7ebfd7cd649334a6ed13fa42f911ab2e" parent="96976378faa1876ea9deffb4c23c5016" type="folder">15-18</container></did><accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e8f33c13c32daa15598a2e144e9f900f" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="f9fe4184a3747d2a188f580115529ca2" label="Mixed Materials [A0000000075943]" type="box">101</container><container id="04805b10ef74a6124b3063b8798263d8" parent="f9fe4184a3747d2a188f580115529ca2" type="folder">1</container></did><accessrestrict id="81a1621d7a2a2452c30a530869fc9bea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1258ee39d7e2cce0fa124be57ed0634" level="file"><did><unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 March</unitdate><container altrender="Record Storage Box (Paige)" id="e85fd91c5edced33f499968da3c790f0" label="Mixed Materials [A0000000075943]" type="box">101</container><container id="a990c31790441d75499c5f2a1be5f4fa" parent="e85fd91c5edced33f499968da3c790f0" type="folder">2-8</container></did><accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="dcf6c003359f1d37afb6b89504a47763" level="file"><did><unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 February</unitdate><container altrender="Record Storage Box (Paige)" id="2000ac4d57d031cccdd99d7c63258c89" label="Mixed Materials [A0000000075943]" type="box">101</container><container id="233afa87ea4904528d91b8e04a732f7d" parent="2000ac4d57d031cccdd99d7c63258c89" type="folder">9-17</container></did><accessrestrict id="ee022307e7bb1d19942f259293477255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="565e58207d7c44ee5818fd9f15fde2f0" label="Mixed Materials [A0000000075943]" type="box">101</container><container id="38e8b5f7585195ef7749453f87d42b08" parent="565e58207d7c44ee5818fd9f15fde2f0" type="folder">18-19</container></did><accessrestrict id="cae76792326d54b966f74999980f0522"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="499346d5020cece037a74d774986c858" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="3e22a710d4997cd083964f3d2187fca2" label="Mixed Materials [A0000000075944]" type="box">102</container><container id="58bc50872fe60ea1c10dc11b0a8c47a5" parent="3e22a710d4997cd083964f3d2187fca2" type="folder">1-4</container></did><accessrestrict id="78b76f282a6087796d952eea7ca3851b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e2ff3268992aa759f09a842e60822ffb" level="file"><did><unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 July</unitdate><container altrender="Record Storage Box (Paige)" id="6eb6848803183dcb30cd2459f838212b" label="Mixed Materials [A0000000075944]" type="box">102</container><container id="abcf8be7808b7dffed9f4a289346a042" parent="6eb6848803183dcb30cd2459f838212b" type="folder">5-14</container></did><accessrestrict id="04e11af6b467a1e7c10d7574675c44fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c></dsc>
</archdesc>
</ead>
